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ABSTRACT 
THE ROLE OF THE EXTRACELLULAR MATRIX  
IN MEDIATING MUSCLE SORENESS 
FEBRUARY 2015 
KAREN L. RISKA, B.S., UNIVERSITY OF MINNESOTA DULUTH 
M.S., ST. CLOUD STATE UNIVERSITY 
Ph.D. UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Barry Braun 
The goal of this dissertation was to examine the role of the extracellular matrix 
(ECM) in muscle soreness. Study 1 examined how the disruption of the ECM from a 
minor surgery (e.g. muscle biopsy) affected muscle soreness. Study 1 showed that 
soreness levels increased at 24 h post-biopsy compared to baseline and resolved within 
96 h. However, the level of muscle soreness at 24 h post-biopsy (20 mm) was lower than 
that reported for performing a strenuous and naïve exercise (40–80 mm). These results 
will help review boards at institutions where muscle biopsies are performed understand 
how a muscle biopsy affects individuals. Additionally, these results will help 
investigators better articulate the effects of a muscle biopsy to a study volunteer. 
Study 2 examined the molecular changes of ECM molecules in response to a 
single and repeated bout of exercise. Muscle biopsies were analyzed from baseline, 24 h 
post-Bout 1, and 24 h post-Bout 2 using qRT-PCR, western blotting, and zymography 
techniques. In this study, eight individuals (4 men and 4 women) performed the 
exercise—descending 10 flights of stairs 15 times—and four individuals (2 men and 2 
women) were controls and did not exercise. The exercise and control group both had 
changes in gene expression and in one protein compared to baseline. However, no 
 ix 
 
 
differences were found for either group in zymography. These results indicate that gene 
expression is the prominent alteration ECM molecules in skeletal muscle at 24 h after 
eccentric exercise.  
Study 3 used microarray analysis to examine the difference in gene expression 
between individuals (n=30, men) who presented with high-soreness levels (n=5) 
compared to low-soreness levels (n=7) after eccentric exercise. Muscle biopsies for 
microarray analysis were collected from the exercised leg at 3 h post-exercise and the 
non-exercised leg served as control. The 546 genes differentially regulated were imported 
into Ingenuity Pathway Analysis, which created networks and allowed for the 
identification of the top 100 up- and down-regulated genes. Despite finding that the up-
regulated genes had more significant correlations and a greater number of genes with 
significant correlations compared to the down-regulated genes, these up-regulated genes 
were not more commonly found in one pathway compared to another. These results 
might suggest that the variability of muscle soreness after eccentric exercise is a 
consequence of the variability in the repair and adaptation of skeletal muscle after 
eccentric exercise.  
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1 
CHAPTER 1 
AIMS AND HYPOTHESES 
Introduction 
Many individuals develop muscle pain and soreness after leisure time or work-
related activities (e.g. snow shoveling and raking). On average, 6,000 individuals are 
treated each year for a musculoskeletal soft tissue injury at an emergency room because 
of snow shoveling (63). In the clinical setting, chronic soreness can be a side effect of 
medications (61), and/or an indicator of musculoskeletal (48) and connective tissue 
diseases (34). Muscle soreness has been studied by muscle physiologists since the early 
1900s (20), and it results from strenuous and naïve exercise involving muscle-
lengthening actions, known as eccentric actions, that place increased strain on muscle 
fibers. 
The underlying mechanisms of muscle soreness are not well understood, but 
inflammation and oxidative processes are thought to play a primary role in soreness 
development (5,7,10,13,21,30,37,40,50). Therefore, these two processes have been the 
main targets of research examining muscle soreness (3,35,41,44–47). This focus has 
resulted in numerous studies that tested various modalities aimed at reducing either 
inflammation or oxidative-stress processes (e.g. stretching, ice, vibration, supplements, 
vitamins, NSAIDs, and varying exercise load) (15–17,42,55). However, the biochemical 
and functional results of these studies have not demonstrated that the anti-inflammatory 
or antioxidant modalities were able to counter the muscle soreness development found 
after a bout of eccentric exercise (1,2,4,8,19,24,54,55,58,66). Despite these studies using 
anti-oxidative and/or anti-inflammatory modalities, none of these studies have had an 
  
 
 
2 
effect on muscle soreness and inflammation or oxidative stress markers after eccentric 
exercise (1,2,8,58–60). Thus, it is likely that the underlying causes of muscle soreness 
development include additional pathways and processes that are aside from or in addition 
to inflammation and oxidative processes that reside within skeletal muscle. 
Muscle soreness is the result of damage to skeletal muscle from strenuous 
exercise, especially exercises involving eccentric muscle actions that place increased 
strain on muscle fibers (14,28,36). Damage is evidenced by analysis of muscle biopsy 
samples (20,31,38,39), which has been primarily focused of intracellular components 
such as myofibrillar and cytoskeletal proteins (29,31,67). This focus has produced an 
informative but limited view of the changes that occur to the skeletal muscle after 
eccentric exercise. Skeletal muscle is confined within an intricate and highly organized 
lattice of fibrous and non-fibrous proteins (27,49,53). This lattice network, also known as 
the extracellular matrix (ECM), has received little attention, and its role in the adaptive 
response to eccentric exercise is largely unknown.  
The ECM of skeletal muscle maintains functional integrity of the muscle fiber and 
provides structural support (27). The ECM surrounds individual muscle cells, bundles of 
these cells (a fascicle), and finally around bundles of fascicles (49,53). The location and 
architecture of the ECM provides a scaffold for vessels and nerve fibers that serve 
skeletal muscle (49,53).The quality and architecture of the ECM can be affected by 
mechanical stress and the magnitude of that stress (26). Because the ECM is sensitive to 
mechanical stress, increased or decreased stress to the ECM would likely transfer to 
components that interact with the ECM (e.g. the cytoskeleton via dystrophin-associated 
glycoprotein complex and integrin α7 β1) (62). Because damage to these components 
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would likely be involved in the muscle soreness development process, the primary goal 
of this dissertation was to examine the role of changes to the skeletal muscle ECM in the 
development of muscle soreness. 
The focus of the studies described in this dissertation was to examine the 
development of muscle soreness and its relationship to events (e.g. muscle biopsies and 
eccentric exercise) that disrupt the ECM. Sample size estimates were used to determine 
the number of individuals needed to detect a difference between soreness levels among 
bouts/muscle biopsies and mRNA and protein levels (Appendix A). I approached the 
examination of the ECM and its relationship with muscle soreness in three ways. First, I 
used questionnaires and visual analog scales to examine affective and sensory levels of 
muscle soreness before and after muscle biopsies, eccentric exercise bouts, or eccentric 
exercise and muscle biopsies; physical activity was also measured to determine if 
biopsies or eccentric exercise and their resultant soreness affected physical activity levels. 
Second, I sought to examine the molecular alterations (e.g. gene and protein expression) 
of ECM molecules after a single and a second bout of eccentric exercise. Finally, I used a 
systems approach to identify novel genes in high-soreness responders that were either up- 
or down-regulated when compared to the genes of low-soreness responders after a single 
bout of exercise.  
The first aim of the dissertation was to compare the effects of a single and 
repeated muscle biopsy on muscle soreness to a single and repeated bout of eccentric 
exercise. Because the muscle biopsy procedure affects the ECM, my first goal was to 
determine if the muscle soreness after a single muscle biopsy was similar to muscle 
soreness after a single bout of exercise. If muscle soreness levels after a muscle biopsy 
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are the same or greater than the level of muscle soreness after eccentric exercise, then the 
examination of molecular factors underlying the delayed onset of muscle soreness 
(DOMS) after eccentric exercise would be moot. To compare the soreness level after a 
single muscle biopsy to a bout of eccentric exercise, I measured in Study 1 the levels of 
muscle soreness after a biopsy and the levels of muscles soreness after a bout of eccentric 
exercise at 24 h after the events (e.g. biopsy or exercise). I found that muscle soreness 
was increased by 23% after a biopsy and 40% after eccentric exercise. We had reported 
previously in our lab a 40–80% increase of peak soreness at 24 h post-eccentric exercise 
(21,23). Additionally, physical activity monitors showed that the muscle biopsy did not 
significantly change the physical activity levels (sedentary, light, moderate, and vigorous) 
from the baseline activity level. A repeated muscle biopsy resulted in an 18% muscle 
soreness increase compared to a 23% increase after a repeated bout of eccentric exercise. 
In conclusion, muscle soreness after single and repeated muscle biopsies was less than 
single or repeated bouts of eccentric exercise. Because the soreness levels after biopsies 
were significantly lower than soreness levels reported for eccentric exercise (6,22). I 
became curious about differences in the ECM that could help explain these two soreness 
responses.  
The second aim of this dissertation was to examine the effects of a single and 
repeated muscle biopsy and eccentric exercise bout to changes in gene and protein 
products of the ECM. Because DOMS is “less severe” after a second bout of exercise, 
examining gene and protein expression between Bout 1 and Bout 2 would provide a 
better understanding of the relationship between the ECM molecules and DOMS. The 
adaptation process of skeletal muscle is evident by 120 h post-exercise (12), but it is 
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possible this adaptation could begin much earlier (48 h post-exercise) (56). At present, 
only one study has investigated changes in the ECM molecules after a repeated bout (32), 
but Mackey et al. (32) electrically stimulated (eSTIM) the muscle to perform the 
eccentric exercise. One of the hallmarks of the “repeated bout effect” is the reduction in 
DOMS, and the eSTIM exercise model did not find a reduction in DOMS after a second 
bout eSTIM (32). 
Previous examinations of skeletal muscle ECM molecules after exercise have 
shown an increase in gene, protein, and enzyme activity levels (9,18,32,33,52). However, 
these studies have examined changes of the ECM molecules after many weeks of training 
with an aerobic exercise model (51), or after a single bout of eccentric exercise at time 
points ranging from 2 h to 96 h post-eccentric exercise (9,18,33). Furthermore, the focus 
of these studies has been on changes of the ECM and not on the relationship between 
these changes and DOMS. To address the potential relationship between ECM changes 
and DOMS, I examined in Study 2 the alterations at both the gene and protein level of 
ECM molecules, which transmit the force of eccentric exercise and act as a scaffold for 
nerve fibers. ECM molecules are likely affected by the muscle biopsy procedure as well 
as by eccentric exercise protocol, but they are less affected after a repeated bout given the 
decreased level of DOMS after a second bout of eccentric exercise.   
In Study 1 after Bout 2, I found that muscle soreness measures were less severe 
and did not last as long and that maximal isometric strength was not decreased to the 
same extent it was after Bout 1. Nine ECM genes and their protein products were 
examined (MMP9, MMP2, TIMP1/2, collagen 3, collagen 4, integrin α7, integrin β1, 
tenascin-C, laminin α2). At 24 h after eccentric exercise, four (MMP9, collagen 3, 
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integrin α7, tenascin-C) of the nine genes of interest were differentially regulated and the 
protein product of one of these genes (integrin α7) was significantly altered. There was a 
decrease in the mRNA levels of tenascin-C after Bout 2 when compared to Bout 1. I 
found that collagen 3 and MMP9 mRNA levels were different between Bout 1 and Bout 
2 for both the control and exercise groups. I also found that collagen 3 and MMP9 
mRNA levels were different between men and women. Another novel finding was that 
integrin α7 mRNA levels were elevated in the left leg compared to the right leg, despite 
group (e.g. exercise or control [no-exercise] groups). In addition, the integrin α7 levels 
were elevated in the exercise group compared to the control group. These results for 
integrin α7 mRNA levels and the fact that all subjects were right-leg dominant suggest 
that integrin α7 may be elevated in the exercise group in response to load and/or strain 
placed upon the muscle. Furthermore, I also found an increase of integrin α7 isoform 
X2B from baseline in Bout 1 and Bout 2. These results demonstrated that within 24 h of 
eccentric exercise there are changes in the ECM at both the gene and protein level. 
However, the only association found at 24 h post-exercise in Bout 1 and Bout 2 was for 
tenascin-C mRNA levels and muscle soreness. Because very few associations were found 
between the selected ECM molecules and DOMS after a single and repeated bout of 
eccentric exercise, these results suggested that the ECM may not be involved in the 
DOMS process after eccentric exercise. Therefore, I decided to expand the examination 
of potential targets related to muscle soreness after eccentric exercise.  
Targeting nine genes and their protein products, as in the second aim, allowed me 
to identify one molecule (e.g. tenascin-C) that had a positive relationship with DOMS for 
the repeated bout effect. However, this focused approach did not allow me to determine 
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the role of the ECM in DOMS. It is likely that there are myriad factors, including and in 
addition to the ECM, that are involved in the development of muscle soreness after 
eccentric exercise. Therefore my third aim was to use a systems approach to identify 
novel genes that were differentially expressed in individuals who had either high soreness 
levels or low soreness levels after eccentric exercise. The systems approach identified 
numerous genes that were either up-regulated or down-regulated in the high-soreness 
group (HSG) compared to the low-soreness group (LSG) after eccentric exercise. Some 
of the top up-regulated genes have functions that are involved in tissue morphology, cell 
signaling, cell growth and proliferation, lipid metabolism, and nervous system 
development and function. The top down-regulated genes were involved in transcription 
regulation, cell-to-cell signaling, immunological chemotaxis, and maintenance and 
remodeling of blood vessels. Surprisingly, I found that serine protease inhibitor Kazal-
type 1 (SPINK1) was increased by 18.67-fold in the HSG compared to the LSG. There 
was also a moderately strong correlation between SPINK1 and muscle soreness. SPINK1 
mutations have been shown to be associated with pancreatic cancer,(11,43,64,65) and 
while it is expressed in skeletal muscle, the SPINK1 protein product was first identified 
as a protease secreted by pancreatic acinar cells (25,57). These results will provide future 
skeletal muscle researchers with many potential targets to examine when investigating 
the variability in muscle soreness development among individuals. 
Summary     
The overall purpose of this dissertation was to examine the role of the 
extracellular matrix in the development of muscle soreness after eccentric exercise. I 
approached this by first examining the level of muscle soreness experienced due to a 
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muscle biopsy. Because I proposed that the ECM is involved in the development of 
muscle soreness after eccentric exercise and a muscle biopsy would disrupt the ECM, it 
was important to determine if the disruption to the ECM via the muscle biopsy produced 
a level of muscle soreness that is found after eccentric exercise. If the soreness levels 
were similar, then any molecular analysis of muscle soreness after eccentric exercise 
would actually be an examination of muscle soreness after a biopsy. Results from Study 1 
established that muscle soreness was significantly elevated at 24 h after a muscle biopsy, 
but that this soreness level was lower than that after eccentric exercise with or without a 
biopsy. In fact, no differences were found for muscle soreness between the biopsied and 
non-biopsied legs of the exercise group and after a repeated bout of eccentric exercise, 
the muscle soreness levels of both legs were similar to the level of soreness after a single 
muscle biopsy. These muscle soreness results from a single biopsy and repeated muscle 
biopsies and eccentric exercise bouts and the desire to understand the potential role of the 
extracellular matrix in the development of muscle soreness led to my second study. Study 
2 also provided me with the opportunity to examine molecular changes of the ECM 
associated with soreness levels because I examined muscle biopsies and soreness levels 
after single and repeated bouts. I found that at 24 h after eccentric exercise mRNA levels 
of four of the nine genes of interest were differentially regulated and that the protein 
product of one of these genes was also significantly altered. Because Study 2 indicated 
that very few of the genes that I targeted were significantly altered at 24 h after eccentric 
exercise, I decided that to better understand the molecules associated with muscle 
soreness I would need to take a systems approach. Study 3 revealed that there were 
distinct differences in gene expression between individuals who have high levels of 
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muscle soreness compared to individuals who have low levels of muscle soreness after 
eccentric exercise. Study 2 and 3 revealed that the ECM is associated with muscle 
soreness development after eccentric exercise, but the exact triggers of muscle soreness 
development are still unknown. Results of these studies will provide investigators with a 
foundation for future research in the field of muscle soreness. Moreover, it is likely that if 
the triggers of muscle soreness reside within the ECM, the studies from this dissertation 
will also benefit researchers examining ECM disorders such as fibromyalgia. 
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CHAPTER 2 
REVIEW OF THE LITERATURE 
Introduction   
Eccentric skeletal muscle contractions produce prolonged strength loss, delayed 
muscle soreness, and the release of muscle proteins from the muscle cell into the 
blood—changes indicating muscle damage (23,29,40,58,149). The mechanisms 
underlying these muscle damage events have not been fully elucidated. Many mechanisms 
have been proposed (110,149) but few mechanisms can incorporate explanations for all 
the functional and structural alterations to skeletal muscle after eccentric exercise. The 
muscle damage events initiate a remodeling process in the exercised skeletal muscle 
(8,26,28,30,32,97,172), and remodeled skeletal muscle is less susceptible to future 
muscle-damaging exercises (40,44,69,84,120). The use of molecular techniques has 
allowed investigators to examine changes in gene and protein expression that may 
elucidate the mechanism(s) underlying functional and structural alterations to skeletal 
muscle as a result of eccentric exercise (8,30,84,97,107,129). 
The following sections provide information on muscle structure, the effects of 
eccentric exercise on skeletal muscle, and the current understanding of the underlying 
mechanism(s), particularly with regard to the extracellular matrix.     
Skeletal Muscle Structure  
Skeletal muscle has the unique capability of being able to generate force and 
allow for movement of the skeleton. While skeletal muscle can also assist in other bodily 
functions, e.g. maintain body temperature or serve as a vascular pump (144), it is the 
ability of the skeletal muscle to produce force and its ability to remodel in response to 
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use that are discussed in this review (86,100,117). The force generation by skeletal muscle 
and the ability of skeletal muscle to remodel in response to use is a result of its intra- and 
extracellular structure. 
Skeletal muscle is composed of bundles of muscle fascicles containing bundles of 
muscle fibers, the single cell units of the muscle (140). Each muscle fiber is 
surrounded by a membrane called the sarcolemma and is organized into myofibrils that 
contain the basic contractile unit called the sarcomere (140). The surface of the muscle 
fiber is covered by the sarcolemma, and the innermost layer of the sarcolemma is the bi-
lipid plasma membrane. The sarcolemma is one structure within the extracellular matrix 
surrounding the muscle fiber. Next to the plasma membrane is a thin layer called the 
glycocalyx, above which is the multicomponent basement membrane (140). The extracellular 
layers, proteins, and molecules within these layers assist in the skeletal muscle remodeling 
process by transmitting extracellular signals to the intracellular side and ultimately to the 
nucleus (81,89,93). 
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Figure 2.1: Skeletal muscle and extracellular matrix organization. 
 
The intracellular side of the sarcolemma contains the extrasarcomeric cytoskeletal 
framework (talin, veniculin, a-actinin, and the dystrophin glycoprotein complex) 
(2,4,93). These structures, along with the intermediate filaments (desmin, vimentin, and 
synemin), maintain the structure of the muscle fiber and transmit the force from the 
contractile unit to the surrounding network of the basement membrane and muscle 
fascicles (23). Additionally, the cytoskeletal and intermediate filament network are 
necessary for the transmission of the extracellular signals (2,4,93). These proteins have 
either a direct or indirect ability to transmit extracellular signals (2,92).  Signals may 
occur via a protein attaching to an intermembrane protein (e.g. an integrin associated with 
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the dystrophin glycoprotein complex), and this process results in activating the 
intermembrane protein or activates a secondary messenger protein that then 
biochemically transmits the mechanical signal (2). Extracellular signals are transmitted via 
this framework allowing for the remodeling of the skeletal muscle (50,89). Attached to the 
cytoskeletal framework is the sarcomere, which produces muscle contraction and allows 
the muscle to generate force.  
Effects of Eccentric Exercise 
The muscle can perform contractions without limb movement, and these 
contractions are called isometric (153). The muscle can also produce force while the 
muscle contracts, called concentric actions, or force can be produced while the muscle is 
lengthened, called eccentric actions (153). While the force production of the muscle 
cells is generated by the sarcomere, all components (intermediate filaments, 
cytoskeleton, and the sarcolemma) are inherently involved in each muscle action. 
Eccentric exercise is generally used as a model to induce muscle damage.  
Eccentric Exercise Models and Strength Loss 
Strength loss generally peaks immediately after the eccentric exercise, yet soreness 
does not peak until 24 h after the eccentric exercise (40,58). Cytosolic muscle proteins, 
such as creatine kinase and myoglobin, are found to peak in the blood 96–120 h after 
high-force eccentric exercise (23,58,113,150). At the ultrastructural level, the appearance 
of Z-disc streaming occurs within the first 15 min of eccentric exercise (49,65). The 
timeline of the appearance of functional and structural alterations to skeletal muscle after 
eccentric exercise is vastly different; however, these muscle damage events are generally 
resolved within 10–14 d after eccentric exercise (49,65,124). The peak occurrence for 
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these muscle damage events is affected by the novelty and the intensity of the eccentric 
exercise (30,40). Because the muscle damage indicators are not all present immediately 
post-eccentric exercise, it has been difficult to determine which process (mechanical or 
chemical) initiates the muscle damage events (110,116,170).  
After performing a novel eccentric exercise, immediate isometric strength loss can 
range 15–80% (22,29,30,58,68,103), and recovery of strength has been shown to range 
4–40 d (43,83). Chemical and mechanical stresses mediating the muscle-damage 
events have been used to explain the immediate loss of strength and the delayed 
recovery of strength after eccentric exercise (76,77,130,132). An additional component 
involved in immediate strength loss after eccentric exercise is low-frequency fatigue. 
Low-frequency fatigue is characterized by a greater loss in force when the muscle is 
activated at low frequencies (20 Hz) compared to higher frequencies (50Hz) 
(56,59,126,146).  
For the upper body, eccentric exercise models commonly target the elbow flexors 
(biceps brachii) muscle and for the lower body, eccentric exercise models target the 
knee extensors (vastus lateralis, rectus femoris, vastus medialis, and vastus 
intermedius) muscles. The vastus lateralis is the most commonly investigated knee 
extensor (via biopsy and EMG) in eccentric exercise models (84,88,108); this is likely 
due to its size and location. In addition to allowing different treatments to be analyzed 
by exercising each limb separately, these muscles (biceps brachii and vastus lateralis) 
have been used for performing a muscle biopsy, and thus, allow for assessment of 
muscle damage events via biochemical and molecular techniques (84,107). Because this 
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dissertation uses eccentric exercise of the legs, this review focuses on models of eccentric 
exercise using leg muscles.  
Eccentric exercise models that target the knee flexors of the leg result in a 15–
50% loss in muscle strength immediately after the exercise (51,31,128,135,141,164). The 
difference between a 15% loss compared to a 52% percent loss in muscle strength after 
eccentric is due to the novelty, number of eccentric actions, intensity of the eccentric 
actions, mode of eccentric actions, and also the angle of knee extension used when 
performing the post-exercise isometric muscle strength test (31,51,135,141,164). 
Individuals who were recreationally active and whose activities or training included muscle 
actions similar to the eccentric exercise model showed less of a loss in muscle strength 
immediately after the exercise bout compared to individuals who were naïve to the 
exercise (40). 
Eccentric exercise models of the leg have ranged from employing familiar 
activities (e.g. walking down stairs, step-down activities, and stand-to-sit activities) to 
gym-specific exercise machines (e.g. downhill treadmill running, modified cycle 
ergometer, inverted squats, and leg extension). Additionally, a few researchers (26,49) 
have tried to recreate the morphological muscle damage results seen in animal literature 
by using electrically stimulated eccentric actions during knee extension isokinetic 
actions in human studies. Many animal models of eccentric exercise have used 
electrical stimulation to produce the eccentric actions. The results from these animal 
studies have shown vastly different morphological responses to eccentric exercise 
compared to the morphological responses commonly seen in human studies with 
voluntary eccentric actions (100,108,166,174). 
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The first few eccentric exercise models used in human studies were based on 
everyday actions and were voluntary eccentric actions. Friden et al. used a walking-
down-stairs model and a modified cycle ergometer model (63). Other researchers have 
varied the eccentric exercise model depending on the type of exercise and/or the 
amount of damage they wanted to produce (41,65,66,85,88,174).  
Eccentric actions that required individuals to descend stairs or run on a declined 
treadmill have been used to induce a moderate amount of damage to the muscle. While 
Friden et al. (65) and Yu et al. (174) used this protocol to induce a moderate amount of 
muscle damage, neither reported the amount of induced strength loss or documented the 
muscle damage by morphology. Neither Friden et al. (65) nor Yu et al. (174) measured 
muscle strength loss after the stair descent exercise model and instead used muscle 
soreness measures to indicate that the stair descent exercise model induced a moderate 
amount of damage. However, Friden et al. (65) did measure strength loss with the 
bicycle ergometer model and found a 20% loss after the exercise. They reported that the 
bicycle ergometer model was an intense muscle damage model and the stair descent 
exercise model was only moderate (66).  
Other types of eccentric exercise models, such as the step-down or stand-to-sit 
exercise models, have routinely found a 15–30% immediate loss in muscle strength 
(62,84,97). For example, 300 eccentric to concentric (stand-to-sit-to-stand) actions 
performed with one leg (e.g. right leg) compared to 300 concentric-only actions (sit-to-
stand) performed with the opposite leg (e.g. left leg) resulted in an immediate 33% and 15% 
loss respectively in muscle strength (31). Completing a quarter of the above volume (e.g. 
60 step actions) in an effort to produce a moderate amount of damage resulted in a 15% 
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loss in muscle strength (164). However, performing 300 eccentric actions using an 
exercise model with maximal resistance instead of one’s body weight and isokinetic 
dynamometer resulted in a 47% loss in strength (128). Cycle ergometer exercise models 
have routinely shown a 20–30% loss in muscle strength (66) and isokinetic dynamometer 
exercise models have shown a 20–50% loss (88,128). These studies indicate that 
eccentric exercise models of the leg produce a moderate amount of damage if they use 
the individual’s body weight or involved 100 or fewer eccentric actions.  
The intensity of the eccentric exercise was suggested by Nosaka et al. (120) to 
have a greater correlation to muscle damage markers than the duration. Varying the 
intensity of the exercise while maintaining the number of eccentric actions showed that 
30 eccentric actions at 100% of maximal intensity resulted in a 50% loss in immediate 
muscle strength; while at 40% of maximal intensity, a 30% loss in immediate muscle 
strength was found (29). When eccentric exercise was performed at longer muscle lengths 
(joint angle 120°–40°, full knee extension is 180°) compared to shorter muscle lengths (joint 
angle 160°–80°), a greater strength decrement was elicited (19,118). No significant 
difference has been shown in the overall pattern of strength loss and recovery between the 
sexes (41,142). 
Measuring Strength Loss and Recovery   
The measurement of immediate strength loss at different joint angles allows 
for an indirect measurement of the force-length relationship of the contractile 
elements within the sarcomere. This relationship was first identified in 1940 by 
Ramsey and Street (136) and was further described by Gordon, Huxley (AF), and 
Julian in 1966 (71). The force-generating capacity of skeletal muscle has been 
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measured at different muscle lengths (33,115,118) and the relationship between force 
and length is depicted as a bell-shaped curve. The force/tension is located on the y axis 
and muscle length on the x axis. When the contractile elements, specifically actin and 
myosin, are entirely overlapped they generate little force as shown in the force-length 
curve. As the contractile elements move further apart in the force-length curve, as occurs 
in an eccentric contraction, the force-generating capacity increases until the sarcomeres 
reach their optimal length or the top of the bell-shaped curve. In addition to the role of the 
force-length tension curve in eccentric contractions, the detachment and re-attachment of 
the myosin heads from actin during the eccentric action contributes to the force generated 
in eccentric contractions and allows eccentric force to be higher than concentric isometric 
force 149). For the elbow flexors, the optimal length is at 90º degrees of elbow flexion 
(166) and for the knee extensors, the optimal length is at 60º of knee extension (54).     
Muscle Strength Measures 
Measures of strength immediately after eccentric exercise show a similar rate of 
strength loss after a fatiguing or concentric exercise (118,146,153). Measures of 
isometric strength using electrical stimulation at low frequencies show similar losses in 
maximal isometric strength after eccentric and concentric exercise (59,91,147). Because of 
these similarities, it has been proposed that metabolic and/or chemical processes underlie 
the immediate strength loss. However, the eccentric exercise low-frequency fatigue 
persists for up to 5 d and the concentric exercise low-frequency fatigue persists for only 
4 h (59,147,167). Although the rate and magnitude of the loss in strength during low-
frequency stimulation is similar in these two exercises post-exercise, the mechanism 
underlying this loss in strength does not need to be the same. It is likely that the long 
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lasting (>4 h) low-frequency fatigue evident after eccentric exercise is a result of damage 
to the sarcomere and/or the sarcoplasmic reticulum and t-tubules, and damage to a muscle 
cell is not synonymous with fatigue (e.g. traditional definition of metabolic fatigue).  
Furthermore, passive muscle strength measures, muscle actions theoretically 
independent of fatigue, show a delay in passive tension generation after eccentric 
exercise (74,79,168,169). This delay in development of passive tension is present 
immediately after eccentric exercise and has been proposed to be the result of contracture 
resulting from the excess of Ca2+ within the sarcomere and or the mechanical 
disruption to the sarcomere (5,10,34). Only a few studies have investigated passive 
muscle tension; however, passive tension effects are evident for up to 4 d post-exercise 
(170), and one investigator has shown that the level of maximal passive muscle tension 
prior to eccentric exercise is correlated with the severity of muscle damage after 
eccentric exercise (110).  
While a majority of eccentric exercise studies have evaluated muscle strength loss 
via isometric strength tests, which measure muscle strength loss at just one muscle length 
or joint angle (35,45,48,118,119,165), some investigators have used isokinetic tests or 
isometric strength tests with multiple muscle lengths or joint angles to assess alterations in 
the force-length curve (22,115). Isokinetic strength tests assess maximal muscle force 
throughout an entire range of motion and at a constant velocity. It is important to 
measure muscle force at different muscle lengths before and after eccentric exercise 
because a shift in the force-length relationship of skeletal muscle occurs after eccentric 
exercise (115). This measurement allows for a comparison of the force-length curve 
pattern (54,133), where alterations in these patterns could indicate a greater disturbance 
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in the force-generating capacity of muscle when in a lengthened position vs. shortened 
position.  
In addition to measuring muscle strength at different angles, it is also 
important to address how alterations in the force-velocity relationship could impact the 
immediate loss in muscle strength and its recovery after eccentric exercise. The force-
velocity relationship allowed researchers to differentiate between fast-twitch and slow-
twitch muscle fibers. Based on the force-velocity relationship for fast-twitch and slow-
twitch muscle fibers, the fast-twitch muscle fibers are predominantly used in eccentric 
actions (22). It is expected that the fast-twitch muscle fibers incur more stress during the 
muscle-lengthening contractions and are more likely to be damaged (66,90,102). 
Increased phosphorylation of proteins involved in protein synthesis (154) and activated 
satellite cells (27) were found in Type II muscle fibers compared to Type I after eccentric 
exercise. Because the force generated during an isometric contraction may not adequately 
assess the alterations to fast-twitch muscle fibers, it has been proposed that measurements 
of strength loss should include isokinetic actions at slow (0.52 rad·sec-1) and fast 
velocities (3.14 rad·sec-1) (22). 
Eccentric, or muscle-lengthening, contractions are thought to damage the muscle 
because the muscle is signaled to continue generating maximal force while lengthening 
past the optimal length (e.g. >80º of knee extension) or on the descending limb of the bell-
shaped curve. The overstretching of a sarcomere during the eccentric exercise action 
(while the contractile elements are activated) generates tension within the sarcomere and 
could cause mechanical damage to a sarcomere and/or allow for the leakage of Ca2+ and 
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Na+ into the muscle cell (11,12,148,170). The increased level of Ca2+ in the muscle 
cell could perpetuate the muscle damage via activating proteases (160,175). 
The rightward shift in the force-length curve indicates that the muscle length 
increases after the eccentric exercise (12,21,74). The shift is thought to occur because of 
chemical and/or mechanical alterations to skeletal muscle during the eccentric exercise 
actions (110). Chemical alterations have been proposed to degrade components of the 
cytoskeletal and contractile apparatus via Ca2+ activated protein kinase and thus produce 
the rightward shift in the length-tension curve (10,12,175). Mechanical alterations have 
also been proposed to explain the rightward shift in the length-tension curve (74,79,116). 
In the mechanical process, stress to the sarcomere during the lengthening contraction results 
in the sarcomere popping; this popping is thought to occur to multiple sarcomeres 
throughout the muscle fiber (115). Because the elastic components within the sarcomere 
cannot withstand the tension, the elastic spring(s) (specifically the titan molecule) detaches 
from the myosin in the affected sarcomeres, which results in an inability of these 
sarcomeres to realign, an inability to produce force, and thus a shift of the length-tension 
curve (115,127).  
Muscle Strength Recovery 
Muscle strength recovery is assessed by measuring muscle strength using the 
methods described previously (e.g. isometric, isokinetic and passive measures) at 
multiple time points after the exercise protocol. Most investigators have measured 
muscle strength recovery by assessing muscle strength at 24 h increments after the 
eccentric exercise bout (36,42,44,49,122,142). These studies indicate maximal muscle 
strength returns to the baseline 7–10 d after exercise (29,44,49,58,124,142). A few 
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individuals, referred to as high-responders, showed a prolonged recovery of muscle 
strength, as muscle strength had not returned to baseline by 30 d post-exercise (43). 
Additionally, one study that measured muscle strength at 2 h, 4 h, and 20 h after 
eccentric exercise showed a return of muscle strength to almost baseline values at 2 h 
and 4 h post-exercise. However, at 20 h post-exercise, strength loss decreased back to 
the level of immediate strength loss (103). The return of muscle strength to almost 50% 
of its baseline value at 2 h and 4 h post-exercise and then the loss of strength at 20 h 
strongly suggest that a secondary damage event occurs to the muscle after the eccentric 
exercise.  
Delayed Muscle Soreness 
Muscle soreness after performing eccentric contractions is referred to clinically as 
mechanical hyperalgesia because the muscle is tender to touch and the soreness presents 
only when the muscle moves or is palpated (6,7). Delayed onset muscle soreness 
(DOMS) peaks 24–48 h after strenuous, unaccustomed exercise and generally resolves 7–
10 d after exercise (43,49,84,124,149). The novelty of the exercise and the intensity of the 
repetitions will affect the time to peak and the resolution of muscle soreness. The 
mechanism to explain how muscle soreness develops after the muscle-damaging event is 
not well understood. 
DOMS is commonly measured using a visual analog scale (VAS) where an 
individual marks his/her soreness level with a vertical dash on a 100 mm horizontal line 
(0 mm=no soreness and 100 mm=very sore). The VAS can measure the sensory part of 
muscle soreness, but it is thought that DOMS also has an affective component. The 
affective component encompasses the individual’s perception of unpleasantness, and 
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this perception has been shown to peak at 48 h after eccentric exercise (103). The 
affective component of DOMS is measured with either the Descriptor Differential Scale 
(DDS) or the McGill Pain Questionnaire (MGPQ) (72,103,111). Measuring both the 
sensory and affective components of muscle soreness thus provides a more 
comprehensive assessment. 
The development of muscle soreness is thought to result from a combination 
of mechanical and biochemical events after a muscle-damaging exercise that sensitizes or 
stimulates the pain afferents (Type III and IV nerve endings). The Type IV nerve afferents 
respond to mechanical and noxious chemical stimuli (47,58,149,150,152). The 
mechanical event initiates biochemical changes producing muscle soreness. However, it 
has also been proposed that mechanical disruption to the extracellular matrix (ECM)—a 
layer of the basement membrane that resides above the sarcolemma—itself is sufficient to 
sensitize the nerve endings because they are located in the ECM (149). 
The damage process has an acute (minutes after the exercise) and longer lasting 
(>12 h until 10–12 d after the exercise) inflammatory phase (103). In the acute phase, 
cytokines (signaling molecules involved in the immune process) and chemical stimulants 
(prostaglandins, histamine, bradykinin, and nitric oxide) either directly or indirectly 
initiate a process that culminates in sensitizing or stimulating the nerve endings in the 
ECM, producing muscle soreness (112,150). The acute phase of the inflammation process 
results in increased permeability, increased muscle protein degradation, and increased 
inflammatory cell adherence to the damaged sarcolemma area (103,112). All of the above-
listed chemical stimulants have been implicated in sensitizing the pain afferents, but 
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prostaglandin E2 (PGE2) is the best candidate to directly affect nerve sensitivity (103,147). 
PGE2 has been shown to cause increased nerve ending sensitivity (147).  
Resident macrophages of the ECM have the capability to synthesize PGE2 
(147), and it has been reported that neutrophils provide essential products for PGE2 
synthesis (13). While PGE2 is a prime candidate in contributing to the development of 
muscle soreness, it is not the only factor involved in muscle soreness development. 
The chemical stimulant histamine acts indirectly to sensitize the nerve endings. Histamine 
increases capillary permeability, which allows neutrophils to leak out of the capillary at 
the site of muscle injury (13,103). The increased permeability would also allow 
fluid to accumulate at the site of the injury and could result in increasing the pressure 
upon the nerve endings and thus promote sensitization of the nerve endings (13,103). The 
chemical stimulants bradykinin and nitric oxide have less well understood roles in the 
development of DOMS as their actions are commonly involved in the development of 
acute inflammatory pain and not delayed pain or soreness (13,103). 
The chemical stimulants released during the acute phase result in neutrophil 
chemotaxis, monocyte chemotaxis, and secondary tissue injury (103). The neutrophils 
and the monocytes travel to the site of injury via the bloodstream and have the capacity to 
ingest foreign substances, or in the case of muscle damage, the parts of the damaged 
myofiber are ingested (103,150). Upon ingestion of damaged tissue of foreign substances, 
the neutrophils release cathepsin and gelatinase granules (13,103). Cathepsin is 
involved in the degradation of the intracellular components of the muscle, and the 
gelatinase degrades the components of the ECM (93). In this manner, the inflammatory 
factors involved in removing the damaged parts of the myofiber can initiate secondary 
  
 
 
30 
damage to the eccentrically exercised muscle fiber. Because this secondary damage event 
is a result of the longer lasting inflammatory process that occurs 12–24 h after eccentric 
exercise it is possible that the peak muscle soreness that occurs 24–48 h after eccentric 
exercise is related to the longer lasting inflammatory phase of inflammation. 
Several studies examined the treatment of muscle soreness with non-steroidal 
anti-inflammatory drugs (NSAIDs) (78,103,132,159,162) or antioxidants (15,70), but 
results of effectiveness of these treatments have been inconsistent 
(78,103,132,157,158,162). Stauber et al. (149) indicated that the mechanical strain to 
the ECM from the eccentric exercise may be sufficient to sensitize the nerve endings 
within the ECM. Hough in 1902 (82) was the first to propose that the soreness after 
a naïve exercise bout may result in damage to the connective tissue that surrounds 
the muscle fiber. A treatment that could increase the ability of the ECM to resist the 
strain during or after eccentric exercise could reduce the sensitization of the nerve endings 
within the ECM. There are relatively few studies that have examined alterations to the 
ECM from the high-strain eccentric exercise protocols (25,49,105,106,149). 
Blood Indices of Eccentric Exercise Damage 
Other indirect indicators of muscle damage after exercise are level of cytosolic 
muscle-specific proteins in the blood (41,58,113). Two such proteins, myoglobin and 
creatine kinase (CK), commonly increase in the blood after eccentric exercise (38,150). 
The levels of these proteins in the blood do not indicate the amount of damage the skeletal 
muscle has incurred, but they do imply that the sarcolemma has been compromised as a 
result of the eccentric exercise (18,121,162). These proteins are too large to passively 
diffuse through the muscle sarcolemma, and high levels of these proteins can only be 
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detected in the blood if the sarcolemma has been damaged (18,150). Because eccentric 
exercise imposes strain on muscle connective tissue studies have investigated collagen-
breakdown products and levels of proteins that regulate collagen degradation in the 
blood after eccentric exercise (1,9,18,33,163). 
Cytosolic Muscle Proteins 
Myoglobin and CK levels are not increased in the blood immediately after 
exercise but peak 4–7 d post-eccentric exercise (37,40,142). The peak of myoglobin 
concentration and CK activity levels in the blood after maximal eccentric exercise does not 
correlate with the peak of maximal strength loss or peak muscle soreness (58,121). This 
suggests that the mechanisms underlying the release of these cytosolic muscle proteins may 
be different from those that produce strength loss and muscle soreness. Because the peak 
occurs many days after the damaging bout of exercise, it may result from secondary 
damage to the muscle induced by the inflammatory process. The initial damage to the 
sarcolemma from the damaging exercise may not produce an area sufficient to allow 
for the release of cytosolic muscle proteins. However, it is thought that infiltrating 
macrophages may cause further damage to the ECM and the sarcolemma allowing for 
the cytosolic muscle proteins to be released into the blood (103,150).  
Two studies have shown lower blood CK activity after eccentric exercise when 
ibuprofen was administered (55,87,131).  When individuals were given a prophylactic dose 
(for 5 d before, 2.4 mg/d) of ibuprofen versus a placebo, lower CK activity level was 
observed 72 h post-exercise in the NSAID group (130). A therapeutic 400 mg dose of 
ibuprofen was administered every 8 h after eccentric exercise for 48 h; the ibuprofen 
group showed a lower CK activity level compared to the placebo group at 48 h post-
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exercise (156).  These two studies that demonstrated NSAID’s effectiveness at reducing 
CK levels after eccentric exercise indicate that reducing the anti-inflammatory 
response could blunt the secondary damage process proposed to occur. Attenuation of an 
exaggerated inflammatory response may allow the muscle to repair at a faster rate and 
return to baseline quicker. 
Connective Tissue Proteins 
Treatments aimed at attenuating the strain to the muscle during eccentric exercise 
might inhibit the secondary damage event induced by an exaggerated inflammatory 
response. The intimacy of the ECM to the muscle plasma membrane and the appearance of 
cytosolic muscle proteins in blood after eccentric exercise indicate that the collagen matrix 
supporting skeletal muscle is most likely damaged by eccentric exercise. Results 
indicate that high-intensity exercise that produces strain can induce collagen turnover (52) 
that can lead to increased levels of collagen-breakdown products in the blood after 
eccentric exercise. 
Levels of collagen-breakdown products and the enzymes that degrade collagen 
or inhibitors of the collagen-degrading enzymes have been shown to be elevated after 
eccentric exercise (17,18,155). In humans, serum measurements after eccentric exercise 
showed serum hydroxyproline peaked 48 h post-exercise and remained elevated until 72 h 
post-exercise (155). Within tendons, the collagen fractional synthesis rate increases after 
exercise (114). Evaluation of the collagen-degrading enzymes’ (MMP-2 and MMP-9) serum 
levels showed an increase in MMP-9 immediately after eccentric exercise (96). The 
levels of the tissue-inhibitor of metalloproteinases (TIMPs)—inhibitors of collagen-
degrading enzymes—in serum showed an increase in TIMP-1, but not TIMP-2 
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immediately after exercise (95). These results indicate the ECM and intramuscular 
connective tissue are sensitive to the strain of eccentric exercise. 
Morphological Alterations to Skeletal Muscle 
Eccentric exercise imposes a considerable amount of strain upon skeletal muscle 
because the muscle, connective tissue, and tendon are lengthening while the sarcomeres 
within the muscle are shortening. Stauber et al. (149) proposed that strain to the muscle 
fiber from eccentric exercise could result in the following: 1) breaking the connective 
tissue “struts” that link adjacent myofibers; 2) the basal lamina being peeled away from the 
muscle fiber, exposing the plasma membrane; 3) plasma membrane rupture; 4) the 
sarcomere being pulled apart, potentially disrupting the sarcoplasmic reticulum or the 
plasma membrane; and 5) a break in the myofiber without disrupting the basal lamina 
(149). Incidentally, all or just a few of the above possibilities could occur in a number of 
combinations due to the eccentric exercise (149). Skeletal muscle biopsy studies have 
allowed for the investigation of histochemical, immunohistochemical, and ultrastructural 
alterations to skeletal muscle after eccentric exercise. 
Cross-sectional analysis of muscle biopsies allows for the investigation of 
structural associations or loss of associations within and surrounding muscle fibers 
after a damage-inducing stimulus. Longitudinal analysis of skeletal muscle biopsies 
indicates gross alterations to skeletal muscle organization. Protein targets commonly 
used to assess structural organization of skeletal muscle are desmin, dystrophin, and Z-
discs (49,65,174). Their location and their functional roles within the muscle fibers have 
made them prime targets to investigate how a stimulus (e.g. eccentric exercise) affects 
the organization of skeletal muscle components and potentially the functional outcomes 
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after eccentric exercise. Desmin anchors the repeating Z-disc structures to one another 
and, therefore, desmin is thought to play an important role in the structural 
organization of skeletal muscle and assist in force transmission (101,104). The Z-discs 
integrate the contractile (actin and myosin) and passive components (titin and nebulin) of 
the muscle myofilaments with the cytoskeletal apparatus via the binding of desmin to 
the Z-disc (66,73,100).  
This integration allows for mechanical transmission of forces within the active and 
passive elements of the myofilaments and the cytoskeleton (24,53,143). This location 
positions desmin and the Z-discs in the area where the greatest strain from the 
eccentric action occurs. Desmin also assists in linking the cytoskeletal-contractile 
system to the dystrophin-associated proteoglycans complex (DAPC) (66,101). 
Differential alterations in desmin staining of muscle cross-sections have been seen after 
eccentric exercise (49,174). Dystrophin, the main protein in the DAPC, is critical in 
the relay of signals (mechanical or chemical) to the nucleus from areas that arise external 
of the sarcolemma (e.g. ECM) (46,99). Loss of dystrophin results in gross muscle 
disturbances, which include loss of muscle strength and increased serum CK levels 
(99,101). Immediately after eccentric exercise, longitudinal muscle sections show focal 
disturbances in the cross-striated band pattern of muscle fibers (65). These focal 
disturbances occur at the Z-disc of the muscle fiber and are commonly referred to as Z-disc 
streaming (66,149,174). 
Changes to the structural architecture of skeletal muscle have been proposed to 
explain the immediate strength loss and the delayed recovery of muscle strength after 
performing eccentric exercise (64,94,118). However, no definitive relationship has been 
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determined between morphological alterations to muscle fibers and functional alterations to 
skeletal muscle after eccentric exercise (e.g. immediate strength loss, delayed recovery of 
muscle strength, or DOMS). 
Immunohistochemical Alterations 
Myofiber 
Staining of muscle fibers with antibodies specific to protein targets has allowed 
researchers to examine structural alterations at the microscopic level. A decrease in 
staining for selected proteins could indicate a decrease or damage to that protein within 
the skeletal muscle architecture. 
After eccentric exercise, skeletal muscle biopsies from animals showed an increase in 
the absence of staining for desmin (desmin-negative) and dystrophin (100,129). In humans, 
desmin and dystrophin have been investigated to assess alterations to skeletal muscle 
architecture after eccentric exercise (50,171). The absence of desmin staining after eccentric 
exercise has not been consistently demonstrated in humans (49,171,174). Crameri et al. (49) 
showed a decrease in desmin-stained fibers by 24 h that continued to decrease up to 192 h 
after eccentric exercise. Yu et al. (171) showed an increase in desmin-stained fibers at 
24–48 h and again at 168–210 h post-eccentric exercise. The difference in desmin 
staining between these two studies could be a result of differences in the eccentric exercise 
intensity. Crameri et al. (49) used a novel approach to investigate exercise-induced 
alterations to skeletal muscle where one leg performed the eccentric exercise voluntarily 
(VOL) and the other leg was electrically stimulated (eSTIM) to perform the eccentric 
exercise (49). The eSTIM leg showed an increase in necrotic fibers and desmin-negative 
fibers at 24 h and an increase in the amount of desmin-negative fibers at 96 h after 
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eccentric exercise, while the VOL leg did not show any necrotic fibers or alteration in 
desmin staining (49). Crameri et al. (49) found less post-exercise strength loss for the 
eSTIM leg than the VOL leg. Therefore, the extensive morphological disruption seen in 
the eSTIM leg compared with the VOL leg is not associated with muscle strength loss. 
Additionally, muscle soreness was the same in the eSTIM and VOL legs. These results 
indicate that the extent of disruption to the myofiber (e.g. Z-disk streaming) is not related 
to strength loss or muscle soreness. 
Intramuscular Connective Tissue and Extracellular Matrix 
While Hough in 1902 (82)  proposed that alterations to the connective tissue of 
muscle play a role in the functional changes to skeletal muscle after eccentric exercise, 
few studies have investigated alterations to the intramuscular connective tissue 
(IMCT) and the ECM of skeletal muscle after eccentric exercise. The endomysium, which 
is closely integrated with the ECM, is markedly disturbed after eccentric exercise (149). 
After eccentric exercise, chondroitin 6-sulfate proteoglycan staining was found to be 
diffuse instead of sharp around muscle fibers at 24 h, and at 48 h chondroitin 6-sulfate was 
absent from the damaged edge of the myofiber (149). Skeletal muscle biopsies at 48 h after 
eccentric exercise showed a widening of the perimysial area between fascicles (149). The 
widening of the perimysial area indicates that the eccentric exercise produced connective 
tissue damage. IMCT has recently received attention for its ability to enable lateral force 
transmission between contracting muscle fibers (93,134). These studies demonstrate that 
the IMCT contributes to the generation of skeletal muscle force. Therefore, alterations 
found in the organization of IMCT after eccentric exercise likely play a role in muscle 
strength loss and recovery after eccentric exercise.  
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Ultrastructural Alterations 
Alterations to skeletal muscle after eccentric exercise have been documented 
by examining the number and extent of myofibrillar disruptions (66,68,172). Analysis of 
the ultrastructural alterations to skeletal muscle shows eccentric exercise initiates a process 
that produces gross disturbances to the organization of sarcomeres, particularly at the level 
of the Z-disk. For this review, the ultrastructural alterations are characterized in three 
ways: as Z-disk disturbances if the Z-disc appears widened and irregular; as Z-disc 
smearing if the Z-disc extends irregularly into the A and I band and involves one or more 
sarcomeres; and as Z-disc streaming if the Z-disc smearing is evident in multiple myofibrils 
(64). 
The Z-disc disturbances appear within 15 min after eccentric exercise (49). 
Evaluation of the Z-disc disruption in skeletal muscle biopsies showed a greater amount of 
Z-disc streaming at 2–3 d compared to 1 h post-eccentric exercise (66,171).  These results 
indicate that even though morphological alterations of skeletal muscle occur immediately 
after eccentric exercise this appearance of disruption to the myofiber continues to increase 
after muscle soreness and muscle strength have begun to return to baseline. These 
ultrastructural alterations to skeletal muscle after eccentric exercise occur despite using 
eccentric exercise protocols with low-intensity vs. high-intensity actions and despite the 
limb (arm vs. leg) being exercised (65,68,118,125,173). Additionally, no difference has 
been seen in the extent or amount of disruption to the Z-disc between men and women 
after eccentric exercise (150). 
Greater disturbances to the Z-disc were evident in muscle biopsies of the leg 
eccentrically exercised via eSTIM compared to the leg wherein the VOL eccentric exercise 
actions were performed (49). As mentioned earlier, there was less strength loss post-
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exercise for the eSTIM leg compared with the VOL leg. These results indicate that 
disruption within the myofiber as evident in the Z-disc streaming does not affect muscle 
strength loss and, therefore, morphological alterations to the myofiber cannot fully 
explain the functional alterations to skeletal muscle after eccentric exercise. 
Furthermore, a muscle biopsy can only assess morphological, biochemical, and 
molecular alterations to the 250–500 mg sample of muscle biopsied and may thus not be 
representative of the entire skeletal muscle. Muscle biopsies provide beneficial information 
regarding the events that occur within the tissue after eccentric, but these results must be 
kept in context, as the procedure to procure biopsy sample may itself produce damage to the 
fibers, cause an increase in serum cytosolic muscle proteins, initiate an inflammatory 
response, and alter gene expression (174).       
Connective Tissue, the Extracellular Matrix, and the Transmembrane System 
This section provides an overview of the components within connective tissue 
of skeletal muscle, ECM, and the cytoskeletal transmembrane system. The effects of 
eccentric exercise are also addressed. 
Connective Tissue of Skeletal Muscle 
The ECM is intimately connected to the sarcolemma of skeletal muscle fibers and 
is also integrated with a collagen fiber network to form the connective tissue of skeletal 
muscle (93,134,140). The outermost layer of the collagen fiber network organizing skeletal 
muscle is the epimysium. The epimysium is commonly referred to as the fascia of 
skeletal muscle, and this layer envelops the bundles of muscle fascicles (93,134,140). The 
individual fascicles of skeletal muscle are enveloped in a collagen fiber network called the 
perimysium, and the individual myofibers within the fascicles are ensheathed in the 
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endomysium (93,134,140). The collagen network surrounding these levels of organization 
within skeletal muscle contains different amounts of collagen subtypes and acellular 
material (98,134,140). In addition, to having within the layers different amounts of 
collagen subtypes (e.g. collagen Type I, Type III, Type IV, etc.), the layers have a 
different structural organization of the collagen subtypes. 
The composition and structure of the collagen fiber network-organizing skeletal 
muscle allow it to provide the following: tensile strength and support for skeletal 
muscle (93,140), and a scaffold for capillaries (140), fine motor and sympathetic nerve 
branches. The network contains cellular (e.g. macrophages and fibroblasts) (93,140) 
and acellular material (e.g. fibrils, matrix metalloproteinases); it determines the 
elasticity skeletal muscle exhibits; and it coordinates the transmission of mechanical 
forces generated by the sarcomeres to the tendon (49,124,140). The epimysial and 
perimysial layers of the collagen fiber network contain Types I and III collagen, and the 
endomysial layer has Types I and III collagen in its reticular layer and Type IV collagen in 
the basement membrane (93). The endomysium collagen fibers are organized in a 
random arrangement, which allows for movement during muscle contractions. The 
perimysial collagen fibers are organized into multisheet layers that run transverse to the 
myofibers, this structural arrangement allowing the collagen fibers to hold the 
myofibers in place (93). The epimysium collagen fibers are organized into two layers of 
wavy collagen fibrils that form a sheetlike structure at the tendon (140). In addition to 
different amounts of collagen types and their organization within the layers of the 
muscle connective tissue, there are differing amounts of protein and carbohydrate within 
these regions (113). Eccentric exercise places considerable strain upon muscle, and the 
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intimacy of the connective tissue to skeletal muscle results in strain to the connective 
tissue. The composition of the connective tissue network assists the muscle in absorbing 
and distributing the strain. All three layers of connective tissue are affected by eccentric 
exercise; however, it is expected that gross disturbances to the connective tissue are 
localized to the muscle fibers activated during the eccentric action, and thus the 
endomysial region would be most profoundly affected. In fact, Stauber et al. (149) 
showed gross disturbances to the once tightly organized endomysial region after 
eccentric exercise. It is expected that eccentric exercise will promote expression of genes 
whose protein products contribute to the structural integrity of connective tissue. 
Therefore, this overview of the components within connective tissue of skeletal muscle, 
ECM, and the cytoskeletal transmembrane system focuses on molecular alterations that 
support the connective tissue in the endomysial region and will pay particular attention to 
the ECM layer, which begins at the bi-lipid plasma membrane of skeletal muscle and 
extends into the IMCT layer of the endomysium. 
Extracellular Matrix of Skeletal Muscle 
The ECM is sandwiched between the endomysium and the plasma membrane 
and includes the sarcolemma that surrounds the plasma membrane of skeletal muscle 
fibers (93,134,140). The sarcolemma itself, is composed of layers that contain collagenous 
(fibrils of Types I, II, III, and IV collagen) and non-collagenous material (proteins and 
proteoglycans) (140). The innermost layer of the sarcolemma that is next to the bi-lipid 
membrane is a glycocalyx layer; following the glycocalyx is the basal lamina, which 
consists of the lamina reticular region and the lamina densa region. Following the basal 
lamina is the reticular layer (140). 
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The glycocalyx coats the bi-lipid membrane with proteoglycans, predominantly 
heparan sulfate (140). The layers of the basal lamina contain different amounts of 
collagen, proteoglycans, and cells. The lamina reticular layer of the basal lamina is 
proposed to contain the protein fibronectin and Types I and III collagen; the fibronectin 
assists in the adhesion of cells (e.g. fibroblasts and myoblasts) to collagen material 
(molecules, polypeptides, and fibrils) (140). Fibroblasts synthesize collagen peptides, 
matrix metalloproteinases (MMPs), and TIMPs (93). MMPs have substrate specificity 
for the collagen and ECM components they degrade. MMP-1 and MMP-8 are 
collagenases that predominantly degrade Types I and III collagen, while MMP-2 and 
MMP-9 are gelatinases that primarily degrade Type IV collagen and other ECM 
components (e.g. laminin, aggrecan, decorin, and fibrillin) (2,26,93). TIMPs are synthesized 
by muscle fibers and inhibit the conversion of the pro-MMP peptide to the cleaved and 
activated MMP, and thus TIMPs inhibit the degradation action of MMPs (95). The activity 
of TIMPs has been shown to change in parallel with MMP activity (26,145). 
The two most commonly studied MMPs in skeletal muscle are MMP-2 and 
MMP-9 and the most commonly studied TIMPs in skeletal muscle are TIMP-1 and TIMP-
2 (2,26,75,139). In animals, exercise has been shown to increase the expression level and 
activity level of MMP (96). Intensity of the exercise has been shown in animals to affect the 
expression and activity level of MMPs (26). Low-intensity exercise had no effect on 
expression of MMP-2, but high-intensity exercise caused an increase in mRNA 
expression of MMP-2 (1,139). The expression level and activity level of MMP-9 in the 
exercised limb were not different from the control limb (26). In humans, MMP levels 
have been shown to be altered after endurance exercise, immobilization, and eccentric 
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exercise (106,138,161). These data suggest MMPs and consequently TIMPs are 
important in the remodeling process of skeletal muscle. Therefore, it is expected that 
eccentric exercise will result in an increase in the expression level and activation level of 
MMPs and TIMPs within skeletal muscle ECM. 
The lamina densa region contains the protein laminin and Type IV collagen; 
laminin functions in the same manner as fibronectin, but laminin can also bind collagen 
to the intermembrane protein integrin (140). Mice lacking laminin show growth 
retardation and muscle dystrophy (93). Next to the basal lamina layer is the reticular layer, 
which contains Types I and III fibrils of collagen and proteoglycans (e.g. fibromodulin, 
decorin, biglycan, lumican, tenascin-C, proline, syndican, perlecan, agrin, laminin, 
fibronectin, aggrecan, heparan sulfate, and chondroitin sulfate) (140). The proteoglycans 
within the reticular layer assist in fibril fusion, fibril alignment, and spacing between 
fibrils (93,140). Many of these proteoglycans (e.g. perlecan, heparan sulfate, biglycan, 
laminin) have been shown in vitro to have increased expression in response to stretch 
(3,96,137). After eccentric exercise in humans, tenascin-C showed increased mRNA and 
protein expression compared to the control (31,49). The combination of the basal lamina 
and the reticular layer make up the basement membrane of the sarcolemma. 
Transmembrane Cytoskeletal System of Skeletal Muscle 
The transmembrane system links and mediates interactions between the ECM and 
the intracellular cytoskeleton (67) and consists of the dystrophin-associated protein 
complex (DAPC), focal adhesion kinases (FAK), laminins, and integrins. Because the 
ECM is sensitive to mechanical stress, increased or decreased stress to the ECM would 
likely transfer to components that interact with the ECM (e.g. transmembrane system) and 
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result in alteration in levels of the transmembrane system mRNA and their respective 
protein products (61,81,97,161). The ECM is able to transfer the mechanical signals it 
receives to the intermembrane system, which can then translate the mechanical signal 
into a biochemical signal via the intermembrane or transmembrane proteins (4,57,89,). 
Integrin is a transmembrane protein localized in the sarcolemma that links to the collagen 
network of the ECM via laminin α-2. Integrins are a paired protein complex that consists of an α 
integrin and a b integrin (137). The α7 and β1 integrins are the most abundant integrins found in the 
skeletal muscle (53,89). In animals, mutations in integrins result in muscle dystrophy  (46). In 
addition to their link with the ECM, the integrins also associate with the cytosolic components of 
skeletal muscle. They are connected to the cytoskeletal and contractile proteins via the DAPC, 
and they also interact with cytosolic-signaling cascades via FAKs. Integrins have been 
shown to convert the mechanical signals (strain and stress) from the ECM to an adaptive 
response (e.g. hypertrophy) within the cell (61). This action is possible because integrins 
are transmembrane proteins. They bind to collagen and some proteoglycans (e.g. 
fibronectin, tenascin-C, and laminin) of the ECM and the DAPC of the muscle cytosol. 
DAPC and FAKs are localized at the cytosolic domain of the α7-β1 integrins 
and the localization of these protein groups are termed a focal adhesion complex 
(FAC) (57,81). It has been suggested that the α7-β1 integrins transmit the mechanical 
strain or lack of mechanical strain from laminin α -2 a protein, which interacts with the 
collagen fiber network of the ECM (16,61,81,143). Boppart et al. (16) showed increased 
protein levels of α7-β1 integrins and greater phosphorylation of the AKT1 protein in 
mice post-downhill running compared to pre-downhill running. Additionally, 
dystrophin-deficient mice overexpressing α7-β1 integrins have a reduction in muscle 
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dystrophy symptoms (e.g. elevated creatine kinase and muscle damage) (16). It is 
possible that the increased load and contraction that occur during eccentric exercise will 
result in increased levels of laminin a-2 and integrin α7-β1 mRNA and protein. The 
FAK will show increased tyrosine phosphorylation because of the increased protein levels 
of the α7-β1 integrins. These alterations to the ECM may serve as a signal to initiate 
sarcomerogenesis and skeletal muscle remodeling (151). 
Recently, an animal model in dystrophin-lacking mice (mdx mice) showed that 
an inducible activated (phosphorylated) AKT1 prevented the strength loss produced by 
eccentric exercise (14). The lack of strength loss was attributed to the activated Akt 
promoting up-regulation of genes whose protein products are part of the cytoskeletal 
filaments (e.g. desmin) and the intermembrane system (e.g. integrins). 
Repeated Bout of Eccentric Exercise and Muscle Function 
Eccentric exercise is well known to produce muscle damage that is manifested by 
DOMS and prolonged losses in strength and range of motion (36,49,58,124). These 
temporary alterations in muscle function have been shown to be reduced after a repeated 
bout of exercise. A single bout of novel eccentric exercise initiates a remodeling process 
that facilitates muscle adaptation (23,44,119). The adaptation confers protection to future 
bouts of similar exercise, such that a subsequent exercise bout results in decreased 
strength loss and reduced soreness response compared to the initial bout of exercise 
(44,80) This adaptation between the first and second bout, is called the “repeated bout 
effect” (RBE) (39). The mechanisms underlying the RBE are unknown, but processes 
involved in protein synthesis, inflammation, and motor control have been proposed to 
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play a role (20,149,150). The RBE has been shown to last for up to six months and is no 
longer apparent between nine to 12 months after the initial bout of exercise (123,124). 
 Repeated Bout of Eccentric Exercise and the Extracellular Matrix 
Few investigators have examined the ECM after a single much less a 
repeated bout of eccentric exercise. However, Mackey et al. (105) had subjects 
undergo two electrically stimulated exercise bouts (i.e. eSTIM1 and eSTIM2) and 
found that changes in laminin-β1, collagen 1 and collagen 3 were significantly 
different at 30 d after a single bout of eccentric exercise compared to a repeated 
bout performed 1 mo after a single bout. In addition, Mackey et al. (105) found that 
heat shock proteins 27 (HSP 27) and 70 (HSP 70), chemokine ligand 2 (CCL2), 
connective tissue growth factor (CTGF), and tenascin-C (TNC) mRNA levels were 
all attenuated at 48 h after a repeated bout of eccentric exercise compared to 48 h 
after a single bout of exercise. Mackey et al. (105) proposed that the elevation of 
HSP 27, HSP 70, CCL2, and TNC after a single bout of eccentric exercise was 
because these molecules were involved in de-adhesive and disassembly processes in 
the ECM in order to reorganize it. These results suggest that the attenuation of gene 
expression for these molecules after a repeated bout of eccentric exercise was due to 
a reorganized matrix after the first bout and thus the matrix was able to manage the 
strain of the second bout. The recent focus in the last five years by investigators on 
the ECM has begun to shed light on the importance of ECM components to skeletal 
muscle repair, adaptation, and hypertrophy (16). Mackey et al. (105) were the first to 
investigate alterations to ECM-related proteins after a repeated bout of exercise.  
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While Mackey et al. (105) have investigated changes in the ECM molecules after 
a repeated bout, these results must be viewed with caution because the eccentric exercise 
model used was eSTIM and not voluntary. Malm et al. (109) and Crameri et al. (49) have 
shown that voluntary eccentric exercise does not display the extensive amount of Z-line 
streaming or inflammation that is found after eSTIM. Furthermore, one of the hallmarks 
of the “repeated bout effect” is the reduction in DOMS, and Mackey et al. (105) did not 
find a reduction in DOMS after a second bout of eSTIM eccentric exercise.  
Summary 
Eccentric exercise is known to produce muscle damage by imposing muscle strain 
(36,60,63). Indirect markers of muscle damage include prolonged muscle strength loss, 
DOMS, and the appearance of muscle and connective tissue proteins in the blood. Direct 
evidence of muscle damage has been provided using light and electron microscopy 
techniques on muscle biopsy samples taken post-exercise. There is much evidence for 
damage to the myofibrillar structure post-exercise. However, there is also some evidence 
that structural and cellular components of the ECM are affected; the ECM responds to 
strain by promoting transcription and translation of many of its structural components. 
Given the paucity of information on ECM changes after voluntary eccentric exercise and 
the important function that the ECM plays in muscle, more work is needed to elucidate 
the role of the ECM in the muscle damage and repair processes.   
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CHAPTER 3 
MUSCLE SORENESS: COMPARING MUSCLE BIOPSIES 
TO ECCENTRIC EXERCISE (Study 1)  
Abstract 
We examined the effect of a single muscle biopsy (baseline muscle biopsy, MB1) 
and repeated biopsies on skeletal muscle soreness between a control group (biopsies only; 
n=2 men and n=2 women) compared to an exercise group who performed eccentric 
exercise and had muscle biopsies (n=4 men and n=4 women). We used three different 
tests to measure muscle soreness: the Brief Pain Inventory Short Form (BPISF; 
Apppendix B) the McGill Pain Questionnaire (MGPQ; Appendix C), questionnaire, and 
two task-related measures of muscle soreness using a visual analog scale (VAS). All 
three tests showed that peak muscle soreness was elevated at 24 h after a single and 
repeated biopsies (~25 mm in VAS) and that this soreness was resolved by 96 h after 
single or repeated biopsies. This peak soreness was significantly less than that found after 
combined eccentric exercise and a muscle biopsy (~40 mm in VAS). Muscle soreness 
after eccentric exercise and a muscle biopsy did not resolve until 120 h. Baseline biopsies 
should be performed at least 96 h before exercise to ensure resolution of soreness from 
the biopsy in studies examining exercise-induced muscle soreness.  
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Introduction 
Despite the widespread use of the muscle biopsy procedure in kinesiology 
research, little information is known regarding the effects of a single or repeated biopsies 
on muscle soreness and daily physical activity, both of which could confound 
interpretation of study results. In 1902, Hough (14) documented soreness of skeletal 
muscle that appeared 8–10 h and peaked 12–24 h after a strenuous eccentric exercise. 
Hough (14) attributed the delayed soreness to a rupture within the muscle fibers. Almost 
80 years later, Friden et al. (11) confirmed damage to muscle fibers by ultrastructural 
analysis of skeletal muscle biopsies after eccentric exercise and associated this damage 
with soreness development (12). Yu and colleagues (28,29) showed that the 
ultrastructural damage, which peaked at 4–7 d post-exercise, was not related to the peak 
of delayed onset muscle soreness (2–3 d post-exercise). Numerous studies have used 
skeletal muscle biopsies as a useful tool to investigate the underlying mechanisms of 
exertional muscle damage and its sequelae. (2,8,16,21,22) However, only one of these 
studies (21) measured biopsy-related soreness development and found that the muscle 
biopsy did not cause a significant elevation in muscle soreness. 
Recently, Tarnopolsky et al. (25) examined the safety and size of muscle biopsy 
samples from 13,500 biopsies performed at McMaster University by one neuromuscular 
clinician. Using a Bergstrom needle with suction, they collected three biopsy samples 
from one insertion of the biopsy needle, resulting in an overall sample size of 150–200 
mg (25). Complications arose in one out of 519 biopsies, and the most common 
complication was a local skin infection (25). These results indicate that relatively large 
samples can be obtained with few and minor complications, supporting biopsy as a 
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relatively safe research technique. To test that multiple biopsies did not affect results, 
Malm et al. (21) performed repeated biopsies at the same incision site on exercised and 
non-exercised (control) individuals. Immunological changes (e.g. an increase of 
macrophages near the edge of the biopsy-incision site) were found with repeated muscle 
biopsies in both groups; however, the changes in the non-exercised (control) muscle were 
equal to or greater than those in the exercised muscle. In addition, Friedmann-Bette 
examined gene expression among multiple biopsies (four muscle biopsies) and found no 
difference from the baseline biopsy for the following genes of interest: interleukin-6 (IL-
6), IL-6 receptor, insulin-like growth factor 1, p21, phosphofructokinase, and glucose 
transporter. The results from Malm et al. (21) and Friedmann-Bette et al. (13) suggest 
that inflammatory processes can be affected if the multiple biopsies are taken from the 
same site and that multiple biopsies do not affect the muscle growth signaling processes. 
Therefore, we can examine the vastus lateralis muscle as it is easier to take multiple 
biopsies that are more than 2 cm apart. This will ensure that any muscle soreness 
identified after the biopsy and future analysis of gene and protein expression is not 
attributed to the inflammatory processes identified by Malm et al. (21) and Friedmann-
Bette and colleagues (13). 
The purpose of this study was to compare muscle soreness and daily physical 
activity levels between two groups of healthy subjects after muscle biopsies of the vastus 
lateralis: 1) a control group (n=4) who had a baseline plus two additional muscle 
biopsies; and 2) an exercise group (n=8) who had a baseline biopsy, performed two bouts 
of eccentric exercise, and then had a muscle biopsy within 24 h of each exercise bout. We 
assessed the effect of the biopsy (e.g. control group muscle biopsy 1, 2, and 3 [MB1, 
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MB2, MB3] and exercise group MB1) and the eccentric exercise+biopsy (exercise group 
muscle biopsy 2, and 3 [MB2 and MB3]) on muscle soreness and daily living using two 
questionnaires (the BPISF and MGPQ; see Appendices B and C). We also used the VAS 
of 100 mm and two tasks (e.g. walking down a flight of stairs and two single-legged 
squats) to assess muscle soreness. For the stair task, subjects descended the flight of stairs 
and then recorded the peak soreness for each leg (e.g. exercised leg without a muscle 
biopsy [EXNB] compared to the exercised leg with a muscle biopsy [EXB]). The 
soreness task of two single-legged squats allowed us to differentiate the muscle soreness 
of the EXNB leg compared to the EXB leg and the control group’s biopsy leg (CON) 
soreness at Bout 0 (muscle biopsy 1, MB1-baseline muscle biopsy), Bout 1 (muscle 
biopsy 2, MB2), and Bout 2 (muscle biopsy 3, MB3). In addition to the measures of 
muscle soreness, we also used an activity monitor to assess the effect of a muscle biopsy 
(MB1) on daily physical activity. 
Methods 
Study Design 
The study protocol and informed consent document were approved by the 
University of Massachusetts Amherst Institutional Review Board for human subjects. All 
subjects provided written consent. Subjects were randomized to have either their 
dominant or non-dominant leg biopsied at baseline (muscle biopsy 1, MB1). Baseline 
measures (before the biopsy) of muscle soreness of the quadriceps were assessed on two 
separate visits, with at least 2 d but not more than 5 d between the baseline visits. The 
post-biopsy muscle soreness measures were assessed daily for 7 d. The three measures of 
muscle soreness were used at every visit where soreness was assessed: (100 mm VAS, 
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BPISF, and MGPQ). Maximal isometric strength was assessed at the baseline visits and 
at 7 d post-MB1 and 14 d post-MB2. MB1 (Bout 0 muscle biopsy) was taken 3–5 d after 
subjects completed the baseline measures of muscle soreness and isometric strength 
testing. The MB2 was taken 24 h after the first exercise or no-exercise bout (Bout 1), and 
MB3 was taken 24 h after the repeated exercise or no-exercise bout (Bout 2). Bout 1, the 
first bout of exercise or no-exercise (control group), occurred one week after the baseline 
muscle biopsy (Bout 0, MB1). Bout 2, the repeated bout of exercise or no-exercise, 
occurred two weeks after Bout 1. The control group completed the study in the same 
timeline as the exercise group. The study timeline is shown in Figure 3.1. 
 
 
      Figure 3.1: Study timeline. 
Subjects 
Twelve healthy male and female subjects (n=6 male, 6 female) enrolled and 
completed the study. Of the 12 subjects, eight were randomized into the exercise group 
and four were randomized into the no-exercise control group. The exercise and control 
* 
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groups were balanced for sex. Subjects were also randomized as to which leg was 
biopsied first (MB1); the contralateral leg was biopsied for the second (MB2) and third 
(MB3) biopsy time points.  
All subjects were recruited from the University of Massachusetts Amherst and 
surrounding area. Individuals were eliminated from the study if they 1) had an occupation 
requiring heavy weight lifting or had participated in a weight-training activity of the 
lower body within the past six months; 2) were a smoker; 3) had undergone orthopedic 
surgery in the leg (unless cleared by a physician) or had any skeletal, muscular, or 
neuromuscular dysfunction; 4) had participated in a leg muscle soreness trial within the 
previous six months; 5) were currently participating in or planning on participating in a 
research study involving an investigational drug, supplement, medical device, or exercise 
protocol; 6) were currently taking any medication that would interfere with the study 
results such as products with analgesic properties as labeled; 7) were taking dietary 
supplements during the course of the study except the study treatment; 8) had consumed 
any narcotic preparation (e.g. codeine) or illicit drugs (such as marijuana, etc.) within the 
previous seven days; or 9) had any serious medical condition, including but not limited to 
diabetes, hypertension, kidney, cardiovascular, or pulmonary disease. In addition, biopsy 
care instructions were reviewed verbally with all subjects. If subjects were not willing to 
follow the biopsy care instructions, they would have been excluded from the study; 
however, none were excluded for this reason.  
Individuals who met the inclusion criteria, agreed to follow the biopsy care 
instructions, and completed the baseline muscle function measures were randomized for 
baseline leg biopsy (dominant leg or non-dominant leg to be biopsied first) and reported 
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to the lab for the muscle biopsy. All subjects were provided with a standardized snack 
(Oscar Myers Lunchable® with 8 oz. of water) 4 h prior to the skeletal muscle biopsy. 
They were not allowed to eat after this snack until the biopsy was completed. The caloric 
content of the standardized snack was 360–370 calories (8–12 g total fat, 51–63 g total 
carbohydrate, and 10–12 g protein). 
Muscle Biopsy Procedure 
Subjects were transported to and from Hartford Hospital where the biopsy 
procedure was performed. A licensed physician performed the needle biopsy procedure 
under local anesthesia using a Bergstrom needle with suction. A small incision (about 0.5 
–2.0 cm) was made into the skin and fascia of the vastus lateralis. The Bergstrom 5–6 
mm biopsy needle was then inserted into the muscle, and suction was used to allow a 
specimen of muscle tissue to be “clipped” with the needle. The biopsy needle was rotated 
90° to the right, suction was applied, and another sample was collected; this was repeated 
to collect a third sample. When the needle was removed from the muscle, by using this 
three-“clip” method, the overall specimen size was about 150–200 mg. For four of the 12 
subjects, the biopsy needle was reinserted and the three “clips” were performed a second 
time because at the first collection the specimen size yielded less than 100 mg of tissue. 
To reduce the risk of bleeding post-biopsy, subjects were instructed not to consume any 
anti-inflammatory drugs (i.e. non-steroidal anti-inflammatories (NSAIDS) like Ibuprofen 
or aspirin) or any aspirin-containing drugs such as Alka-Seltzer, Pepto-Bismol, or certain 
decongestants (i.e. Dristan) within 4 d of the muscle biopsy.   
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Physical Activity Assessment 
At the beginning of the study, the subjects completed the 7-day short form 
International Physical Activity Questionnaire (IPAQ). They were asked to maintain the 
same level of physical activity until the muscle biopsy procedure and were given an 
Actical physical activity monitor (Mini Mitter Co., Inc., Bend, OR) to wear for 48 h prior 
to the baseline muscle biopsy. The activity monitor was set to collect activity data in 15-
sec epochs and the data were downloaded to a computer. Subjects continued to wear the 
monitors for all waking hours during the 48 h after the baseline muscle biopsy procedure, 
and they were instructed to not wear the monitor while showering or sleeping.  
Timeline 
Subjects completed two baseline strength-measure visits that were separated by at 
least 2 d, but not more than 5 d, as shown in Figure 3.1. Subjects were given a physical 
activity monitor to wear between these baseline visits and asked to complete an activity 
log. Muscle soreness was measured prior to the baseline muscle biopsy (MB1) and at 24 
h intervals up to 120 h post-MB1. At 120 h after MB1, all subjects returned for the 
exercise or no-exercise session (Bout 1): the exercise group performed an eccentric 
exercise that used both legs (descending stairs) and had a strength measure (e.g. maximal 
isometric strength at 70°) before and after the exercise bout. The control group did not 
exercise, but they completed the same strength measure. The following day (24 h post-
Bout 1) all subjects completed the muscle soreness measures before the muscle biopsy 
(MB2). This biopsy was collected from the leg contralateral to that biopsied at MB1. 
Muscle soreness was measured at 24 h intervals up to 120 h post-MB2. Two weeks after 
exercise or no-exercise Bout 1, subjects returned to the lab for exercise or no-exercise 
  
 
 
66 
Bout 2. The following day (24 h post-Bout 2) all subjects completed muscle soreness 
measures before the muscle biopsy (MB3). This biopsy was collected from the same leg 
that was biopsied at MB2. Muscle soreness was measured at 24 h intervals up to 120 h 
post-MB3. 
Eccentric Exercise Protocol and No-Exercise Protocol 
Subjects in the exercise group performed eccentric actions of the knee-flexors. 
They ran down 10 flights of stairs (e.g. 11th floor to the first floor) 15 times (15 “sets” of 
stairs) and used the elevator to return to the top of the flight of stairs. Each flight of stairs 
consisted of two sets of 12 steps, so subjects ran down 24 steps between each floor. Each 
step rise was 17.78 cm, the run was 29.21 cm, and the tread width was 154.94 cm. The 
average amount of work done was -31.53 kJ ± -4.10 kJ (mean  ± SEM). The subjects 
were monitored by an investigator at the top and the bottom of the stairs and were 
encouraged to maintain a rate between 2.09 and 2.87 steps/sec down the stairs. This rate 
of descending the steps resulted in the subjects completing the 10 flights of stairs between 
90 and 115 sec and an overall 22–26 min bout of eccentric exercise (including time 
waiting for the elevator between “sets”). This protocol was used previously by others and 
has been shown to result in muscle damage (11,28,29). Subjects in the control group did 
not perform the stair exercise, but they reported to the Muscle Biology and Imaging 
Laboratory and performed the muscle strength tests. Both groups were instructed to 
maintain their regular activity level throughout the duration of the study. 
Muscle Soreness Measures 
Subjects were asked to perform two tasks with the quadriceps and then record 
their soreness using a VAS. The VAS is a 100 mm horizontal line: One end of the line (0 
  
 
 
67 
mm) indicates no soreness and the other end (100 mm) indicates severe soreness (great 
pain and difficulty while completing the task). For the first task-related VAS muscle 
soreness rating, subjects performed two stand-to-sit (STS-VAS) motions using only a 
single leg (the biopsied leg). For the second task-related muscle soreness rating, subjects 
were asked to descend a flight (10 steps) of stairs (Stair-VAS). The stair descent began 
with the left leg, and subjects were allowed to use the handrail to regain their balance but 
were monitored to ensure they did not use the handrail to support their weight. After each 
task, subjects were then asked to record the peak soreness of their quadriceps muscle by 
placing a vertical line on the VAS. In addition, the time to descend the stairs at their 
preferred walking pace was recorded to examine if the muscle biopsy or the biopsy and 
exercise session had changed the preferred walking pace for a task that they would 
perform on a daily basis. After completing the soreness tasks, subjects completed the 
BPISF and the MGPQ. 
Muscle Strength Measures 
Following the pre-biopsy soreness evaluations, the subjects performed a maximal 
isometric strength test. They sat on the Biodex machine (Biodex System 4 Pro, Biodex 
Medical Systems, Shirley, NY), with their legs relaxed and knees flexed in a 90o angle. 
The chair, back support, and lever arm of the Biodex were positioned so that the axis of 
rotation of the Biodex lever arm was in line with the lateral condyle of the femur. For the 
isometric strength test, the lower leg was then secured in the knee attachment with the 
foot in a flexed position. Knee extension range of motion (ROM) was set from the knee 
in a flexed position at 90o until the knee was extended to 0o of knee flexion (straight leg). 
The Biodex lever arm moved the leg to a 70° position, and subjects were asked to first 
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attempt to extend their leg for 3 sec with maximal effort and then attempt to flex their leg 
for 3 sec, also at maximal effort; they repeated this action three times for one set. Because 
the test was isometric, the lever arm did not move while the subjects contracted with full 
effort. The isometric strength test was repeated until three trials were within 10% of each 
other. After each maximal isometric set, 1-min rest was given.  
Data Analysis 
All statistical analyses were performed using SigmaPlot 11.0. Baseline 
characteristics for men and women are shown in Table 3.1 (e.g. age, height, weight, leg 
dominance, and maximal isometric strength). All baseline measures were analyzed for 
validity and reliability using a repeated measures ANOVA (rmANOVA) and an 
interclass correlation (Pearson product moment) between the two baseline visits. The 
rmANOVA provided the main effect of time (day) and group (sex was used as a grouping 
factor).  
The change in isometric strength pre- to post-biopsy was analyzed with an 
rmANOVA with the main effect of time (e.g. pre- vs. post-biopsy), group (control vs. 
exercise) and leg (biopsied vs. non-biopsied). All measures (isometric strength, soreness, 
and physical activity) were analyzed for a normal distribution and equal variance. If the 
measure failed the normality or variance test, the appropriate non-parametric test was 
used to analyze the measure. Changes in task-related muscle soreness (e.g. STS-VAS, 
Stair-VAS) were analyzed with rmANOVA for the main effect of time (baseline and days 
post-biopsy), bout (e.g. muscle biopsy 1 (MB1)=Bout 0, MB2=Bout 1, and MB3=Bout 
2), group (e.g. control vs. exercise), leg (biopsied vs. non-biopsied leg) and their 
interactions. The muscle soreness assessed via questionnaires (e.g. BPISF, and MGPQ) 
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was analyzed with a Kruskal Wallis test for the main effects analyzed in the task-assessed 
muscle soreness measures (e.g. time, bout, group, and leg). Percent of time spent in 
sedentary, light, moderate, and vigorous physical activity for one day was analyzed with 
an rmANOVA for the main effect of time (pre- vs. post-biopsy) and group (sex). We also 
examined the total activity counts and the amount of steps pre- and post-biopsy using a 
Students t-test. The percent difference between the average isometric strength at baseline 
and the assessment at 7 d post-biopsy was analyzed with an rmANOVA for the main 
effects of visit, group, sex, and leg. 
Results 
Fifteen individuals completed the interview and read the informed consent for this 
study; 12 signed the informed consent, enrolled, and completed the study. The 12 
individuals enrolled in the study were six men and six women. The physical 
characteristics of the 12 subjects are (mean ± SEM): age 23.0 ± 1.6 yr, height 174.1 ± 
2.78 cm, and weight 85.68 ± 9.48 kg. Of the 12 subjects, eight were randomized into the 
exercise group and four were randomized into the control (non-exercise) group. The 
physical characteristics for the two groups are shown in Table 3.1. There was no 
significant difference between the groups for age (p=0.335), height (p=0.903), or weight 
(p=0.261). The exercise and control (non-exercise) groups were balanced for sex.  
Table 3.1: Characteristics for exercise and control groups.  
 
 Exercise Control 
Age (y) 22.13 ± 1.10 24.75 ± 2.20 
Height (cm) 173.83 ± 2.91 174.63 ± 5.43 
Weight (kg) 91.39 ± 11.76 74.26 ± 8.27 
Values are mean ± sem.  
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Subjects received a standardized snack that was consumed 3–5 h before the 
biopsy. After the biopsy, an ice pack was kept on the incision site for 30 m, and during 
this time all subjects were given Tylenol (500mg), a snack (juice box and a granola bar), 
and a physical activity monitor to wear. All subjects consumed the entire biopsy snack 
prior to each biopsy and had the same snack prior to each biopsy. One of the subjects 
declined taking the Tylenol after the biopsy and was instead given an extra packet of 
Tylenol to take away in case it was needed later. At the end of the biopsy visit, subjects 
were given the biopsy care instruction sheet, icepacks, and individual Tylenol packets to 
take home.  
On subsequent visits the biopsy site was inspected for redness, swelling, bleeding, 
elevated temperature, and/or tenderness. The biopsy dressing was then changed and 
subjects were provided with additional Tylenol packets. During this study none of the 
subjects presented with an infection or irritation at the biopsy incision site. However, 
three subjects did present with blisters by 72 h post-biopsy at the terminal points of the 
steri-strips that were used to close the biopsy incision. It is likely that the steri-strips 
pulled on the skin and caused this irritation. All subjects were contacted via telephone at 
48 h and 96 h post-biopsy, and none reported changes at the biopsy incision site since 
their previous visit to the laboratory.  
Physical Activity Assessment 
All subjects wore the Actical for 48 h before and after the baseline muscle biopsy. 
The percent of time the person spent in sedentary, light, moderate, and vigorous activity 
during the 48 h blocks were compared using a 1-way repeated measures ANOVA to 
examine the main factor of time (pre- vs. post-biopsy). All measures of physical activity 
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are shown in Table 3.2 and Figure 3.2. There was no significant difference pre- to post-
biopsy for time spent in sedentary activity p=0.078, for light activity p=0.201, for 
moderate activity p=0.119, or for vigorous activity p=0.200. These results indicate that 
within the first 48 h after a muscle biopsy the physical activity levels were similar to their 
pre-biopsy levels. As shown in Figure 3.3, the daily average for total activity count 
between time points suggests that the biopsy affected their physical activity level, but it 
did not reach significance (p=0.061); pre-biopsy average daily activity count was 
176,216.25 ± 39,256.42, and post-biopsy was 79,938.9 ± 9,456.75. However, we did find 
a significant decrease in total daily steps (p=0.047) after the biopsy compared to before; 
pre-biopsy steps were 7,561.78 ± 1,278.85, and post-biopsy were 4,549.4 ± 813.8. These 
results indicate that subjects were following the biopsy protocol and resting their leg in 
the days after the muscle biopsy. 
Table 3.2: Percent of time spent in different levels of physical activity after a single 
muscle biopsy. 
 Baseline Post-Biopsy % Change from Baseline 
Sedentary 80.0 ± 2.4 84.2 ± 1.4 5.25% 
Light 12.0 ± 1.4 10.2  ±  0.9 -15% 
Moderate 7.0 ± 1.2 4.6 ± 0.6 -34.4% 
Vigorous 0.3 ± 0.2 0.0 ± 0.0 100% 
Values are mean ± sem. 
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Figure 3.2: Percent time spent in different levels of physical activity pre- and post-biopsy. 
Values are mean ± sem. 
 
  
* 
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Figure 3.3: Total daily average for A) steps and B) activity counts pre- and post-baseline 
muscle biopsy. Values are mean ± sem. *p <0.05 from pre-biopsy. 
 
 
Muscle Soreness Measures 
Eccentric exercise causes delayed onset muscle soreness, which peaks between 24 
h and 48 h post-exercise (5). In the present study, we investigated muscle soreness using 
three different measures. The first measure, task-related VAS, has commonly been used 
in our lab to assess muscle soreness post-exercise (10). The second and third measures 
used questionnaires to assess pain.  All muscle soreness measures indicated that peak 
soreness occurred at 24 h for Bout 0 and at 48 h for Bout 1 and Bout 2 (p < 0.05). These 
results are shown in Table 3.3 and Figure 3.4 for the Stair-VAS and STS-VAS, in Table 
3.4 and Figure 3.5 for the MGPQ, and in Table 3.5 and Figure 3.6 for the BPISF 
questionnaire.  
Task-Related Visual Analog Scale 
The stair descent exercise required both legs to undergo eccentric actions, and 
because the muscle biopsy was performed on the same leg 24 h after Bout 1 and Bout 2 
we were able to measure 1) the effect of the exercise on muscle soreness, and 2) the 
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effects of the exercise and muscle biopsy on muscle soreness. The control group did not 
perform the exercise, but still had a muscle biopsy and we measured the soreness of a 
single (Bout 1) and repeated muscle biopsy (Bout 2) on the same leg—the baseline 
muscle biopsy was on the contralateral leg. Traditionally, a single-legged stand-to-sit-to-
stand task (STS-VAS) has been used in our lab to measure muscle soreness of the 
exercised knee extensors, but our exercise model was stair descent so we also measured 
muscle soreness after stair descent (Stair-VAS). The task-related Stair-VAS was 
performed in the laboratory. Because subjects did not report to the laboratory for the 72 h 
and 120 h visit, the Stair-VAS was not measured at these time points as not all subjects 
had access to stairs. Subjects were able to perform the STS-VAS at home for the 48 h and 
96 h visit.  
Table 3.3: Task-related visual analog scale (VAS) soreness levels hours after a muscle 
biopsy. 
 STS (mm) Stair (mm) Stair Descent (sec) 
0 h 0.96 ± 0.55 0.38 ± 0.27 6.25 ± 0.24 
24 h 25.46 ± 4.89* 24.96 ± 4.33* 6.25 ± 0.37 
48 h 15.75 ± 3.55* - - 
72 h 8.33 ± 3.49* 4.64 ± 3.36 8.09 ± 1.41* 
96 h 3.58 ± 2.33 - - 
120 h 1.83 ± 1.14 1.25 ± 0.99 6.17 ± 0.41 
168 h 0.75± 0.59 0.38 ± 0.38 6.20 ± 0.37 
Note: STS, stand-to-sit-to-stand motions. Values are mean ± sem. 
*Indicates (P < 0.05) from 0 hour (baseline). 
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Figure 3.4: Visual analog scale (VAS, 100 mm) results for muscle soreness task activities 
(e.g. stand-to-sit-to-stand (VAS-STS) and stair descent (VAS-Stair) for the exercise 
group (A1–A4) and the control group (B1–B4). *p >0.05 between hours post-bout, φ p > 
0.05 between bouts, τ p >0.05 between exercise vs. control.   
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Using the STS-VAS, we detected a difference in soreness between the biopsied 
(Figure 3.4.A1) and non-biopsied (Figure 3.4.A3) leg after Bout 0, Bout 1, and Bout 2 
(p=0.039); however, using the Stair-VAS measure, we found no difference between 
biopsied (Figure 3.4.A2) and non-biopsied (Figure 3.4.A4) legs (p=0.1018). The task-
related muscle soreness measures showed that muscle soreness increased to a greater 
extent in the exercise group despite leg biopsied or bout compared to the control group (p 
<0.0001) at all time points. The exercise group had significantly higher task-related 
soreness levels for both legs after Bout 1 compared to the control group biopsied leg at 
Bout 1 (p <0.05) as assessed with both task-related VAS measures. The exercise group 
also had significantly lower task-related soreness levels after Bout 2 compared to Bout 1 
(p <0.05) for both legs. In addition, the soreness levels of the biopsied and non-biopsied 
leg in Bout 2 for the exercise group were not significantly different from the biopsied leg 
for the control group at Bout 0 and Bout 1.  
McGill Pain Questionnaire 
Sensory and Affective Measures of Pain 
The MGPQ assessed four aspects related to pain: sensory, affective, non-task-
related VAS, and current pain index; these results are shown in Table 3.4 and Figure 
3.5.A1–A4 and 3.5.B1–B4. Subjects did not fill out a different MGPQ for the biopsied 
and non-biopsied leg; therefore, the four pain aspects measured with the MGPQ 
encompass both legs for the exercise group and the biopsied leg, only, for the control 
group. The McGill Pain Sensory score assessed pain intensity by tabulating 11 pain 
quality items (e.g. throbbing, stabbing, sharp) with a potential of three points per item (0 
point=none, 1 point=mild, 2 points=moderate, 3 points=severe). Muscle pain intensity 
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(e.g. sensory score) was significantly elevated (p >0.05) for the exercise group compared 
to the control group at 48 h and 72 h post-Bout 1 compared to 0 h post-Bout 1 and to 48 h 
and 72 h post-Bout 0 (Figure 3.5.A1 and 3.5.B1). The second aspect of the MGPQ 
assessed the affective component of pain and measured the unpleasantness caused by the 
pain using four pain quality items (e.g. fearful, tiring-exhaustive, sickening, punishing 
cruel) with the same three-point scale used for the sensory score. The exercise group 
compared to the control group had a significantly (p <0.05) higher affective score at 48 h 
post-Bout 1 compared to 0 h post-Bout 1 and to 48 h post-Bout 0. The exercise group 
also reported a significantly lower affective score after Bout 2 compared to Bout 1 and 
Bout 0 at 48 h. The control group did not report a significant increase in unpleasantness 
after the muscle biopsy at any time point (p=0.451) or among bouts (p=0.422). 
 
Table 3.4: McGill Pain Questionnaire (MGPQ) scores hours after a muscle biopsy, n=12. 
 Sensory Affective VAS Non-Task Current Pain 
0 h 0.08 ± 0.08 0.00 ± 0.00 1.06 ± 0.63 0.00 ± 0.00 
24 h 6.75 ± 1.00* 0.33 ± 0.19 27.75 ± 5.35* 1.13 ± 0.23* 
48 h 2.17 ± 0.47* 0.00 ± 0.00 10.25 ± 2.28* 0.38 ± 0.18 
72 h 1.25 ± 0.45 0.00 ± 0.00 4.81 ± 1.18 0.25 ± 0.16 
96 h 0.50 ± 0.19 0.00 ± 0.00 2.63 ± 1.17 0.13 ± 0.13 
120 h 0.08 ± 0.08 0.00 ± 0.00 3.13 ± 2.37 0.25 ± 0.16 
168 h 0.08 ± 0.08 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Values are mean ± sem. 
*Indicates  (P <0.05) from 0 hour (baseline). 
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Figure 3.5: McGill Pain Questionnaire (MGPQ) results for the exercise group (A1–A4) 
and the control group (B1–B4). Included plots are the averaged scores for the following 
parameters: 1) sensory score, 2) affective score, 3) non-task VAS, and D) current pain 
index. Results are mean ± SEM. *p >0.05 between hours post-bout, φ p > 0.05 between 
bouts, τ p >0.05 between exercise vs. control. 
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Non-task Visual Analog Scale and Current Pain Index 
The MGPQ contains a VAS, but this scale does not use a task (VAS-non-task), 
and the results are shown in Figure 3.5.A3 and Figure 3.5.B3 for the exercise and control 
group. The non-task VAS measured muscle soreness due to the muscle biopsy in the 
control group but, because subjects filled out a single questionnaire, the exercise group 
reported their maximal soreness indifferent to the leg biopsied. There was a significant 
difference between the exercise and control group (p=0.0049), hours post-bout (p 
>0.0001), and among bouts (p >0.0001). At 24 h after Bout 0 the exercise and control 
group had a significantly (p > 0.05) higher level of non-task VAS soreness (27.75 mm ± 
5.34 mm and 37.38 mm ± 18.69 mm, exercise and control group, respectively) compared 
to 0 h (0 mm ± 0mm for both legs). At 48 h after Bout 1, the exercise and control group 
had a significantly (>0.05) higher level of non-task VAS soreness (60.88 mm ± 9.84 mm 
and 40.13 mm ± 10.62 mm, exercise and control group, respectively) compared to 0 h (0 
mm ± 0mm for both legs) and 24 h (39.81mm ± 8.74 and 36.38 mm ± 9.94 mm, biopsied 
and non-biopsied legs, respectively). The exercise group also had a significantly higher 
level of non-task VAS soreness in Bout 1 at 72 h and 96 h compared to baseline. After 
Bout 2, the exercise and control group had a significantly (p >0.05) lower level of non-
task VAS soreness at 48 h compared to Bout 1 (18.63 mm ± 4.04mm and 13.25 mm ± 
6.40 mm, exercise and control group, respectively). The final pain-measuring aspect of 
the MGPQ was the Current Pain Index (CPI), which required the subjects to rate their 
pain based on a 6-point scale (0=no pain and 5=excruciating pain). The results of the CPI 
are shown in Figure 3.4.A4 and 3.4.B4 for the exercise and control group, respectively. 
There was no significant difference in Bout 0 for time or group. In Bout 1, the exercise 
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group had a significantly higher CPI at 48 h (p >0.001) and 72 h (p=0.002) compared to 0 
h, while the control group in Bout 1 had a significantly higher CPI level at 48 h post-Bout 
1 (p=0.001) compared to 0 h. In addition, at 48 h the exercise group had a significantly 
higher CPI level in Bout 1 compared to Bout 0 (p >0.05) and Bout 2 (p >0.001), a 
difference that was also evident at 72 h (p=0.016). There was no significant difference in 
CPI level for the control group among bouts (p=0.422).  
Using the sensory and affective pain assessments of the MGPQ, we detected a 
repeated bout effect in the exercise group. In the control group the MGPQ non-task VAS 
indicated that a second biopsy (e.g. MB3, Bout 2) from the same leg as biopsied in Bout 
1 (MB2) resulted in less soreness than the second biopsy (Bout 1, MB1). However, when 
the muscle biopsy was performed in the contralateral leg (e.g. Bout 0, MB1 compared to 
Bout 1, MB2) the muscle soreness level was not significantly lower. These results 
demonstrate that each of the four pain aspects assessed by the MGPQ can detect the 
repeated bout effect after eccentric exercise and indicate that a second biopsy in the same 
leg results in less soreness.   
Brief Pain Inventory Short Form  
Severity and Interference Measures of Pain 
The BPISF, similar to the MGPQ, measured the sensory aspect of pain, but 
instead of measuring items of pain intensity, the BPISF measures items of pain severity 
as shown in Figure 3.6.A1–A4 and 3.6.B1–B4 (exercise and control groups, 
respectively). The exercise group reported a significant (p <0.05) increase in pain severity 
at 24 h and 48 h for all three bouts compared to 0 h, as shown in Figure 3.6.A1. The 
increase in pain severity reported by the exercise group a day after the exercise in Bout 1 
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(24 h post-Bout 1) was significantly (p >0.001) greater than the pain severity reported by 
the control group, which did not exercise. The day after the muscle biopsy (24 h post-
Bout 0 and 48 h post-Bout 1), the control group reported a significant (p <0.001) 
elevation of pain severity as shown in Figure 3.6.B1. However, there was no significant 
difference between the pain severity of the control and exercise groups at 48 h despite 
bout. The BPISF also measured how the exercise and/or muscle biopsy affected the 
subjects’ daily life by measuring the level of interference resulting from the pain/soreness 
based on nine pain interference items using an 11-point Likert Scale (0=does not interfere 
and 10=completely interferes). The tabulated interference pain score showed that the 
exercise produced pain that significantly interfered with their daily life (p=0.0001). In 
Bout 1, the exercise group reported greater interference with daily tasks at 24 h (1.68 ± 
0.61) and 48 h (3.79 ± 0.44) compared to the control group (0 ± 0 and 1.04 ± 0.58 for 24 
h and 48 h, respectively) as shown in Figure 3.6.A2 and 3.6.B2. The exercise group also 
reported a significantly (p=0.002) lower level of pain interference in Bout 2 at 48 h and 
72 h compared to Bout 1 and Bout 0 at these time points. The exercise resulted in a 
significant increase in pain severity and pain that interfered with activities of daily living, 
but both of these measures indicated the repeated bout effect, as they were reduced 
significantly in Bout 2 compared to Bout 1.  
Table 3.5: Brief Pain Inventory Short Form (BPISF) scores hours after a muscle biopsy. 
 Severity Interference Tylenol 
users 
Tylenol dose (mg) % Relief 
0 h 2.3 ± 1.8 2.0 ± 1.7 0 0.0 ± 0.0 0.0% ± 0.0% 
24 h 8.8 ± 1.0* 15.5 ± 2.7* 11 1458.3 ± 242.0* 49.2% ± 6.6%* 
48 h 3.8 ± 0.7* 5.3 ± 2.0 8 1250.0 ± 295.2* 33.3% ± 11.0% 
72 h 2.0 ± 0.8 0.8 ± 0.4 4 1000 ± 246.2* 21.0% ± 10.4% 
96 h 1.8 ± 0.9 0.6 ± 0.5 0 0.0 ± 0.0 0.0% ± 0.0% 
120 h 1.2 ± 0.6 0.2 ± 0.2 0 0.0 ± 0.0 0.8% ± 0.8% 
168 h 0.2 ± 0.1 0.0 ± 0.0 0 0.0 ± 0.0 0.0% ± 0.0% 
Values are mean ± sem. * Indicates  (P < 0.05) from 0 hour (baseline). 
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Figure 3.6: Brief Pain Inventory Short Form (BPISF) questionnaire results for the 
exercise group (A1–A4) and the control group (B1–B4). Included plots are the averaged 
scores for the following parameters: 1) severity, 2) interference, 3) Tylenol use, and D) 
Tylenol % relief. Results are mean ± SEM. *p >0.05 between hours post-bout, φ p >0.05 
between bouts, τ p >0.05 between exercise vs. control. 
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Tylenol Use and Percent Relief from Tylenol 
One of the subjects from the exercise group declined taking the Tylenol after the 
baseline biopsy or the biopsies after Bout 1 and Bout 2 and was instead given an extra 
packet of Tylenol to take away in case it was needed later. This subject reported never 
taking Tylenol after the baseline biopsy or the biopsy in Bout 1 and Bout 2. Therefore, 
this subject was removed from the analysis of Tylenol use and percent relief from 
Tylenol. The seven exercise subjects who took the Tylenol used 1500 mg the day of the 
biopsy and the day after in Bout 0, 1, and 2 and reported a 42.50 % ± 8.40 % relief of 
their pain for Bout 0 (biopsy only), a 27.50 % ± 9.01 % relief of their pain for Bout 1 
(eccentric exercise Bout 1 and biopsy), and a 31.25 % ± 9.93 % for Bout 2 (eccentric 
exercise Bout 2 and biopsy) as shown in Figure 3.5.A4. The control group reported a 62.5 
% ± 7.5 % relief of pain for Bout 0 (biopsy, e.g. right leg), an 80.00 % ± 4.1 % relief of 
pain for Bout 1 (biopsy, e.g. left leg), and a 75.01 % ± 10.4 % relief of pain for Bout 2 
(biopsy, e.g. left leg) for the same dose of Tylenol as the exercise group at one day after 
the biopsy, as shown in Figure 3.6.B4. The control and exercise group used Tylenol until 
96 h in Bout 0. In Bouts 1 and 2, the control group only used the Tylenol until 48 h, while 
the exercise group continued to use Tylenol until 120 h in Bout 1 and until 96 h in Bout 
2, as shown in Figure 3.6.A3 and 3.6.B3.  
Similar to the results from the MGPQ, the BPISF questionnaire also indicated a 
repeated bout effect after eccentric exercise for the sensory and affective measures of 
muscle pain (e.g. pain severity and pain interference). In addition, only the pain severity 
measure was significantly elevated after a muscle biopsy and neither pain severity nor 
pain interference was significantly different for the control group among bouts. The 
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Tylenol use and percent relief due to the Tylenol data indicates that pain resulting from a 
muscle biopsy required the use of Tylenol the first few days after the first muscle biopsy 
and only for the first day after a repeated biopsy—despite the biopsy being collected from 
the ipsilateral or contralateral leg. Unlike the non-task VAS of the MGPQ, which 
indicated less soreness after the muscle biopsy in Bout 2 compared to Bout 1 and Bout 0, 
there was no reported difference in Tylenol use between bouts after a muscle biopsy.    
Muscle Strength Measures 
Baseline maximal isometric strength was measured at two visits separated by 2–5 
d before Bout 0. There was no significant difference between the two baseline 70° 
isometric strength measures (p=0.372). The baseline measures of muscle strength were 
not different between the exercise and control group. Because there was no significant 
difference between the baseline strength visits, the baseline strength assessments were 
averaged. The measure of maximal isometric strength was used to assess if the exercise 
protocol produced muscle damage, and therefore it was only measured at baseline and 
pre- and post-Bout 1 and Bout 2 because Bout 0 did not have any exercise.  
All subjects had a muscle biopsy (MB1, baseline biopsy) between the baseline 
and pre-bout strength measure, and therefore the averaged baseline strength measures 
were compared to the pre-bout strength measure using a Student’s t-Test. There was no 
significant difference in the strength measure between the averaged baseline visits 
compared to pre-bout strength (p >0.700, isometric strength; p=0.074). The control group 
did not perform the exercise and therefore they did not complete the post-bout strength 
measure. As expected, the exercise group had a significant (p=0.018) decrease in strength 
after the eccentric exercise, as shown in Table 3.6 and Figure 3.7. In addition, the 
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exercise group did not have a significant (p >0.290) decrease in strength post-Bout 2 
compared to pre-Bout 2. Maximal isometric strength data indicate that the exercise group 
experienced the repeated bout effect. For the control group there was no difference 
between baseline, pre-Bout 1, and pre-Bout 2 for strength (p=0.744), as shown in Table 
3.6 and Figure 3.7. Overall, these results indicate that the eccentric exercise of stair 
descent was sufficient to produce a repeated bout effect for strength. Isometric strength 
was not significantly different from baseline at 6 d post-muscle biopsy, and multiple 
biopsies (e.g. control group) did not significantly affect strength.  
Table 3.6: Isometric and passive torque hours after a muscle biopsy. 
  
Isometric Extension 
  
Peak Torque (N-m) 
  
70° 
Baseline 1  251.3 + 28.6 
Baseline 2  258.6 + 31.0 
Average of Baseline Visits 
 
 253.77 ± 31.1 
168 h Post-Biopsy 252.2 ± 31.8 
Values are mean ± sem. 
 
 
 
Figure 3.7: Maximal isometric strength 70° (N-m) of the exercise (A) and                 
control (B) groups. Values are mean ± sem. *Indicates p <0.05 from Pre-Bout. 
  
 
 
86 
Discussion 
Skeletal muscle soreness has been used by researchers to document the recovery 
of muscle from damaging exercise (3,14,21). However, many researchers also use muscle 
biopsies to examine the molecular changes to muscle after a damaging exercise. Here we 
show that the muscle biopsy alone produces a significant amount of muscle soreness. We 
have also shown the effects a muscle biopsy has on physical function (e.g. a decrease in 
total daily steps and likely in total activity counts). The results from this study can help 
inform institutional review boards and other researchers on how a muscle biopsy affects 
an individual (e.g. peak sensory and affective aspects), how long the effects are present 
after the muscle biopsy procedure, and if the biopsy confounded measures of muscle 
soreness and strength.  
We used a three-pronged approach in this study to examine muscle soreness and 
how this soreness affected the subject’s daily life after a muscle biopsy. The first 
approach to examine muscle soreness used a typical laboratory measurement—a visual 
analog scale (VAS, 0–100 mm). In our lab, subjects perform a task that requires them to 
use the affected muscle group and then record their level of soreness on the scale. For this 
study we used two tasks: the first task was to perform stand-sit-stand (STS-VAS) action 
using just the affected leg, and the second task was to walk down stairs (Stair-VAS). We 
found the muscle biopsy elicited a significant increase in muscle soreness with both 
soreness tasks. The second approach entailed the use of two questionnaires. Both the 
MGPQ and the BPISF  have a sensory component and an affective component. 
Therefore, we were able to measure the unpleasantness of the biopsy procedure and to 
what degree the soreness affected the subjects. The third approach was the use of 
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physical activity monitors because they provide an objective measure of physical activity 
levels. This is in contrast to the task-specific VAS and the questionnaires, which are 
subjective measures of muscle soreness.  
VAS Task-Specific Soreness 
The increase in muscle soreness at 24 h after a biopsy only was ~25 mm for both 
tasks, STS-VAS and Stair-VAS. The soreness elevation of ~25 mm is approximately 
40% less than the soreness level commonly reported in studies using a leg eccentric 
exercise model without a biopsy procedure (5). In addition, by 96 h post-biopsy all 
subjects reported a soreness level of ~3 mm and that level was not significantly different 
from their baseline soreness level (~1 mm). After a bout of eccentric exercise, muscle 
soreness does not generally return to baseline until 120 h (5); high-responders have a 
more prolonged return to baseline levels (~14 d) (4,6). These results indicate that both 
peak soreness and duration of soreness after a biopsy is significantly less than after a bout 
of eccentric exercise. The VAS soreness tasks allowed us to measure the sensory 
components of soreness (e.g. severity of soreness) felt after a muscle biopsy procedure, 
but the VAS measures do not allow us to understand how this soreness affects the 
subjects’ daily life (e.g. sickening, tiring-exhaustion, fear causing, walking ability, 
relations with other people, work, and sleep).  
Overall, the task-related VAS measures indicate that muscle soreness from 
eccentric exercise and/or a muscle biopsy returns to baseline by 96 h despite bout. And 
that in the exercise group, the repeated bout effect was achieved with the stair descent 
exercise as shown by the significantly lower levels of muscle soreness in Bout 2 
compared to Bout 1 at all time points after the exercise. 
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Pain Questionnaires: Sensory Component 
We found that the sensory component of the BPSIF, the MGPQ, and the non-task 
VAS from the MGPQ indicated a significant elevation of muscle soreness at 24 h after 
biopsy, but the level of muscle soreness was smaller than the task-specific muscle 
soreness measurement (e.g. VAS-Stair and VAS-STS). Of interest, the STS-VAS muscle 
soreness levels in Bout 1 at 72 h of 41.07 mm ± 10.88 mm and 33.71 mm ± 12.76 mm 
(biopsied and non-biopsied leg, respectively) were similar to the non-task VAS muscle 
soreness level of 38.33 mm ± 9.52 mm; however, unlike the non-task VAS measure, the 
STS-VAS measures of muscle soreness were not found to be significantly greater at 72 h 
compared to baseline. At 96 h after Bout 1 the task-related muscle soreness measures 
were again not different from baseline, while the non-task VAS found muscle soreness 
was still significantly elevated despite similar amount (mm) of soreness between the two 
non-task and task-related VAS measures. These results suggest that non-task and task-
related VAS muscle soreness measures detect muscle soreness similarly, but that the non-
task VAS may assess muscle soreness at later time points (e.g. 72 h and 96 h post-bout) 
better than the task-related VAS.  
Based on the BPISF, soreness was significantly elevated at 48 h post-biopsy, and 
the sensory component of the MGPQ also showed that at 72 h post-biopsy, soreness was 
not significantly different from baseline, indicating that the individuals were no longer 
sore from the biopsy procedure. Because the task-specific VAS found that individuals 
still had soreness at 96 h post-biopsy and the MGPQ reported that individuals had 
returned to baseline 24 h prior, we believe that the MGPQ underestimates the intensity 
and duration of muscle soreness after a muscle biopsy because the subjects were not 
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performing a task to measure their muscle soreness. It is likely that when the subjects 
recalled their peak level of soreness as they filled out the BPISF and the MGPQ, they had 
difficulty ascribing a score to their peak soreness because the soreness was not as 
noticeable throughout the day. The muscle soreness from the biopsy may have only been 
noticeable when the subject performed an activity or contracted the muscle. These results 
suggest that using an activity or task to measure muscle soreness may be more 
appropriate to measure peak soreness. These findings illustrate the need for muscle 
soreness researchers to use a common tool or a standard set of tools to evaluate muscle 
soreness after a biopsy or eccentric exercise so that studies examining modalities to treat 
muscle soreness can be compared. 
Pain Questionnaires: Affective Component 
 Because soreness after a biopsy had not been previously investigated, we 
expected that the affective component of the questionnaires would be significantly 
elevated in the days after the muscle biopsy. However, we found that the affective 
component of the MGPQ was not significantly different from baseline at any time point 
and the BPISF was only elevated at 24 h post-biopsy. It is likely that the BPISF was able 
to measure the affective component better than the MGPQ in the present study because 
the BPISF had an ordinal scale that ranged from 0–10 (0=does not interfere, to 
10=completely interferes) instead of the 0–3 (0=none, to 3=severe) used in the MGPQ. 
For the MGPQ, individuals rated the quality of their pain with these characteristics: fear 
causing, punishing-cruel, sickening, and tiring-exhaustive. For the BPISF, individuals 
rated their amount of interference with these characteristics: quality of life, daily 
activities, walking ability, sleeping, mood, and relations with people. While the biopsy 
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procedure itself may have elicited severe pain ratings for being fear causing, sickening, 
punishing-cruel, and tiring-exhaustive, on the MGPQ none of these characteristics were 
selected at 24 h post-biopsy and none of these characteristics were found to be 
significantly elevated 24 h after a single or repeated bout of eccentric exercise. 
Since the control group did not exercise they were not expected to report 
interference of their daily tasks from pain at 24 h, but it was expected that the pain of the 
muscle biopsy would interfere with their daily life. Of note, the MGPQ also found that 
the muscle biopsy did not affect their daily lives. These results suggest that in young, 
healthy individuals, a muscle biopsy does not affect or interfere significantly with 
activities of daily living. 
The difference in the duration of Tylenol use between Bout 1 and Bout 2 (e.g. 
taking Tylenol for 120 h vs. 96 h) for the exercise group may be related to the repeated 
bout effect for DOMS. Incidentally, the percent relief from Tylenol in Bout 1 and Bout 2 
for the exercise group was significantly less than the control group at 48 h (p >0.05). 
Within the first 24 h post-biopsy, over 70% relief was provided by the Tylenol for the 
control group; this, combined with the fact that the control group did not report taking 
Tylenol after 48 h in Bout 1 and Bout 2, indicates that any pain remaining after 48 h post-
muscle biopsy did not require Tylenol for management. However, the exercise group 
found less relief from pain, and four of the seven individuals in that group continued to 
manage their pain until 72 h post-bout, one individual requiring Tylenol to manage the 
pain from the muscle biopsy at 120 h. This indicates that the exercise likely affected pain 
to a greater extent than the biopsy alone, and that Tylenol use can indicate soreness. 
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Physical Activity Monitor 
Physical activity monitors have been commonly used to assess physical activity 
and to measure changes in physical activity (9,19,24). In addition, physical activity 
monitors have been used to assess one’s recovery from surgery (17,23,27). However, 
these studies have examined individuals who underwent a surgery requiring a hospital 
stay. The muscle biopsy procedure used in this study was similar to protocols used in 
other studies and does not require a hospital stay (13,15,16,18,20,21,25,26). A muscle 
biopsy is a minor surgery, such that a local anesthesia is used and often the incision does 
not require stiches (25). Many researchers have had the subjects perform strenuous 
activity after a muscle biopsy (1,7). After the biopsy in this study, our subjects were 
encouraged to maintain their regular activities (e.g. laundry, grocery shopping, etc.) but 
were instructed to refrain from vigorous activity for the first 48 h after the biopsy. The 
decrease in vigorous physical activity pre- and post-biopsy was therefore not a result of 
the biopsy affecting the subjects, but instead was because the subjects were instructed to 
not perform vigorous activity for the first 48 h after the biopsy. These instructions 
account for the decrease in vigorous activity from 0.3% to 0.0% after the muscle 
biopsy—a 100% difference between pre- and post-biopsy. Interestingly, both the light 
and moderate activity decreased by 15% and 34%, respectively, after the muscle biopsy 
compared to baseline. Light and moderate activity were both strongly negatively 
correlated to the increase in sedentary activity. However, we did not find a correlation 
between any activity level and the task-related VAS soreness levels. It is possible that our 
inability to detect a significant difference between activity levels before and after the 
biopsy was due to small sample size or using a monitor that is best at measuring total 
activity and not time in specific activity levels (19). When we analyzed total activity 
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counts we did not find a significant decrease after the biopsy compared to before. But, we 
did find that subjects took fewer steps after a muscle biopsy compared to before a biopsy. 
Activity monitors may underestimate activity at vigorous levels and overestimate activity 
at light levels (9). The negative correlation found between sedentary activity and light 
and moderate activity suggest that the muscle biopsy did affect physical activity levels. In 
addition, the decrease in steps after as compared to before a muscle biopsy indicates that 
the muscle biopsy did affect the subject’s physical activity. Using a monitor that can 
distinguish between sitting and standing, such as an activPal™, may be more sensitive 
and indicate a significant difference between pre- and post-biopsy.  
Conclusion 
We found that a muscle biopsy does not affect muscle soreness more than a 
moderate eccentric exercise protocol, either in peak soreness or duration (5,11,16). 
However, we cannot say how a muscle biopsy performed at later time points (e.g. 48 h, 
72 h, 96 h, or 120 h) post-eccentric exercise would affect muscle soreness. We had 
expected that the muscle biopsy would produce a significant and potentially prolonged 
affective soreness; however, this was only true 24 h post-biopsy. Finally, we had 
expected that the use of a physical activity monitor would provide us with a better 
understanding of how the recorded levels of muscle soreness may affect one’s daily 
activity. Rather, we found no correlation between these measures when using an Actical 
to measure physical activity levels. It is important to note that the muscle biopsy 
procedure only resulted in a minimal elevation of affective measures of soreness at 24 h, 
that the modest increase in the task-related VAS measure of soreness returned to baseline 
by 72 h, and that there was no effect on physical activity levels. These results indicate 
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that researchers examining treatments for muscle soreness can feel confident that a 
baseline biopsy scheduled 2–3 d prior to an exercise will not confound their results. 
Finally, while the muscle biopsy did result in a decrease of average daily steps after the 
biopsy, the peak soreness level and the duration of muscle soreness indicate that a muscle 
biopsy is less “damaging” to the skeletal muscle than a bout of eccentric exercise.   
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CHAPTER 4 
DELAYED ONSET MUSCLE SORENESS & MOLECULAR CHANGES IN 
SKELETAL MUSCLE EXTRACELLULAR MATRIX AFTER ECCENTRIC 
EXERCISE (Study 2)  
Abstract 
We sought to examine the relationship between delayed onset muscle soreness 
(DOMS) and the molecular response of the extracellular matrix (ECM) remodeling 
molecules (MMP9, MMP2, TIMP1, TIMP2, and TNC) and mechanotransduction 
molecules (ITGA7, ITGB1, COL3, COL4, and LAMA2). We wanted to identify which 
genes and their protein products may provide protection from a future bout of exercise 
and be related to the reduction in DOMS found after a second bout of exercise. These 
molecules were examined at baseline (MB1), 7 d after MB1 (MB2), and 14 d after MB2 
(MB3); the exercise group completed the exercise bout 24 h prior to MB2 (Bout 1) and 
MB3 (Bout 2). Our model induced muscle soreness after eccentric exercise (Bout 1 and 
Bout 2) (p <0.05). TNC mRNA levels increased (p=0.016) after Bout 1 of eccentric 
exercise compared to baseline and decreased (p <0.016) after Bout 2 compared to Bout 1. 
The TNC mRNA results were correlated with DOMS at 48 h post-exercise in Bout 1 
(r=0.621, p=0.031)  and Bout 2 (r=0.935, p=0.036), but none of the other ECM 
remodeling genes or mechanotransduction genes were correlated with DOMS. mRNA 
expression levels for MMP9 (p >0.03) in the control and exercise groups was greater 
after Bout 1 compared to baseline, and COL3 mRNA levels increased (p=0.018) after 
Bout 1 and Bout 2 compared to baseline. ITGA7 (p=0.012) mRNA levels increased after 
Bout 2 compared to baseline. Additionally, the mRNA expression levels for ITGA7 
(p=0.012) in the control and exercise groups were greater in the left leg compared to the 
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right leg for Bout 1 and Bout 2 compared to baseline. The respective protein products for 
TNC, MMP9, and COL3 were unaltered 24 h after a single or repeated bout of eccentric 
exercise. However, we found three isoforms for ITGA7 protein (7X12X2B, 7X1B, and 
7X2B) expressed in the control and exercise group. The protein levels of the 7X2B 
isoform were decreased in Bout 1 for the control and exercise group compared to baseline 
and returned to baseline in Bout 2. Overall, these results demonstrate that only the mRNA 
of TNC, an ECM remodeling molecule, is associated with DOMS and that the remaining 
ECM and mechanotransduction molecules investigated in this study are not associated 
with DOMS or the repeated bout effect. While the TNC and COL3 results are not novel, 
they do confirm the changes in mRNA expression levels after exercise compared to 
baseline reported by previous studies. The effect of a single and repeated bout of 
eccentric exercise on expression levels of MMP9 mRNA and the three isoforms of 
ITGA7 protein are a new contribution to the DOMS literature.  
Introduction 
Delayed onset muscle soreness (DOMS) has been thought to have an origin in the 
connective tissue of skeletal muscle since 1902 (25). DOMS was discovered by Hough 
(25) in 1902 after subjects performed an unaccustomed exercise and in 1973 Talag et al. 
(74) determined that it was the muscle-lengthening versus muscle-shortening exercises 
that produced DOMS. Currently, we understand which activities (e.g. eccentric exercise, 
downhill walking, negatives) produce DOMS but we do not have a clear understanding of 
what causes DOMS. The origins of DOMS have been suggested to be a result of 
inflammation processes due to chemotaxis (12,13,43) in the connective tissue, or 
activation of connective tissue resident cells (83) and molecules (65) (e.g. MMPs and 
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tenascin-C) from the strain of eccentric exercise (19,33,48). Only recently, has a 
connection between a connective tissue molecule called tenascin-C and DOMS been 
found (12 44). Crameri et al. (12) found that skeletal muscle soreness was correlated to 
tenascin-C levels. Malm et al. (49) has also shown that proteins altered after eccentric 
exercise are associated with molecules within the connective tissue of skeletal muscle and 
not the inflammation processes due to chemotaxis.  
While the genes and proteins involved in these remodeling processes are known, 
the genes and proteins that are related to DOMS are not well defined. It is possible that 
genes and proteins that initiate muscle adaptation to eccentric exercise are likely involved 
in the development of DOMS and are sensitive to the load that is placed on the muscle 
and act as mechanosensors. The mechanosensors in skeletal muscle would sense the load 
placed on the muscle and then initiate the proper remodeling response. In order to initiate 
remodeling processes, the mechanosensors would need to be located in an area that 
conducts the force from the myofilaments in the muscle cell to the tendon that attaches to 
the bone (35). The organization of skeletal muscle allows for force to be easily 
transmitted from the myofilaments to the tendon attached to the bone.  
Skeletal muscle cells (muscle fibers) are arranged in parallel and are connected to 
each other through the cytoskeleton (16). The cytoskeleton also connects the muscle 
fibers to a layer of connective tissue called the extracellular matrix (ECM) that surrounds 
the muscle cell (35,58). Together, the cytoskeleton and the ECM allow for the 
transmission of force from the myofilaments to the tendon of the bone (35,58). 
Coincidentally, the organization of the ECM and the cytoskeleton allows for the 
transmission of an external force (e.g. eccentric exercise) to be transmitted to the muscle 
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cell. Stauber et al. (68) showed that in cross sections from skeletal muscle biopsy 
samples, the tight packing of the muscle fibers were shown to be widened, and the ECM 
appeared to be disrupted after eccentric exercise. However, the Stauber et al. (68) study 
did not investigate components of the ECM involved in connecting the ECM to the 
cytoskeleton or remodeling enzymes such as tenascin-C, matrix metalloproteinases 
(MMPs), and tissue-inhibitor of metalloproteinases (TIMPs) or their relationship to 
DOMS. When Stauber et al. (68) investigated the ECM after eccentric exercise, tenascin-
C, MMPs, and TIMPs had not yet been well characterized and their potential role in 
DOMS and skeletal muscle remodeling was not explored. It is important to understand 
how these remodeling proteins are regulated before and after a repeated bout of eccentric 
exercise because they may act as mechanosensors and be involved in DOMS. If their 
activation is suppressed following a repeated bout of eccentric exercise, they may be the 
molecules responsible for rendering a muscle “adapted” to a previous load and having 
less soreness.  
The activity and protein levels of MMPs in human skeletal muscles have been 
shown to be responsive to endurance exercise (24,62,64). MMPs may play an important 
role in the repair and remodeling process after eccentric exercise because they cleave cell 
surface receptors (55), cleave collagens (MMP2 and MMP9 cleave collagen 4) (37), and 
initiate and control inflammatory processes (51). It is likely that the expression and 
activity of MMPs would also increase in skeletal muscle after an acute bout of eccentric 
exercise because the remodeling process in skeletal muscle requires cleavage of cell 
surface receptors and collagen in order to reorganize the ECM. The inflammatory process 
activates macrophages to phagocytize cellular debris (53,54) and promote activation of 
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myogenic precursor cells to assist in the repair and remodeling process. Macrophages are 
a known source of MMPs (7,27,59).  
In a repeated bout of eccentric exercise the muscle has adapted to the strain and 
thus the activation of MMPs, and their expression is expected to be blunted because the 
muscle and the ECM are stronger and more resilient (14). In mice that did not produce 
MMP-9, skeletal muscle remodeling occurred sooner compared to the wild-type mice 
(14). Ablation of MMP9 in this model after muscle damage delayed the remodeling 
process when compared to wild-type, supporting the role of MMP-9 in promoting 
remodeling processes (14). Dhaiya et al. (14) also found an increase in AKT1 
phosphorylation and its downstream products (FOXO and mTOR) as well as a decrease 
in protein levels of collagen I and collagen IV in animals with elevated MMP9 levels. 
These results suggest that MMP9 plays a role in activation of protein synthesis necessary 
for growth via AKT1 and that MMP9’s effect on collagens allows for the expansion of 
the muscle fiber within the ECM matrix (37,87). 
In addition to MMPs and collagens being altered after exercise, the ECM 
molecules tenascin-C, integrins, and laminin are also altered after stretching or exercise 
and may therefore play a role in DOMS (2,13,42,45,50). Of these ECM molecules, 
collagen, integrin and laminin are intimately connected to form the 3-dimensional ECM 
and therefore these molecules play an important role in transmitting force to and from the 
muscle fiber (35). The integrins are a key component to the 3-dimensional meshwork of 
the ECM because they are a membrane protein that has both cytosolic and extracellular 
domains (35,73). The location of integrins suggests that they may act as mechanosensors 
for skeletal muscle. For example, the cytosolic domain of integrins interact with focal 
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adhesion molecules (e.g. focal adhesion kinase [FAK]) and after injury, integrins have 
been shown to cluster and then phosphorylate the tyrosine residues of FAK (73). FAK 
tyrosine phosphorylation (FAKTyr) has been shown to increase after eccentric exercise in 
humans (82), and because FAK is upstream of AKT1, it also increases AKT1 
phosphorylation and can promote protein synthesis. Mice with an increase in integrin α7 
expression compared to wild-type are protected from muscle damage after eccentric 
exercise (2,91) and have muscle hypertrophy (42,91). These data from animal and cell 
culture work demonstrate that integrins play an important role in the repair and 
remodeling process after damage.  
There are no data at this time to support that integrins play a role in the 
remodeling process after eccentric muscle damage in humans. Therefore, it is important 
to determine if integrins play a similar role in human skeletal muscle after eccentric 
exercise as what has been demonstrated in animals (2,91). An increase in integrin protein 
and gene expression after an initial and repeated bout of exercise would suggest that the 
up-regulation is to render the muscle more resilient to the strain resulting in less soreness. 
Splicing of the integrin RNA transcript creates isoforms of integrin that have different 
cytoplasmic (e.g. α7A and α7B) and extracellular domains (e.g. Alpha 7X12X2B, Alpha 
7X1B, and Alpha 7X2B). These different domains affect the function of integrins 
(1,5,67). After a muscle injury in animals (e.g. transection or crush) variants of integrin 
were expressed at different levels and time points (3,34). For example, α7x1 and  α7x2 
are found in animals during myogenesis (34), but in developed healthy adult animal 
muscle, only α7x2 (34) is observed and overexpression of α7BX2 has been found to 
protect animals from injury (3).  Because of their various isoforms, integrins interact with 
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many other ECM molecules (e.g. MMPs, laminin, tenascin-C, collagen, decorin, and 
biglycan) and it is important to determine if there is a relationship with integrin and these 
molecules after a single and repeated bout of exercise because these molecules may be 
related to the variability found in functional indicators of muscle damage (e.g. DOMS 
and strength loss). If this were the case, DOMS may be minimized by understanding 
these cellular changes. In addition, we wanted to examine if humans express different 
isoforms of integrin after skeletal muscle after injury and if these isoforms are related to 
muscle soreness. For example, coordinated changes in the expression of ECM (e.g. TNC) 
and mechanotransduction (e.g. integrins) molecules may indicate a molecular “footprint” 
that signifies when a muscle has been stressed enough to reach a point of resilience 
against another bout of exercise (i.e. protect against DOMS). An index such as this has 
significant clinical importance because you could strain the muscle enough to initiate the 
adaptation process without inducing strength loss and muscle soreness.  
Therefore, we used a descending-stair model of eccentric exercise to identify the 
relationship between DOMS after a single and repeated bout of exercise and changes in 
the integrins and the co-signaling molecules, the MMPs and the collagens. The stair 
descent exercise protocol was used previously by others and has been shown to cause 
muscle damage to the triceps surae (84,85), but muscle damage to the vastus lateralis has 
not been examined using this exercise protocol. However, the vastus lateralis, one of the 
quadriceps muscles, does perform eccentric actions when descending stairs. Talag and 
colleagues (74) showed that the quadriceps developed DOMS when walking at a decline 
on a treadmill, and pilot data from our laboratory showed that DOMS developed in the 
quadriceps after subjects performed the stair descent exercise protocol. Instead of the 
  
 
 
103 
triceps surae, we examined the vastus lateralis because it is a larger muscle and it is easier 
to collect a second biopsy from it that is more than 2 cm away from the initial biopsy. 
Analysis of biopsies that were collected at less than 2 cm apart in non-exercised limbs 
showed the same level of activated inflammatory cells as found in a single biopsy 
collected after strenuous exercise. Biopsies collected at more than 2 cm apart showed no 
increase in activated inflammatory cells. We hypothesized that the gene and protein 
levels of the ECM molecules—integrins, MMPs, laminin, tenascin-C, collagens, 
biglycan, and decorin—and a downstream target (FAKTyr) molecule would be up-
regulated after an initial bout of eccentric exercise and that their expression would be 
positively correlated to DOMS. Since these molecules may be the signals rendering 
muscle more resilient to a repeat bout of eccentric exercise, we hypothesized that there 
would be decreased expression after a repeated bout and a decreased positive correlation 
to DOMS.   
Materials and Methods 
Subjects 
Twelve healthy male and female subjects (6 male and 6 female) enrolled and 
completed the study. Of the 12 subjects, eight were randomized into the exercise group 
and four were randomized into the no-exercise control group. The exercise and control 
groups were balanced for sex. Subjects were also randomized as to which leg would be 
biopsied first (MB1); the contralateral leg would be biopsied for the second (MB2) and 
third (MB3) biopsy time points. The MB2 was taken 7 d after MB1, and the exercise 
group completed Bout 1 of exercise 24 h prior to MB2. The MB3 was taken 14 d after 
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MB2, and the exercise group completed Bout 2 of exercise 24 h prior to MB3. The 
control group had biopsies taken at the same time as the exercise group.  
All subjects signed a written informed consent document approved by the 
University of Massachusetts Amherst Institutional Review Board. All study procedures 
conformed to the standards outlined in the Declaration of Helsinki. All subjects had no 
prior history of musculoskeletal injury of the lower extremity and were willing to refrain 
from participating in new physical activities or taking oral or topical analgesics for the 
duration of the study. Subjects were excluded if they had been involved in a strength-
training program in the past six months or routinely lifted heavy objects or engaged in 
activity with a heavy eccentric component.  
Timeline 
Subjects completed two baseline strength measure visits that were separated by at 
least 2 d, but not more than 5 d as shown in Figure 4.1. Muscle soreness was measured 
prior to the baseline muscle biopsy (MB1) and at 24 h intervals up to 120 h post-MB1. 
120 h after MB1 all subjects returned for the exercise or no-exercise session (Bout 1); the 
exercise group performed an eccentric exercise that used both legs (descending stairs) 
and had strength measures (e.g. maximal isometric strength at 70°). The control group 
did not exercise, but they completed all strength measures. The exercise group performed 
strength measures before and after the exercise bout. The following day (24 h post-Bout 
1) all subjects completed the muscle soreness measures before the muscle biopsy (MB2). 
This biopsy was collected from the contralateral leg that was biopsied at MB1. Muscle 
soreness was measured at 24 h intervals up to 120 h post-MB2. Two weeks after exercise 
or no-exercise Bout 1, subjects returned to the lab for exercise or no-exercise Bout 2. The 
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following day (24 h post-Bout 2) all subjects completed muscle soreness measures before 
the muscle biopsy (MB3). MB3 biopsy was collected from the same leg that was biopsied 
at MB2. Muscle soreness was measured at 24 h intervals up to 120 h post-MB3. 
 
Figure 4.1: Study timeline. 
 
Eccentric Exercise Protocol and No-Exercise Protocol 
Subjects in the exercise group performed eccentric actions of the knee-extensors 
(e.g. quadriceps muscles). Subjects ran down 10 flights of stairs (e.g. 11th floor to the first 
floor) 15 times and they used the elevator to return to the top of the flight of stairs. Each 
flight of stairs consisted of two sets of 12 steps, so subjects ran down 24 steps between 
each floor. Each step rise was 17.78 cm, the run was 29.21 cm, and the tread width was 
154.94 cm. The average amount of work done was -31.53 kJ ± -4.10 kJ (mean ± sem).  
The subjects were given verbal instructions to maintain a rate between 2.09 steps/sec and 
2.87 steps/sec down the stairs. The subjects completed the 10-flight stair descent between 
90 and 115 sec. Overall, the entire bout of eccentric exercise took 22–26 min. However, 
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between each descent subjects had to wait for the elevator and take the elevator to the 
11th floor. They were monitored by an investigator at the top and the bottom of the stairs 
to assist them in maintaining the rate between 2.09 and 2.87 steps/sec down the stairs. 
Subjects in the control group did not perform the stair exercise, but they reported to the 
Muscle Biology and Imaging Laboratory and performed the muscle strength tests. Both 
groups were instructed to maintain their regular activity level throughout the duration of 
the study. 
Muscle Soreness 
We measured muscle soreness in response to performing a task (e.g. single-legged 
stand-sit-stand) to assess soreness of the quadriceps muscles (vastus lateralis, vastus 
medialis, vastus intermedius, and biceps femoris). We measured the soreness from the 
stand-sit-stand task with a visual analog scale (VAS). Muscle soreness was examined at 
baseline and at 24 h increments up to 120 h after the exercise or no-exercise bouts (Bout 
1 and Bout 2). 
Muscle Strength 
We examined maximal isometric strength and passive muscle strength using a 
Biodex machine (Biodex System 4 Pro, Biodex Medical Systems, Shirley, NY).  
Maximal isometric strength measurements allowed us to demonstrate that the eccentric 
exercise resulted in damage after a single and repeated bout of eccentric exercise. For the 
strength tests, subjects were seated upright on the Biodex machine with their legs relaxed 
and the knee flexed in a 90o angle. The chair, back support, and lever arm of the Biodex 
were positioned so that the axis of rotation of the lever arm was in line with the lateral 
condyle of the femur. The leg was then secured in the knee attachment with the foot in a 
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flexed position. Knee extension range of motion (ROM) was set from the knee in a flexed 
position at 90o until the knee was extended to 0o of knee flexion.  
For the maximal isometric test, the Biodex lever arm moved the leg to a 70° 
position and subjects were asked to first maximally extend their leg for 3 sec and then 
maximally flex their leg for 3 sec; they repeated this action three times for one set. The 
isometric strength test was repeated until three trials were within 10% of each other. A 1-
minute rest was given after each maximal isometric set. A pre-exercise and post-exercise 
maximal isometric strength test was performed in the same manner as described above 
after each eccentric exercise protocol for the exercised group. The control group 
performed the maximal isometric test only once. 
Muscle Biopsy Procedure 
A licensed physician performed the muscle biopsy procedure. All subjects were 
transported to and from the biopsy visit. The needle biopsy procedure was performed 
under local anesthesia (approximately 4 ml of 2% lidocaine hydrochloride solution) using 
a 5 mm Bergstrom needle with suction (Depuy, Warsaw, IN). A small incision (about 
0.5–2 cm) was made into the skin and fascia of the vastus lateralis. The Bergstrom 5 mm 
biopsy needle was then inserted into the muscle, and suction was used to obtain a small 
"plug" of tissue before the needle was removed from the muscle. Approximately 150–200 
mg of muscle tissue was collected from each subject. The tissue was divided up into at 
least two 75 mg aliquots and each muscle sample was rinsed with sterile saline solution 
to remove excess blood before the samples were flash frozen in liquid nitrogen. Muscle 
biopsy samples were stored at -80° C until analysis. Subjects were given an Actical 
physical activity monitor (Mini Mitter Co., Inc., Bend, OR) to ensure they did not 
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perform any vigorous activity after the muscle biopsy. 
Subjects received a standardized snack that was consumed 3–5 h before the 
biopsy and consisted of an Oscar Myers Lunchable® with water. The calorie content of 
these snacks was 360–370 (8–12 g total fat, 51–63 g total carbohydrate, and 10–12 g 
protein). After the biopsy, an ice pack was kept on the incision site for 30 minutes, and 
during this time all subjects were given Tylenol (500mg/packet), a snack (juice box and a 
granola bar), and a physical activity monitor to wear. One of the subjects declined taking 
the Tylenol after the biopsy and was instead given an extra packet of Tylenol to take 
away in case it was needed later. At the end of the biopsy visit, subjects were given a 
biopsy care instruction sheet, icepacks, and individual Tylenol packets to take home with 
them. After each visit to the lab for measures of muscle soreness, Tylenol was provided 
to the subjects. Tylenol use for each subject was recorded with the Brief Pain Inventory 
Short Form (BPISF) questionnaire. Subjects were instructed to use the Tylenol as needed 
for pain relief from the muscle biopsy. 
Total RNA Isolation and qRT-PCR 
Total RNA from all muscle biopsies was extracted using the standard TRIzol 
(Invitrogen, Carlsbad, CA, USA) method. Double-stranded cDNA was created using the 
First-Strand cDNA Synthesis kit (Fermentas, Hanover, MD). For all PCR protocols, an 
RT2 Fast SYBR Green/Fluorescein qPCR Master Mix (Catalog PA-012, SABiosciences 
Corporation, Frederick,MD) was used as the reaction buffer. Forward and reverse primers 
specific for the genes of interest were designed by SABiosciences (SABiosciences 
Corporation, Frederick, MD). Integrin Alpha 7 (ITGA7, SABiosciences catalog 
PPH00665A), Collagen 4A2 (COL4A2, SABiosciences catalog PPH002474A), Collagen 
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3 A1 (COL3A1, SABiosciences catalog PPH00439A), Integrin Beta 1 (ITGB1, 
SABiosciences catalog PPH00650A), Laminin alpha 2 (LAMA2, SABiosciences catalog 
PPH21264A), Matrix Metalloproteinase 9 (MMP9, SABiosciences catalog PPH-
00152A), Matrix Metalloproteinase 2 (MMP2, SABiosciences catalog PPH00151B), 
Tissue inhibitor metallopeptidase 2 (TIMP2, SABiosciences catalog PPH00904A), 
Tenascin-C (TNC, SABiosciences catalog PPH02442A). The candidate gene primers and 
the housekeeping gene primers were optimized by SABiosciences to ensure similar 
efficiency and amplification among primer pairs for the genes of interest and the primer 
pair for the reference standard Beta-2-Microglobulin (B2M, SABiosciences catalog 
PPH01094E). 
qRT-PCR reactions were run in 96-well plates with cDNA samples from each 
subject at baseline (MB1), 24 h after Bout 1 (MB2), and 24 h after Bout 2 (MB3) in 
triplicate for each gene of interest. Thus, each plate allowed for analysis of one gene of 
interest and one reference standard for two subjects at each time point. The average 
comparative threshold (Ct) value was used for data analysis. Ct values were directly 
related to the fluorescence of the respective SYBR-green probe after 40 cycles of 
amplification using the CFX96 Real-Time PCR System (Bio-Rad, Hercules, CA, USA). 
Thermal cycling conditions were as follows: one cycle at 95oC for 10 min for enzyme 
activation, 40 cycles at 95oC for 15 sec for denaturation, and one cycle at 60oC for 1 min 
for the anneal/extension step. At the end of each reaction, a dissociation curve analysis 
was run to identify possible primer dimers. Dissociation curve analysis was set for one 
cycle at 95oC for 60 sec; 2 min at 65oC (optics off); followed by 65oC to 95oC at 2oC/min 
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(optics on). The “optics on” indicates the temperature and time during which the 
dissociation curve measures for each gene of interest and housekeeping gene collected. 
To detect expression levels of genes of interest, beta-2-microglobulin (B2M) 
(SABiosciences CatalogPPH01094E -200) was used as a reference standard. B2M is a 
constitutively expressed housekeeping gene that has been validated in humans (26,79). In 
muscle biopsy samples from control and eccentric exercised muscle in our laboratory, we 
found that B2M does not change after a biopsy or eccentric exercise (28). Relative 
quantitation of amplified mRNA was normalized to B2M, compensating for variations in 
mRNA quantity as well as for differences in reverse transcriptase (RT) efficiency. 
Protein Extraction 
The skeletal muscle samples (~50 mg) were homogenized in 250 µl of 
homogenization buffer (10 µl of protease inhibitor [HALT Protease Inhibitor Cocktail–
without EDTA, Thermo Fisher Scientific © Rockford, IL, Pierce Catalog 78410] for 
every 1 ml T-PER [Pierce Tissue Protein Extraction Reagent, Pierce catalog 
#78510,Thermo Fisher Scientific © Rockford, IL USA 61101]) with a handheld 
homogenizer over liquid nitrogen. Thereafter, homogenates were centrifuged at 10,000 X 
g at 4ºC for 5 min. Supernatants were removed and transferred to new 1.7 ml tubes on 
ice. Total protein concentrations of the resulting supernatants were determined with a 96-
well flat-bottom plate using the Coomassie (Bradford) protein assay (Better Bradford 
Protein Assay, Pierce, Rockford, IL).  
Western Blotting 
Equal amounts (30 µg) of protein extracted from ~50 mg tissue samples were 
loaded into four 15% gradient Tris-HCL gels (Bio-Rad, Hercules, CA) for all proteins 
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analyzed except for Tenascin-C, which was analyzed using 5% Tris-HCL gels (Bio-Rad, 
Hercules, CA). Proteins were separated by electrophoresis (40–60 min at 200 V). 15 µl of 
a 250 kDa Precision plus Kaleidoscope Protein Standard (Bio-Rad) was loaded into the 
first and last lane of gel 1 and the first and middle lane of gel 2. Following 
electrophoresis, fractionated proteins were transferred onto a polyvinylidene difluoride 
(PVDF) membrane (GE Healthcare, Piscataway, NJ) for 60–120 min at room temperature 
at 50–70 V; tenascin-C was transferred overnight at 4°C and then for 60 min at room 
temperature at 70 V. After transfer, the membrane was blocked for 60–100 min at room 
temperature with rocking motion in 5% fat-free powdered milk (Carnation® in 1XTBST 
[Tris-buffered saline + 0.1 % Tween]). The membrane was washed three times for 5 min 
each in 1XTBST. After washing, each membrane was individually incubated with a 
rocking motion overnight at 4°C in one of the following primary antibodies that were 
diluted in a solution of 5% BSA in 1X TBST: matrix metalloproteinase 9 (MMP9) 
(1:1000 rabbit polyclonal, AbCam ab7299, Cambridge, MA); matrix metalloproteinase 2 
(MMP2) (1:1000 rabbit polyclonal, AbCam ab37150); tissue inhibitor metallopeptidase 1 
(TIMP1) (1:200 mouse monoclonal, Santa Cruz Biotechnology sc-80365, Santa Cruz, 
CA); collagen 3 (COL3) (1:1000 mouse monoclonal, AbCam ab6310); collagen 4 
(COL4) (1:500 mouse monoclonal, AbCam ab23975); integrin α7 (ITGA7)(1:200 goat 
polyclonal, Santa Cruz Biotechnology sc-27706); integrin β1 (ITGB1) (1:100 mouse 
monoclonal, Santa Cruz Biotechnology sc-73610); laminin α2 (LAMA2) (1:200 mouse 
monoclonal, Novus Biologicals H00003908-M0, Littleton, CO); tenascin-C (1:200 
mouse monoclonal, AbCam ab88280); focal adhesion kinase (FAK) (1:200 rabbit 
polyclonal, Invitrogen AHO0502, Camarillo, CA); focal adhesion kinase phosphorylated 
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at Tyrosine 861 (FAKY861) (1:000 rabbit polyclonal, AbCam ab4804); biglycan (BGN) 
(1:1000 goat polyclonal, AbCam ab585621); decorin (DCN) (1:5000 mouse polyclonal, 
Novus Biologicals H00001634-B01P). The membranes were washed five times for 8 min 
each in 1XTBST. The membranes were incubated in secondary antibody [goat, anti-
mouse IgG HRP (BioRad 172-1011, Hercules, CA) conjugate for TIMP1, collagen 3, 
collagen 4, integrin  β1, laminin α2, tenascin-C, decorin and goat, anti-rabbit IgG HRP 
(BioRad 172-1019) conjugate for MMP9, MMP2, FAK, FAKY861, and donkey, anti-goat 
IgG HRP (AbCam ab6885) conjugate for integrin α7 and biglycan] diluted 1:5000 5% 
BSA in 1XTBST for 1 h, and then washed five times in 1XTBST for 10 min. After 
washing, membranes were treated with enhanced chemiluminescence (GE Healthcare, 
Piscataway, NJ) for 30 sec to 1 min, wrapped in plastic film, and exposed using a Chemi 
Doc XR+ (BioRad Laboratories).  
The loading control for each blot was glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) (AbCam 9484). After probing for primary antibodies of interest, membranes 
were stripped and re-probed with GAPDH (1:1000 mouse monocolonal, AbCam 9484). 
GAPDH has been shown to be a reliable loading control for protein evaluation after 
eccentric exercise (56). Unlike genes, the loading control (e.g. GAPDH) is not as 
susceptible to resident muscle cells contributing to the level of protein identified via 
western blot. However, to ensure that the loading controls were similar, we probed one 
gel for B2M (the loading control in qRT-PCR) and then stripped and re-probed that gel 
with GAPDH; there were no differences in protein level between the loading controls 
among the time points (Baseline, Bout 1, or Bout 2). Bands from each blot were 
quantified via traditional densitometry methods (Image Lab version.3.0.1, BioRad 
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Laboratories). To quantify protein levels at 24 h after Bout 1 and Bout 2, densitometry 
values for protein bands at 24 h post-Bout 1 and post-Bout 2 were compared to baseline 
for the control and exercise groups.  
Zymography 
Protein lysates were prepared similarly to western blot lysates without 2-
mercaptoethanol. 30 µg of protein were loaded onto Criterion Zymogram 10% 
polyacrylamide gelatin gel (Bio-Rad, Hercules, CA) and separated by electrophoresis (60 
min @ 200 V). Following electrophoresis, gels were placed in distilled water for 15 min 
and then the gels were renatured. Renaturation of the proteins was accomplished by 
incubating the gels overnight in renaturation buffer (2.5% Triton-X 100, 5 mM CaCl2) 
with gentle agitation. The gels were then developed with a 24 h incubation at 37°C in 
development buffer (50 mM Tris, pH 7.5, 200 mM NaCl, 10 mM CaCl2). Staining of the 
gels was performed with the staining buffer (50% MeOH, 10% acetic acid, and 0.5% 
Coomassie Blue R-250) at room temperature for 2 h with gentle agitation. Gel destaining 
was performed to visualize the zones of lysis on the zymograms. Gels were destained 
using destaining buffer (50% MeOH, 10% acetic acid and ddH2O) for approximately 1 h 
with repeated changes of the destaining buffer until clear lysis bands were visible against 
the Coomassie Blue-stained background of the gel. Gels were visualized using the Chemi 
Doc XR+ (BioRad Laboratories, Hercules, CA) and then analyzed using inverse 
densitometry methods (Image Lab version.3.0.1, BioRad Laboratories).  
Data Analysis 
The significance level was set to an alpha of 0.05 for the statistical tests. All 
values are reported as mean ± SEM. Subject demographics for the exercise and control 
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group were analyzed for differences between the groups using a Student’s t-test for age, 
height, weight, total physical activity level, and baseline isometric strength. The Baseline 
(Pre-Biopsy/MB1), Bout 1/MB2, and Bout 2/MB3 measures of muscle soreness and 
maximal isometric strength for the exercise group were analyzed using an ANOVA 
repeated measures analysis (rmANOVA).  
The qRT-PCR gene expression data were examined for pipetting errors, 
contamination from the cDNA synthesis process, and contamination from the qRT-PCR 
reactants. Examining the standard deviations from the Ct values for the samples in 
triplicate for the genes of interest (GOI) and the housekeeping genes (B2M) was done to 
identify potential pipetting errors. The replicates of GOI and B2M samples with a 
standard deviation of 1 Ct value were examined to determine which replicate had the 
pipetting error and this sample was then removed. To examine contamination during the 
cDNA process a separate tube was prepared at each round of cDNA synthesis with the 
cDNA reactants from the kit but without any sample RNA isolated from the muscle 
biopsies. RNase free water (Qiagen, Valencia, CA) was used instead of the isolated RNA 
from the muscle biopsy. These cDNA synthesis controls were used as one of the no 
template controls (NTC) for the qRT-PCR reaction to ensure that there was no 
contamination from the cDNA synthesis process. In addition, a second set of NTC wells 
were prepared for the qRT-PCR reactions with RNase water instead of the cDNA muscle 
biopsy samples to ensure that there was no contamination of the qRT-PCR reactants. The 
threshold counts (Ct values) for each individual sample (GOI) and the housekeeping gene 
(B2M) were examined to ensure that the B2M Ct values were not elevated relative to the 
other B2M Ct values on the plate; these Ct values were often close to 30 Ct which 
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suggests inadequate cDNA synthesis (primer annealing). There were two subjects whose 
Bout 1 time point had to be removed because the B2M expression was elevated relative 
to the rest of the B2M Ct levels on the plate. Because not all subjects and time points 
could fit on one plate for analysis, an intraplate control was used to examine the 
expression of the same time point across multiple plates for the same GOI. The intraplate 
data were analyzed for differences in expression levels among plates using a one-factor 
rmANOVA and a Chi-Square one-sample test. Finally, to demonstrate that we were able 
to produce repeatable qRT-PCR data, one GOI was selected (e.g. tenascin-C) and a select 
number of samples were analyzed on two separate days. The results from each plate were 
examined for difference between gene expression using a Students t-test, and interplate 
reliability was examined using a Pearson R correlation.  
The gene expression data were analyzed using a three-way rmANOVA for group 
(exercise vs. control), sex (male vs. female), and leg (left vs. right) over bout/time (Bout 
1/MB2 and Bout 2/MB3). All interactions were also examined. In addition, any 
significant differences in the gene expression between time points were examined for a 
correlation with peak soreness and isometric strength loss.  
The western blot analysis data were also analyzed using a three-way rmANOVA 
for group (exercise vs. control), sex (male vs. female), and leg (left vs. right) over 
bout/time (Bout 1/MB2 and Bout 2/MB3). All interactions were examined. Any 
significant differences in the protein expression between bouts were examined for a 
correlation with peak soreness and isometric strength loss. In addition, because of the size 
of the study it was not possible to run all samples on a single gel. Each gel contained two 
control subjects (1 man and 1 woman) and four exercise subjects (2 men and 2 women) 
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and the gels were analyzed for differences to ensure that differences found for the 
significant effects were not a result of variation in immunoblotting techniques from one 
membrane to the next (i.e. incubation time, antibody concentrations, transfer variability). 
The zymography analysis of matrix metalloproteinase (MMP) activity was 
analyzed by comparing the inverse densitometry values among the three replicate gels. 
The relative change in the inverse densitometry values from Bout 1/MB2 and Bout 
2/MB3 compared to baseline/MB1 were averaged among the three replicate gels and then 
a three-way rmANOVA for group (exercise vs. no exercise), sex (male vs. females), and 
leg (left vs. right) over bout/time (Bout 1/MB2 and Bout 2/MB3). All interactions were 
examined. Any significant differences in the MMP activity expression over time were 
examined for a correlation with peak soreness and isometric strength loss.    
Results 
Fifteen individuals completed the interview and read the informed consent for this 
study; 12 individuals signed the informed consent, enrolled in the study, and completed 
the study. Of the 12 enrolled individuals six were men and six were women. The physical 
characteristics for the 12 subjects are (mean ± SEM): age 23.0 ± 1.6 yrs., height 174.1 ± 
2.78 cm, and weight 85.68 ± 9.48 kg. Eight of the 12 subjects were randomized into the 
exercise group and four were randomized into the non-exercise groups. The physical 
characteristics for the two groups are shown in Table 4.1. There was no significant 
difference between the groups for age (p=0.335), height (p=0.903), or weight (p=0.261). 
The exercise and non-exercise groups were balanced for sex. All subjects were 
randomized for leg (vastus lateralis muscle) that was biopsied first (MB1, baseline); the 
contralateral leg was biopsied for the second (MB2) and third (MB3) biopsy time points 
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(24 h after exercise or no-exercise bouts, Bout 1 and Bout 2). Muscle soreness was 
measured prior to the bouts and then up to 120 h post-Bout 1 and Bout 2.  
Table 4.1: Physical characteristics for each group (results are mean ± sem). 
 Exercise Control 
Age (yr) 22.13 ± 1.10 24.75 ± 2.20 
Height (cm) 173.83 ± 2.91 174.63 ± 5.43 
Weight (kg) 91.39 ± 11.76 74.26 ± 8.27 
 
Muscle Soreness 
We found that muscle soreness was significantly elevated after eccentric exercise 
(p=0.039). We also found that muscle soreness increased to a greater extent in the 
exercise group despite leg biopsied or bout compared to the control group (p <0.0001) at 
each time point. Additionally, muscle soreness after Bout 1 in the exercise group was 
strongly correlated to the work performed during the exercise, r=0.790 and p=0.02. The 
exercise group also had significantly lower soreness levels after Bout 2 compared to Bout 
1 (p <0.05), but the soreness was not strongly correlated (r=0.6192 and p=0.090) to the 
work performed. Overall, the muscle soreness measure indicates that muscle soreness 
from eccentric exercise and/or a muscle biopsy returns to baseline by 96 h despite an 
initial or repeated bout. The repeated bout effect was achieved with the stair descent 
exercise as shown by the significantly lower levels of muscle soreness in Bout 2 
compared to Bout 1 (Figures 4.2.A. and 4.2.B). 
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Figure 4.2: Muscle soreness of the exercise group (A) and the control group (B). *p <0.05 
between hours post-bout, τ p < 0.05 for bout (Bout 0, Bout 1, Bout 2), φ p<0.05 for group 
(exercise vs. control). 
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Muscle Strength 
Loss in maximal isometric strength after eccentric exercise has been used as a 
functional indicator of damage to skeletal muscle (11,20,26,28,85). The stair descent 
exercise produced an approximate 17% decrease in maximal isometric strength after 
exercise compared to baseline (p=0.018), as shown in Figure 4.3. The control group did 
not perform the exercise, but muscle strength was assessed and we found no change in 
maximal isometric strength between baseline and 24 h prior to MB2 (Bout 1) and MB3 
(Bout 2). The exercise group had less of a decrease in maximal isometric strength after 
Bout 2 (13% ± 4%, p=0.290) compared to Bout 1 (18% ± 5%, p=0.018 ).  
 
 
Figure 4.3: Maximal isometric strength 70° (N-m) of the exercise (A) and                 
control (B) groups. Values are mean ± sem. * Indicates p < 0.05. 
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Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
All muscle biopsy samples were analyzed for the effect of leg biopsied and sex to 
ensure that differences found between control vs. exercise or bouts were not due to a 
difference in sex or leg biopsied. Of the nine genes related to the extracellular matrix, 
four genes were found to be differentially regulated (Figures 4.4–4.8) and only one gene 
had a significant relationship with DOMS. The qRT-PCR results of all nine genes of 
interest are shown in Table 4.2 and Appendix D; the appendix contains the raw data for 
each GOI that was normalized to the housekeeping gene, B2M, and graphs of the 
resultant fold-change results for group for Bout 1 and Bout 2. 
Table 4.2: Effects of a single and repeated bout of eccentric exercise on mRNA 
expression (values are mean ± sem). 
 Bout 1 Bout 2 
 Control Exercise Control Exercise 
MMP2 -4.17 ± 0.20 1.36 ± 0.54 -5.25 ± 0.14 -1.63 ± 0.28 
MMP9 3.00 ± 0.37 1.16 ± 0.36 2.24 ± 0.35 1.42 ± 0.58 
TIMP1 1.88 ± 0.35 1.41 ± 0.19 1.33 ± 0.43 -2.49 ± 0.18 
Tenascin-C 1.33 ± 0.47 66.56 ± 15.98 2.00 ± 1.07 25.80 ± 12.46 
Integrin β1 1.16 ± 0.47 1.27 ± 0.24 1.35 ± 0.30 1.61 ± 0.26 
Integrin α7 1.13 ± 0.15 1.51 ± 0.92 -1.20 ± 0.10 2.50 ± 0.58 
Laminin α2 1.09 ± 0.37 1.22 ± 0.33 1.26 ± 0.20 1.19 ± 0.25 
Collagen 3 1.53 ± 0.37 1.69 ± 0.36 2.05 ± 0.50 3.03 ± 1.01 
Collagen 4 1.19 ± 0.03 -1.05 ± 0.25 1.55 ± 0.55 1.74 ± 0.28 
 
MMP9 mRNA was differentially expressed (p=0.0278) between men and women 
(Figure 4.4) despite group (e.g. exercise versus control, p=0.079) and bout 
(baseline/MB1, Bout 1/MB2, and Bout 2/MB3; p=0.517). After Bout 1/MB2, men had a 
2.15-fold increase in MMP9, while women had a 1.76-fold decrease. After Bout 2/MB3 
men and women had decreased MMP9 expression compared to baseline, but MMP-9 
mRNA decreased more in women than in men. For MMP9, there was no significant 
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difference between the exercise and control groups (p=0.079), between the leg biopsied 
(p=0.4299), or between baseline/MB1, Bout 1/MB2, and Bout 2/MB3 (p=0.517) (p 
>0.160).  
 
Figure 4.4: MMP9 expression for men and women after Bout 1 and Bout 2. The exercise 
and control groups are collapsed within each sex. Values are mean ± sem, δ p <0.05 for 
sex (men vs. women). 
 
After a single bout (Bout 1) of eccentric exercise there was a robust increase in 
tenascin-C (66-fold, p=0.016) and after a repeated bout (Bout 2) of exercise, this increase 
was blunted (25-fold, p=0.016), (Figure 4.5). The muscle biopsy alone (control group) 
did not cause a significant increase of tenascin-C expression compared to baseline (1.3-
fold increase and 2.0-fold increase, Bout 1 and Bout 2, respectively). In Bout 1 there was 
a positive and moderately high correlation (r=0.531) for muscle soreness at 24 h post-
exercise with tenascin-C mRNA levels, but this relationship did not reach significance 
δ 
δ 
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until 48 h (r=0.621, p=0.031). Following Bout 2, there was a positive and moderately 
high correlation for muscle soreness with tenascin-C at 24 h (r=0.656, p=0.021) and 48 h 
(r=0.935, p=0.036) post-exercise. 
Figure 4.5: TNC expression for control and exercise groups after Bout 1 and Bout 2. The 
exercise and control groups were significantly different at Bout 1 and Bout 2. The 
exercise group was significantly different at Bout 2 compared to Bout 1. Values are mean 
± sem, * p<0.05 for time, τ p <0.05 for bout (Bout 1 vs. Bout 2), φ p <0.05 for group 
(exercise vs. control). 
 
Integrin α7 mRNA expression was differentially expressed between the exercise 
and the control group (p=0.012), despite bout/MB as shown in Figure 4.6.A. There was 
also a significant effect for the leg biopsied and time (p=0.0028), as shown in Figure 
4.6.B. In Bout 1(MB2), the left leg had a 5.46-fold increase and the right leg had a 1.77-
fold increase in ITGA7 mRNA. Following MB3 the left leg had a 5.23-fold increase and 
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the right leg had a 2.98-fold increase (p=0.0028). 
Figure 4.6.A: ITGA7 expression for control and exercise groups after Bout 1 and Bout 2. 
Values are mean ± sem,  φ p <0.05 for group (exercise vs. control). 
 
 
Figure 4.6.B: ITGA7 expression for left and right legs after Bout 1 and Bout 2. Values 
are mean ± sem, τ p <0.05 for leg (left vs. right). 
φ 
φ 
λ 
λ 
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COL3 mRNA expression was significantly elevated (p=0.018) from baseline for 
the exercise and control groups in MB2 (24 h post-Bout 1) and MB3 (24 h post-Bout 2) 
as shown in Figure 4.7.A. COL3 mRNA was differentially expressed for men and women 
between MB2 and MB3 as shown in Figure 4.7.A. Men had no increase (1.01-fold) in 
MB2 compared to the 2.4-fold increase for women (p=0.008). For MB3, men had a 3.9-
fold increase in COL3 expression, while women decreased to an expression level of 1.8-
fold as compared to the 2.4-fold increase found after MB2 (p=0.008).  
are mean ± sem, τ p <0.05 for leg (left vs. right). 
Figure 4.7.A: COL3 mRNA expression of control and exercise groups after Bout 1 and 
Bout 2. Values are mean ± sem, * p <0.05 from baseline. 
  
* 
* 
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Figure 4.7.B: COL3 mRNA expression of men and women after Bout 1 and Bout 2. 
Values are mean ± sem, δp <0.05 for sex (men vs. women). 
 
The five genes that were not differentially expressed between group (exercise vs. 
control), bout/time (Baseline/MB1, Bout 1/MB2, Bout 2/MB3), leg (biopsied left or right 
leg), sex (male vs. female), or for any of these interactions (e.g. group*bout, group*leg, 
group*sex, etc) are listed below and their results are shown in Table 4.2 and Appendix D. 
The 72kDa type IV collagenase, MMP2, was not differentially expressed (group, bout, 
leg, sex, or any of the interactions; p >0.1347), as shown in Appendix D Figure D.2. An 
inhibitor of the MMPs, tissue inhibitor of metalloproteinases 2 (TIMP2) was not 
differentially expressed (group, time, leg, sex or any of the interactions; p >0.1768), as 
shown in Appendix D Figure D.3. The intermembrane protein, integrin β-1 mRNA, was 
not differentially expressed (group, bout, leg, sex, or any of the interactions; p >0.073), as 
δ 
δ 
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shown in Appendix D Figure D7. Finally, two structural ECM molecules laminin α-2 
(LAMA2) and collagen 4 (COL4) were not differentially expressed (group, bout, leg, sex, 
or any of the interactions), p=0.2716, LAMA2, Appendix D Figure D.8 and p >0.0986, 
COL4 Appendix D Figure D.5. 
Western Blotting 
All muscle biopsy samples were analyzed for the effect of leg biopsied and sex to 
ensure that differences found for control vs. exercise or bouts were not due to differences 
in sex or leg biopsied. Because of the number of samples, 12 subjects and their three time 
points, we used two gels to analyze each protein. As an intergel control, one sample time 
point from one subject was used on both gels, and we found no significant differences 
between this sample on each gel for any of the nine proteins analyzed.  
The protein products of all nine genes examined above for differential expression 
were examined using gel electrophoresis and western blotting. Of the nine proteins 
examined, only integrin  α7 (ITGA7) protein levels were altered as a result of the 
intervention.  
In the current study, we found that two control and four exercise individuals 
expressed all three isoforms (7X12X2B, 7X1B, and 7X2B) of integrin α7, that two 
control and two exercise individuals expressed two isoforms, and that two exercise 
individuals only expressed one of the integrin α7 isoforms. The expression of the 
isoforms was not dependent on group (exercise vs. control) or time point (Baseline 
(MB1), Bout 1(MB2), or Bout 2 (MB3)). Each integrin α7 isoform was analyzed 
separately, and in Appendix E the three identified isoforms are referred to as Band 1 for 
isoform Alpha 7X12X2B, Band 2 for isoform Alpha 7X1B, and Band 3 for isoform 
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Alpha 7X2B. Of the three isoforms detected, only isoform 7X2B levels were found to be 
different from baseline and between bouts (p <0.05). Compared to baseline, protein levels 
of integrin α7 isoform 7X2B in Bout 1 in the control and exercise groups decreased 48.5 
% ± 11.4 % and 51.8 % ± 15.3 %, respectively. In Bout 2, integrin α7 isoform 7X2B 
protein levels in the control and exercise group had returned to baseline levels (Appendix 
E).  
Zymography 
There was no change in gelatinase activity for MMP9 and MMP2 pro- and active 
levels. These results indicate that a muscle biopsy alone does not increase activity of the 
MMPs and they suggest that at 24 h post-eccentric exercise MMP activity is not altered. 
These results suggest that at 24 h post-eccentric exercise MMP2 and MMP9 do not play a 
role in the repeated bout effect (Appendix F).  
Discussion 
The present study expanded the examination of ECM structural molecules to 
include integrin β1 and integrin α7. We sought to identify acute changes (24 h post-
exercise) in the expression of a subset of genes and their respective protein products 
located in the ECM (MMP9, MMP2, TIMP2, tenascin-C, integrin β1, integrin α7, 
laminin α2, collagen 3, and collagen 4) after a single and repeated bout of stair descent 
eccentric exercise. We also sought to examine the relationship between these molecules 
and muscle soreness. Since the muscle biopsy procedure affects the ECM and because 
muscle biopsies have an effect on inflammation and may have an effect on muscle 
soreness (47) we examined changes in the expression of genes and protein products listed 
above in a control group of individuals who did not exercise, but had the same number of 
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biopsies as an exercise group. We demonstrated that the stair descent exercise elicited 
“muscle damage” as shown by the functional indicators of muscle damage (e.g. 
immediate decrease in maximal isometric strength [Figure 4.3] and DOMS [Figures 
4.2.A. and 4.2.B.]). We also showed that the stair descent exercise resulted in a repeated 
bout effect, shown by a decrease in functional indicators of muscle damage; a decrease in 
maximal isometric strength and a decrease in the maximal level of DOMS, as well as a 
faster return to baseline soreness levels after the second bout of exercise.  
Skeletal Muscle Soreness 
The measurement of muscle soreness allowed us to demonstrate that the stair 
descent exercise provided a repeated bout effect in the vastus lateralis. The stair descent 
exercise model has been used previously (21,85); however, the triceps surae was assessed 
for muscle soreness and damage and not the vastus lateralis. In the control group the peak 
level of muscle soreness was zero mm (no soreness), while the eccentric exercise group 
had ~45 mm of muscle soreness at 24 h after the exercise in Bout 1 and ~25mm in Bout 
2. As expected, we found a strong correlation between soreness and work done in Bout 1 
(r=0.790 and p=0.02) but not in Bout 2 (r=0.6192 and p=0.090). Overall, we were able to 
show the repeated bout effect was achieved with the stair descent exercise as shown by 
the significantly lower levels of muscle soreness in Bout 2 compared to Bout 1 and the 
loss of a soreness correlation with eccentric exercise in Bout 2.  
Muscle Strength Measures 
We found in the current study that the exercise protocol produced an approximate 
17% strength loss in the quadriceps after Bout 1 and we also found that the exercise 
produced a repeated bout effect. While this strength loss is less than the strength loss (20– 
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40%) reported by others (6,12,26,28) in the quadriceps after an acute bout of exercise, the 
achievement of the repeated bout effect indicates that the exercise protocol induced 
sufficient muscle damage. The studies that found greater losses in strength after eccentric 
exercise used an isokinetic dynamometer (6,12,28) or a stand-and-sit task (26) to produce 
the strength loss. Previous studies (20,86) have used the same eccentric exercise protocol 
that we used to examine muscle function of the calf muscles (e.g. triceps surae). Friden et 
al. (20) and Yu et al. (86) found that a stair descent exercise (10 flights of stairs 
descended 15 times) produces immediate strength loss in the triceps surae (20,86). We 
showed that the stair descent exercise produced strength loss of the vastus lateralis and a 
repeated bout effect.  
Expression of Regulatory and Structural Genes and Proteins in the ECM 
The role of tenascins as important adhesion molecules was first demonstrated in 
1988 (10). We have learned since then that tenascins play a more complex and varied role 
within the ECM (17–19,31,81). Tenascins have been shown to modulate inflammatory 
processes and regulate the repair/rebuilding process of the extracellular matrix  (17–
19,31,81). In the present study, we found that tenascin-C (TNC) mRNA expression 
increased in the exercise group after Bout 1. Furthermore, the expression was 
significantly blunted after a repeated bout of exercise compared to the first bout. Aside 
from the time point used, these results are not novel, but confirm work by Mackey et al. 
(45) who showed  that tenascin-C mRNA and protein levels at 48 h post-exercise were 
elevated after a single bout of eccentric exercise via electrical stimulation and then 
reduced after a repeated bout of eccentric exercise via electrical stimulation.  
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Mackey et al. (45) attributed the changes in tenascin-C at 48 h after eccentric 
exercise to be associated with de-adhesion activities in preparation of remodeling the 
ECM. Because the ECM surrounds the skeletal muscle, any repair or growth of the 
muscle would require reorganization of the ECM, and the de-adhesion properties would 
provide access to the injured site for repair and removal of the damaged material (19,45). 
The de-adhesion and re-adhesion properties would also ensure that the ECM does not 
confine the growing muscle and thus limit its function (e.g. strength production and 
movement) (19,29).  After the removal of the damaged debris and/or the remodeling 
phase of the muscle the re-adhesion properties of tenascin-C would ensure that muscle is 
reconnected to the ECM and that the muscle is able to transmit the force generated by the 
myofilaments to the tendon (19,30).   
In the present study, tenascin-C levels in Bout 1 and Bout 2 were positively 
correlated to soreness levels at 24 h and 48 h post-exercise in Bout 1 and Bout 2, 
respectively. The correlation between soreness and tenascin-C levels after Bout 2 would 
suggest that the expression level of tenascin-C is due to the second bout of exercise and 
not a result of Bout 1 and would likely indicate that re-adhesion is not the only process 
that tenascin-C is promoting after a second bout of exercise. Furthermore, we did not find 
that individuals with the highest mRNA expression of tenascin-C (i.e. high responders) 
after a single bout of exercise had the lowest level of soreness or strength loss after a 
repeated bout of exercise. These results would indicate that tenascin-C was not promoting 
an enhanced adaptation to eccentric exercise in the high-responders. It’s apparent that 
tenascin-C is involved in the adaptation process that produces the repeated bout effect 
after eccentric exercise. Also, the de-adhesion and re-adhesion processes, as well as 
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myogenic repair and growth processes affected by tenascin-C levels, are the way that 
tenascin-C likely repairs and promotes adaptation to skeletal muscle after eccentric 
exercise. 
Tenascin-C and MMPs have been shown to co-localize at sites of inflammation 
(32,69,78) and it is likely that together they orchestrate the de-adhesion and disassembly 
of the ECM molecules and the de-adhesion from transmembrane proteins after damage 
from mechanical strain. MMPs are regulated in three different ways to include gene 
expression, cleavage of the proenzyme, and via TIMPs, which are the innate inhibitors of 
the MMPs. In the present study we found that there was a significant difference in mRNA 
expression of MMP9 between men and women and a trend (p=0.08) for group 
differences. Combining the exercise and control group mRNA levels after Bout 1, we 
found that men had a 2.1-fold increase in MMP9 gene expression and women had a 1.8-
fold decrease. In a mouse crush model of muscle damage, MMP9 was localized to the 
endomysial area beside damaged muscle fibers during the process of regeneration (88). 
These results suggest that we were amplifying MMP9 mRNA expression of invading 
inflammatory cells and not just skeletal muscle expression after eccentric exercise. 
Invading inflammatory cells (e.g. neutrophils, leukocytes, and macrophages) arrive 
within 24 h after injury (70,75) and would have been present at the time point of the 
muscle biopsy used in this study. Because MMP9 is secreted by macrophages, 
neutrophils (41), and leukocytes (39) and because MMP9 has been correlated to 
activation of neutrophils (41) and recruitment of pro-inflammatory macrophages (39), it 
is likely that our significant increase in MMP9 mRNA expression level is due to 
amplification of MMP9 from these cells. While we did not measure systemic 
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inflammation or inflammatory cells in the ECM of the muscle biopsies in this study, we 
believe that based on previous research (26,38,57), inflammatory cells are the probable 
source of MMP9 mRNA expression.  
At present, this is the first study to investigate the changes in MMP9 mRNA in 
skeletal muscle after eccentric exercise in humans. Previous studies in animals (8,9) and 
humans (63,64) have found increases of MMP9 mRNA levels after high-intensity aerobic 
exercise, but the effect of eccentric exercise had not been investigated. Although we 
found a significant difference for MMP9 mRNA expression between men and women in 
MB2 and MB3, we were not sufficiently powered to conclude that there was a difference 
in the regulation of MMP9 via gene expression.  
The second way that the MMPs are regulated is via cleavage of the proenzyme, 
which results in an activated MMP9 enzyme that degrades gelatinolytic material (e.g. 
collagens). We used zymography to measure MMP9 protein activation after eccentric 
exercise. We were surprised to not see any changes in the latent and active forms of the 
MMP9 protein (Appendix F). Since MMP9 is up-regulated with strain, and activation of 
MMP9 only requires the cleavage of the proenzyme, we expected that the eccentric 
exercise stimulus would induce cleavage of the latent MMP9 form and that we would see 
an increase in active MMP9 protein levels after the muscle biopsy as well as the exercise. 
It is likely that the muscle resident or infiltrating inflammatory cells did not have 
sufficient time to produce and secrete MMP9 in order for MMP9 to be cleaved and 
detected by zymography.  
We were not able to draw any firm conclusion about the biopsy and its effects on 
MMP9 activation as there may have been an infiltrate (e.g. an inflammatory cell) in the 
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tissue. All tissue samples were rinsed in saline immediately after collection, but we did 
not isolate mononuclear or inflammatory cells from the tissue. MMP9 is highly up-
regulated when inflammatory cells are activated (9,62,89) and previous studies (47) have 
shown that muscle biopsies can increase the number of inflammatory cells in the ECM of 
skeletal muscle. The muscle also has resident inflammatory cells (71) and it is likely that 
these cells and not an inflammatory response secreted the MMP9. In addition, we were 
also not able to make any conclusions about the eccentric exercise and its effects on 
zymography due to the variability of gelatinase activity found in the individuals after the 
single and repeated exercise bouts.  
Rullman et al. (64) demonstrated increased gelatinolytic activity of MMP9 after 
exhaustive exercise; however, they examined tissue at 2 h after exercise and not 24 h 
after exercise so it may be possible that MMP9 is secreted and activated immediately 
after the insult to the muscle and not at later time points (e.g. 24 h post-exercise). It is 
also likely that MMP9 is produced and secreted at later time points, but that the activation 
of the MMP9-proenzyme and the enzyme activity of MMP9 were affected by regulators 
called tissue inhibitor metalloproteinases (TIMPs). In the present study we examined 
TIMP2’s mRNA expression level, but we did not see any change in mRNA levels of 
MMP2 or TIMP2. Activated MMP9 and pro-MMP9 (60)  can bind to TIMP1 and because 
we found a change in mRNA expression for MMP9, we chose to examine protein 
expression of TIMP1 instead of TIMP2. If the protein level of TIMP1 was up-regulated 
along with MMP9, this coordinated change may suggest that TIMP1 is up-regulated so 
that it can bind to MMP9 and inhibit MMP9’s gelatinolytic activity. However, we did not 
see any change in TIMP1 protein expression levels and therefore we do not believe that 
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the lack of MMP9 gelatinolytic activity was due to MMP9 being bound to TIMP1. 
Animal models have shown the importance of integrins in protecting skeletal 
muscle from damage (4), and in humans, mutations in the integrin α7 gene can cause 
congenital myopathies (22). To our knowledge, this is the first study to show an increase 
in integrin α7 (ITGA7) mRNA in humans at 24 h after eccentric exercise, (Figure 4.6.A 
and 4.6.B). Interestingly, we found a decrease in protein levels at 24 h post-exercise 
(Figure 4.8). Changes in mRNA expression do not always coincide with changes in 
protein expression, and observational changes in protein products of these genes may not 
appear until 24–96 h after a stimulus (e.g. exercise, injury) (40). Furthermore, post-
translational modification (e.g. ubiquitination, cleavage, addition of disulfide bridges) can 
affect the ability to detect protein products of expressed genes in western blotting because 
the protein may be degraded (e.g ubiquitination).  
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Blot #1 
 
 
Blot #2 
 
 
Figure 4.8: Protein expression of ITGA7 X2B isoform of control and exercise groups 
after Bout 1 and Bout 2. Values are mean ± sem. The representative blot is shown below 
the graph, and the first six lanes of the two blots are control subjects and the last 12 lanes 
represent the exercise group. Each letter represents a subject and each number represents 
the muscle biopsy time point (e.g. 1 is muscle biopsy 1). *p<0.05 from baseline. 
 
Our increase in integrin α7 mRNA after a single bout of exercise is consistent 
with animal research showing increases in mRNA acutely after exercise (2,4). A mouse 
model of downhill running found that the muscle damage promoted an increase of 
* 
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integrin α7 mRNA expression at 3 h post-exercise (4). We had hypothesized that mRNA 
for the integrins (α7 and β1) would have increased after Bout 1 and then returned to 
baseline levels after Bout 2, but instead we found that integrin α7 increased to a greater 
extent after Bout 2 compared to Bout 1. Specific integrins may mediate the repeated bout 
effect, as shown by the elevation in integrin α7mRNA in Bout 1 and a greater increase in 
integrin α7 mRNA after Bout 2. Because integrins have also been shown to protect 
against damage (2), the increase of integrin α7 mRNA found in Bout 2 for the exercise 
group may be preparing the muscle for future strenuous exercise.  
The control group, which did not perform exercise, showed an increase of integrin 
α7 mRNA after MB2 (Bout 1) and a decrease after MB3 (Bout 2) compared to MB2 
(Bout 1). The increase after MB2 may be a result of the first muscle biopsy (MB1) and 
the decrease of integrin α7 after MB3 may be related to MB2. After MB1, the control 
group reported muscle soreness (~20 mm) at 24 h after the biopsy in the non-biopsied 
leg; the non-biopsied leg in MB1 was biopsied in MB2 and MB3. The soreness results 
suggest that after a muscle biopsy, individuals may inadvertently damage the non-
biopsied leg by relying on the non-biopsied leg instead of the biopsied leg when sitting, 
walking downstairs, or performing an activity that uses eccentric actions predominantly 
(e.g. bending to pick up something). In animals an increased expression level of integrin 
α7 protected the muscle from damage (2,4) and it’s possible that increased expression of 
integrin α7 after MB2 was an effort to protect the muscle from future inadvertent 
eccentric exercise events. Because the same leg was biopsied in MB2 and MB3, it’s 
likely that individuals again relied on the non-biopsied leg and therefore the integrin α7 
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level decreased in MB3 because the non-biopsied leg was performing the inadvertent 
eccentric exercise or that a different integrin isoform was expressed at this time. 
While integrin α7 gene expression increased after MB2 and decreased after MB3, 
the protein results for integrin α7 after a bout of eccentric exercise (Bout 1/MB2) did not 
mirror the gene expression changes. In fact, the observed decrease that we saw in integrin 
α7 protein after a bout of eccentric exercise does not support previous research data or 
our hypothesis (2,4). For example, mice lacking the integrin α7 protein show greater 
damage after a bout of downhill running exercise (-20°, 17 m/min, 30 min) and did not 
experience a repeated bout effect (4,61). We observed three isoforms of integrin α7 
(7X12X2B, 7X1B, and 7X2B ) and the 7X2B isoform, an extracellular domain variant 
(5), was the isoform that was deceased after MB2. Cell culture studies have shown that 
the extracellular domain isoforms have different binding properties to laminin. For 
example, the extracellular domain α7X2B binds preferentially to laminin-1 (90) and the 
α7X1 isoform binds to laminin-8 (80). The interaction of integrins with the various 
laminins can result in the clustering of receptors, the recruitment of focal adhesion 
molecules, and the initiation of phosphorylation cascades (15,66). However, we did not 
see a change in protein or mRNA expression in the laminin we examined (laminin α2) 
and therefore we are unsure of the role of the integrin α7X2B isoform after eccentric 
exercise. 
Similar to the reason for the gene expression results, we believe that the protein 
expression results are related to the MB1 and not the eccentric exercise because protein 
expression of the integrin α7X2B isoform was decreased to the same extent in the 
exercise and control group at MB2. Furthermore, the fact that protein levels for both 
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groups returned to baseline levels after Bout 2/MB3 would also indicate that the decrease 
in protein levels are not due to the acute or repeated bout of exercise, especially since all 
exercise subjects did experience the repeated bout effect. The return to baseline levels for 
both groups after MB3 compared to MB2 could indicate that individuals were more 
accustomed to the effects of a muscle biopsy and returned to their daily routine sooner. 
At MB3 we did not biopsy the non-biopsied leg from MB2 and therefore we cannot be 
sure that our explanation above for the change in integrin α7 protein is correct. However, 
the response of integrin α7 levels at MB3—integrin α7 protein level returning to 
baseline—as a result of the individuals being accustomed to the effects of the biopsy is 
supported by the muscle soreness data, particularly in the control group. In the control 
group the biopsied leg muscle soreness after MB3 was significantly lower than muscle 
soreness in the biopsied leg after MB2. Because muscle soreness is a functional indicator 
of muscle damage the lower soreness level in the biopsied and non-biopsied leg after 
MB3 suggest that the leg had less damage and did not require protection via an up-
regulation of integrin α7X2B. These results suggest that specific integrins may be 
sensitive to muscle-lengthening actions that we perform on a daily basis (e.g. sitting 
down, stair descent) and could therefore be a good indicator of the muscle adapting to 
daily activities and eccentric exercise.  
The protein results presented in this study should be viewed with caution because 
the control and exercise subjects took ibuprofen, a non-selective COX inhibitor, after 
each muscle biopsy (e.g. baseline/MB1, Bout 1/MB2, and Bout 2/MB3). In a population 
similar to the one used in the present study, ibuprofen blunted protein synthesis in the 
first 24 h after eccentric exercise, as is evidenced by a reduction in fractional synthesis 
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rate (76,77). These studies administered the COX inhibitors during and/or immediately 
prior to the exercise bout, and the present study did not administer the non-selective COX 
inhibitor until after the eccentric exercise and subsequent muscle biopsy. In the present 
study the exercise bout was 24 h prior to the biopsy and subjects did not use ibuprofen 
during or after the exercise. The baseline muscle biopsy was collected 6 d prior to the 
first bout of eccentric exercise and it is possible that the use of a non-selective COX 
inhibitor from 120 h prior until 48 h prior to the exercise session may have affected the 
protein levels after the Bout 1 exercise. At present there is no data on the use of ibuprofen 
2 d to 5 d prior to an exercise bout and its effects on protein expression in the first 24 h 
after eccentric exercise. It is unlikely that the use of ibuprofen after the first muscle 
biopsy affected the protein synthesis rates in the first bout of exercise of our study 
because we would have expected to see a decrease in all protein levels in the muscle 
biopsy collected 24 h after the exercise. Because we did not see an overall reduction in all 
of the protein levels examined, it is likely that the ibuprofen did not have an effect on 
protein levels in the present study.  
We found mRNA expression of collagen type 3A1 (COL3) in skeletal muscle to 
be higher in women after a single bout of exercise compared to baseline and a repeated 
bout of exercise, and in men after a single bout of exercise. However, the lower delta Ct 
levels of COL3 at baseline in women compared to men suggests that a sex difference 
existed at baseline. These data are similar to the levels of collagen type 1A and COL3 in 
tendon, which have been reported to be lower in women compared to men (52,72), 
despite no effect of the menstrual cycle on synthesis rates of collagen 1A (52). COL3 
mRNA expression in men after an acute bout of exercise has been shown to be no 
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different than baseline (23). We found a similar result in COL3 mRNA levels for men in 
our study. In women, the elevation of COL3 mRNA expression after 24 h in Bout 1 and 
the depression of COL3 mRNA expression after 24 h in Bout 2 has not been previously 
reported. However, protein results via immunohistochemistry may support our COL3 
mRNA results in men and women. Mackey et al. (46) found no differences in COL3 
staining intensity at 4 d and 22 d post-exercise in men and women; however, the 
variability of COL3 staining was greater than the variability found for the other collagens 
measured at these time points. The variability for COL3 protein in that study may 
indirectly support the mRNA results from the present study, sex difference at MB2 and 
MB3, because Mackey et al. (46) had both men and women in that study (5 men and 4 
women) and it is possible that the high level of variability seen for COL3 protein at 4 d 
and 22 d post-exercise was due to sex differences.   
Conclusion 
This is the first study to examine the gene and protein expression levels of ECM 
molecules and their role in the development of muscle soreness using a voluntary single 
and repeated bout of eccentric exercise. We did find a repeated bout “effect” for muscle 
soreness and maximal isometric strength measured post-exercise compared to baseline 
for the quadriceps using the stair descent exercise model. When comparing our strength 
loss and DOMS results to other eccentric exercise studies, we found that the stair descent 
exercise model produced a moderate amount of muscle damage to the vastus lateralis 
(26,28,36,44). We found that skeletal muscle ECM is affected by a single and repeated 
bout of eccentric exercise as shown by the change in mRNA expression levels of an ECM 
remodeling molecule (e.g. TNC) and the mechanotransduction molecules (integrin α7 
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and COL3). Our study confirmed the elevation of tenascin-C after a single and repeated 
bout of eccentric exercise and found a strong correlation with soreness at 24 h and 48 h 
after both exercise bouts. Furthermore, the correlation with soreness is specific to damage 
as a result of eccentric exercise and not due to minor surgery (e.g. muscle biopsy) as 
tenascin-C was not correlated to peak soreness from a muscle biopsy.  
The increased mRNA expression of COL3 and integrin α7 after both bouts of 
exercise was unexpected, as we had expected only to see an increase in the mRNA 
expression of COL3 and integrin α7 after the first bout of exercise. We are the first study 
to report changes in MMP9 mRNA in skeletal muscle after eccentric exercise in humans. 
We identified three integrin  α7 isoforms in human skeletal muscle via western blotting. 
This finding was novel and unexpected as some of the control and exercise subjects 
expressed all three isoforms and some subjects expressed only two isoforms. 
Additionally, the decrease of the integrin α7X2B isoform was unexpected because 
Boppart et al. (4) found in animals that integrin α7 expression increased after a bout of 
eccentric exercise.  
While we have contributed new information to the literature on eccentric exercise, 
our results do not support our hypothesis. We identified that tenascin-C mRNA 
expression is positively related to muscle soreness after eccentric exercise, but not muscle 
soreness after a muscle biopsy. In the exercise group, the mRNA of tenascin-C was 
significantly lower after Bout 2 compared to Bout 1, indicating that there is an adaptation 
to the initial exercise bout that attenuates the response to a subsequent bout (i.e. a 
“repeated bout effect”). Although we were not sufficiently powered to determine if there 
was a sex effect for MMP9 and COL3, our data suggest that there is a difference in gene 
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expression between men and women for these two genes. Because the animal literature 
suggests that an increased expression of integrin α7 plays a role in protecting the muscle 
from damage (4), our finding of an increase in integrin α7 gene expression after eccentric 
exercise suggests that integrin α7 may perform a similar role in human skeletal muscle. 
The observation of three isoforms of integrin α7 being expressed differently (e.g. some 
exercise and control subjects expressed all three isoforms and some subjects expressed 
only two) were unexpected and these data suggest that even at baseline there was a 
difference within the exercise and control subjects. Because there was no change in the 
number of isoforms an individual expressed between bouts/MBs, it is possible that 
integrin α7 isoform expression was related to previous adaptations the skeletal muscle 
had made before this exercise insult. Understanding the role of the different isoforms in 
human skeletal muscle may provide information on how skeletal muscle adapts to 
strenuous exercise. Since integrins play an important role in signal transduction, it is 
possible that the different isoforms initiate a different adaptation processes via their 
interactions with laminins and potential downstream effectors (e.g. phosphorylation of 
FAK and AKT). Based on our findings, we suggest that future studies should focus on 
the integrins, understanding the relationship between integrin isoform expression and 
exercise intensity, and their interaction with signal transduction molecules (e.g. laminins, 
AKT, FAK). This information may help identify why individuals adapt differently to 
eccentric exercise. It is possible that these integrin isoforms are involved in the repeated 
bout effect. By examining the effects of exercise intensity on integrin α7 expression, we 
may be able to create better exercise programs that allow individuals to adapt to exercise 
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without the dramatic loss in muscle strength or elevation in DOMS that occurs after 
performing an exercise involving eccentric actions. 
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CHAPTER 5 
PRELIMINARY INVESTIGATION OF MUSCLE SORENESS  
USING A SYSTEMS BIOLOGY APPROACH (Study 3) 
Introduction 
Skeletal muscle soreness is a common consequence following exercise if an 
individual is naïve to the activity or if the activity is strenuous. Eccentric, or lengthening, 
contractions are likely to result in muscle soreness due to the high forces associated with 
this type of exercise (9,39). While ultrastructural damage to muscle can be evident during 
or immediately following exercise (16,41,47), muscle soreness typically appears after a 
delay, peaking in the hours to days following exercise (9,17,26). Though most cases of 
delayed onset muscle soreness (DOMS) resolve on their own, muscle soreness can be 
clinically relevant when it presents in diseases of muscle (34), diseases of connective 
tissue (22), and as a side effect of one of the most widely prescribed medications—statins 
for high cholesterol (13,21,37,43,50,54).  
Since the initial reporting of the phenomenon of DOMS after exercise by Hough 
et al. (26), researchers have attempted to understand its origins and to test potential 
treatments. At present, researchers have not been able to explicitly state why muscle 
soreness lags behind the structural damage and the strength loss evident immediately 
after eccentric exercise (5,9,11,17,35). Proposed mechanisms have included changes in 
biochemical signaling (45,46,51), mechanical disruption (11,18,19,32,39,47,55), and 
increased neural sensitivity (14,25). These potential mechanisms likely work in concert 
with other exercise-induced changes within muscle to produce the complex phenomenon 
of DOMS, which is also known to be widely variable across individual responses (28,29). 
To better target potential therapies, we sought to better understand the molecular profile 
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of skeletal muscle as it relates to the degree of muscle soreness experienced by 
individuals following a standardized eccentric exercise protocol. 
Gene expression profiling has previously been used to study the molecular events 
taking place in skeletal muscle after eccentric exercise-induced muscle damage 
(5,20,33,44,53). Using microarray technology to better understand the biological 
processes after eccentric contractions has illuminated the up-regulation of novel 
inflammatory targets in skeletal muscle (6,31), down-regulation of muscle degrading 
enzymes (33,53), and up-regulation of unique repair and remodeling molecules/enzymes 
(33,35), demonstrating an organized effort from the muscle to respond to the damaging 
event and repair itself. However, to date, these molecular profiles have not been used to 
study changes as they specifically relate to the severity of muscle soreness.  
Muscle soreness typically peaks 24–48 h post-eccentric contractions; however, 
the peak of muscle soreness has been shown to be variable among individuals even when 
controlling for the type of exercise performed (e.g. downhill running vs. eccentric 
resistance exercise) (10). Individuals who “respond” to eccentric contractions with 
greater strength loss, greater soreness, and/or higher creatine kinase CK levels have been 
reported to be high-responders: These individuals were greater than two standard 
deviations above the mean (8). To identify novel molecular processes related to the 
magnitude of exercise-induced DOMS, we re-examined gene expression data from our 
previous study (31): (35 males with paired exercised and control muscle biopsy samples 
following standardized exercise) using an unbiased clustering technique to select high 
and low outliers for peak soreness evoked by the exercise. We compared gene expression 
changes in the high-responders to those in the low-responder group and also correlated 
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changes in gene expression to the amount of peak muscle soreness experienced by each 
subject. We then created a table containing the most robustly up-regulated and down-
regulated genes (p >0.01), their location, their molecular processes, and their correlation 
with peak muscle soreness so that we could identify molecular targets for future research 
in muscle soreness studies.  
The overall goal of the study was to identify novel genes and their resultant 
protein products associated with peak DOMS. I hypothesized that the high-soreness 
individuals would have different genes up- and down-regulated compared to the low-
soreness individuals. Specifically, I hypothesized that the up-regulated genes in the high 
high-soreness group would be primarily located in muscle resident cells and involved in 
muscle growth and adaptation processes (e.g. collagens,matrix metalloproteinases) and 
that the down-regulated genes would be primarily located within the muscle cell, 
specifically the nucleus, and involved in transcription and translational processes 
associated with inflammation.  
Materials and Methods 
Approach 
We re-analyzed mRNA microarray data from a previous study (Hyldahl et al. 
(31); N=35; damage evoked by eccentric contractions on an isokinetic dynamometer; 
biopsy at 3 h post-exercise) with a new focus; instead of looking at differential gene 
expression after eccentric exercise, we examined differential gene expression between 
subjects who developed high levels of muscle soreness compared to low levels of muscle 
soreness after eccentric exercise. Subjects were clustered into the soreness groups using a 
hierarchical cluster analysis program with a Euclidean distance similarity metric. We 
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consider this a preliminary investigation because we were only able to identify target 
genes and pathways that are related to muscle soreness variability following a 
standardized exercise since the protein products would not be up-regulated at the time 
point (3 h post-exercise) used by Hyldahl et al. (31).  
All subjects had signed a written informed consent document approved by the 
University of Massachusetts Amherst Institutional Review Board. All study procedures 
conformed to the standards outlined in the Declaration of Helsinki. All subjects had no 
prior history of musculoskeletal injury of the lower extremity and were willing to refrain 
from participating in new physical activities or taking oral or topical analgesics for the 
duration of the study. Excluded were those who had been involved in a strength-training 
program in the past 6 mo or routinely lifted heavy objects or engaged in activity with a 
heavy eccentric component. 
Exercise 
Hyldahl et al. (31) examined the biological processes of skeletal muscle damage 3 
h after eccentric exercise by microarray to identify differentially expressed genes. 
Detailed methods have been previously published. Briefly, subjects performed a single 
leg extension eccentric exercise at 30°/sec that consisted of 10 sets of 10 repetitions using 
the Biodex System 4 dynamometer (Biodex Medical Systems, Shirley, NY, USA). 
Subjects were instructed to “kick” throughout the ~75° of motion and were given a 1-sec 
rest between repetitions and a 1-min rest between sets. (31) Biopsies were performed at 3 
h post-exercise. 
Muscle Soreness 
Detailed methods have been previously published (31). Briefly, the subjects were 
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asked to perform the task described below using the leg that was eccentrically exercised 
and then record their soreness using a visual analog scale (VAS). The VAS is a 100 mm 
horizontal line where one end of the line (0 mm) indicates no soreness and the other end 
(100 mm) indicates severe soreness (great pain and difficulty while completing the task). 
For the VAS muscle soreness task, subjects performed two stand-to-sit (STS-VAS) 
motions using only a single leg (the leg eccentrically exercised). After the task, subjects 
were then asked to record the peak soreness of their quadriceps muscle by placing a 
vertical line on the VAS. Muscle soreness was measured before the exercise and at 24 h 
increments post-exercise up to 120 h post-exercise using the above protocol. 
Muscle Strength 
Detailed methods have been previously published. In brief, following the pre-
exercise soreness evaluations, the subjects performed a baseline maximal isometric 
strength test. They sat on the Biodex machine (Biodex System 4 Pro, Biodex Medical 
Systems, Shirley, NY), with their legs relaxed and the knee flexed in a 90o angle. The 
chair, back support, and lever arm of the Biodex were positioned so that the axis of 
rotation of the Biodex lever arm was in line with the lateral condyle of the femur. The leg 
was then secured in the knee attachment with the foot in a flexed position. Knee 
extension range of motion (ROM) was set from the knee in a flexed position at 90o until 
the knee was extended to 0o of knee flexion. For the maximal isometric test, the Biodex 
lever arm moved the leg to a 70° position and subjects were asked to first maximally 
extend their leg for 3 sec and then maximally flex their leg for 3 sec; they repeated this 
action three times for one set. The isometric strength test was repeated until three trials 
were within 10% of each other. A 1-min rest was given after each maximal isometric set. 
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A pre-exercise and post-exercise maximal isometric strength test was performed in the 
same manner as described above after each eccentric exercise protocol. 
Muscle Biopsy Procedure 
A licensed physician performed the needle biopsy procedure on the vastus 
lateralis under local anesthesia using a Bergstrom needle with suction. A small incision 
(about 0.5–2.0 cm) was made into the skin and fascia of the vastus lateralis. The 
Bergstrom 5-6 mm biopsy needle was then inserted into the muscle, and suction was used 
to obtain a small "plug" of tissue when the needle was removed from the muscle. 
Approximately 150–200 mg of muscle tissue was collected from each subject and, after 
rinsing the muscle sample with sterile saline solution to remove excess blood, the 
samples were flash frozen in liquid nitrogen. The muscle biopsy samples were stored at -
80°C until analysis.  
Hyldahl et al. (31) collected muscle biopsy samples for the microarray analysis 
from the eccentric exercised leg and control leg (non-eccentric exercised) at 3 h post-
exercise from 35 healthy male subjects aged 18–30 y. The subjects arrived fasted on the 
day of the biopsy visit. At 4 h prior to the muscle biopsy they were given a standardized 
snack. They were not allowed to eat after this snack until the biopsy was completed. The 
caloric content of the standardized snack was 400 calories, (approximately 
55% carbohydrate, 30%  fat, and 15% protein (equivalent to about two cereal bars, one 
box of juice, and one box of 2% milk).  
Total RNA Isolation and Microarray Hybridization 
Detailed methods have been previously published. In brief, Hyldahl et al. (31) 
extracted total RNA from skeletal muscle samples of 35 subjects using the standard 
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TRIzol (Invitrogen, Carlsbad, CA, USA) method. Of the 35 subjects, only 30 subjects 
had viable RNA for cDNA synthesis. Double-stranded cDNA was created using the 
Ovation Pico WTA system (NuGEN, San Carlos, CA, USA) according to the 
manufacturer’s instructions. Cy3 labeling and hybridization onto an Agilent Whole 
Genome Microarray (Agilent, Santa Clara, CA, USA) were done at Gene Logic 
(Gaithersburg, MD, USA) according to the manufacturer’s specifications.  
Data Analysis 
Subject demographics for the two soreness groups were analyzed for differences 
between the groups using a Student’s t-test for age, height, weight, and baseline isometric 
strength. The pre- and post-exercise measures of muscle soreness and maximal isometric 
strength for both groups were analyzed using an ANOVA repeated measures analysis. 
Peak skeletal muscle soreness values from Hyldahl et al. (31) (peak values 
occurred 24–48 h post-exercise) were clustered using hierarchical cluster analysis 
(Cluster 3.0, Stanford University and Human Genome Center, University of Tokyo), with 
a Euclidean distance similarity metric. The results of the clustering method described 
above were viewed in Java Tree. The high-soreness group (HSG) and the low-soreness 
group (LSG) were selected visually from the clusters identified in Java Tree View. The 
hierarchical clustering program uses a Euclidean distance similarity metric to put the 
soreness data into clusters based on the distance between each data point. To visually 
represent the process, data would be arranged along a ruler and the cluster at the upper 
end would comprise the HSG with the cluster at the opposite end representing the LSG. 
The microarray data from Hyldahl et al. (31) were log transformed and then each 
subject’s exercise leg was normalized to the sample from their control leg. An ANOVA 
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(p <0.05) was performed on the microarray data between the HSG and LSG using Partek 
Genomics Suite software (Partek, Inc, Version 6.4). The outputs were then filtered on p-
value (p <0.01) for fold change between the high soreness and low soreness individuals 
prior to examining the Pearson product moment correlations of these genes. Only the 
corrected p-values for the Pearson correlations are shown in Table 5.1 and Table 5.2.  
Detailed baseline results have been previously published. In brief, there were 35 
males (mean ± SEM) (20.9 ±  0.5 yr, 178.9 ±  1.2 cm, and 80.6 ±  2.9 kg) and their 
baseline isometric strength was 237.422 ±  9.74 N-m. The HSG cluster had five males 
(20.3 ±  0.3 yr, 177.1 ±  2.7 cm, and 88.8 ±  9.5 cm) and the LSG cluster had seven males 
(22.6 ±  1.7 yr, 185.8 ±  4.3 cm, and 91.5 ±  8.5 cm). There was no significant difference 
among the baseline measures for age (p=0.268), height (p=0.096), or weight (p=0.846) 
between the HSG and LSG. There was no significant difference (p=0.509) between 
baseline isometric strength of the HSG (246.5 ±  21.9 N⋅m) and LSG (219.9 ±  28.5 N⋅m). 
Cluster Analysis 
The results of Java Tree View from the hierarchical cluster analysis (Cluster 3.0) 
with a Euclidean distance similarity metric are shown in Figure 5.1. The cluster analysis 
identified the uppermost cluster (i.e. top cluster) in Figure 5.1, which contained five 
individuals from Hyldahl et al. (31) with a soreness level >63mm. The lowermost level-
one cluster (i.e. bottom cluster) in Figure 5.1 contained seven individuals from Hyldahl et 
al. (31) with a soreness level less than 21 mm. Based on the hierarchical cluster analysis, 
the HSG had a peak soreness cutoff level of ≥63 mm on the VAS and the LSG had peak 
soreness cutoff level of ≤21 mm. Overall, the HSG had a soreness level of 66.94 mm ± 
2.89 mm (mean ± SEM) and the LSG had a soreness level of 14.43 mm ± 1.35mm. The 
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cluster levels identified by the cluster analysis were used to create the histogram bins 
shown by Figure 5.2 for demonstrating the variability of peak muscle soreness values. 
 
 
Figure 5.1: Hierarchical cluster analysis of soreness from Hyldahl et al., 2011. 
Individuals with peak VAS soreness levels >63 mm were clustered in the high-soreness 
group (HSG) and individuals with peak VAS soreness levels <21 mm were clustered into 
the low-soreness group (LSG). 
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Figure 5.2: Histogram of peak muscle soreness VAS showing the bins used in the 
hierarchical cluster analysis to generate the HSG and LSG. 
 
 
Indirect Markers of Muscle Damage 
Skeletal muscle soreness and isometric strength loss were both significantly 
affected after the eccentric exercises performed by Hyldahl et al. (31), shown in Figure 
5.3.A (muscle soreness) and 5.3.B (isometric strength). At 24–96 h post-exercise, 
Hyldahl et al. (31) found a significantly (p <0.05) elevated muscle soreness level 
compared to before the exercise. Skeletal muscle isometric strength was significantly 
reduced after eccentric exercise. 
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Figure 5.3: Functional indicators of muscle damage from Hyldahl et al., 2011. A) 
Delayed onset muscle soreness in Hyldahl et al. and HSG and LSG after eccentric 
exercise. B) Maximal isometric strength 70° in Hyldahl et al. and HSG and LSG before 
and after eccentric exercise. Values are mean ± sem. *p >0.05 for effects of time. τ p 
>0.05 for effects of group (HSG vs. LSG). 
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Microarray Analysis 
Microarray analysis identified 41,000 genes that were differentially regulated 
after eccentric exercise compared to the control leg in Hyldahl et al. (31) at p <0.05. 
When we examined the ratio of these “eccentric exercise genes” in individuals with high 
soreness compared to those with low soreness we were able to identify 1517 genes that 
were differentially regulated at p <0.05. To examine correlations between the 
differentially regulated genes we used a more stringent p <0.01, which yielded 546 genes 
differentially regulated between individuals with high vs. low soreness after eccentric 
exercise. Of the 546 genes, 409 were up-regulated while 137 were down-regulated. The 
top 100 up-regulated and down-regulated genes at p <0.01 are shown in Tables 5.1 and 
5.2, respectively (located at the end of the chapter).  
Of the top 100 up-regulated genes, 67 were found using the Gene Ontology 
Database (GEO) to have known biological location(s) and function(s) and 33 were 
classified as unknown genes (Table 5.1). Of these 67 known genes, 16 were located in the 
nucleus, 22 were cytosolic (cytosol, cytoskeleton, and cytosolic membranes), and 25 
were associated with the plasma membrane (e.g. extracellular region, apical, 
intermembrane, and internal side of the membrane), and four were located in the 
extracellular region. The top up-regulated gene was serine protease kazal type 1 (SPINK) 
located in the extracellular region and was increased 18.68-fold between the high-
soreness and low-soreness individuals. SPINK1 had a correlation of 0.643 (p=0.001) with 
peak muscle soreness, as shown in Figure 5.4. However, the strongest significant 
correlation (p <0.0001) was short statue homeobox 2 (SHOX2), which had a moderate 
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positive correlation (r=0.694) with peak muscle soreness and was increased 3.85-fold in 
high-soreness compared to the low-soreness individuals (Appendix G). 
 
 
 
 
 
Figure 5.4: SPINK1 microarray mRNA fold-change correlation with muscle soreness of 
Hyldahl et al., 2011. mRNA expression was correlated to muscle soreness using the 
entire cohort. 
 
Of the top 100 down-regulated genes, 62 were found, using GEO, to have known 
biological location(s) and function(s) and 38 were classified as unknown genes (Table 
5.2). Of these 62 known genes, 17 were located in the nucleus, 28 were cytosolic 
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(cytosol, cytoskeleton, endoplasmic reticulum, and mitochondrion), 13 were associated 
with the plasma membrane (e.g. extracellular region, apical, intermembrane, and internal 
side of the membrane), and four were located in the extracellular region. The top down-
regulated gene was zinc finger protein 621 (ZNF621) located in the nucleus, and was 
decreased 4.75-fold between the high-soreness and low-soreness individuals. ZNF621 
had a moderate negative correlation of r= -0.39 (p=0.03). Of the down-regulated genes 
the strongest significant correlation (p=0.02) was ENST00000378624, also known as 
Threonylcarbamoyladenosine tRNA methylthiotransferase (CDKAL1), which had a 
moderate negative correlation (r= -0.42) with peak muscle soreness and was decreased 
2.05-fold between the high-soreness and low-soreness individuals. 
These microarray results indicate that muscle soreness after eccentric exercise 
involves a greater number of up-regulated (409) genes than down-regulated (137). There 
was also a greater fold change in the up-regulated genes (e.g. SPINK1 was up-regulated 
18-fold) compared to down-regulation (e.g.  ZNF621 was down-regulated by 4.75-fold). 
The top 10 up-regulated genes were all up-regulated by at least 4.2-fold.  
Discussion 
The origins of DOMS after eccentric exercise have eluded researchers since 1908 
(27), as evident by the inconclusive results when investigating the proposed mechanisms 
underlying DOMS (3,7,12,15,23,24,30,38,52). It is likely that the development of DOMS 
after eccentric exercise is multifactorial, which may explain why previous studies have 
not resulted in an evidence-based treatment for DOMS. In studies using eccentric 
exercise as a model to examine muscle damage, researchers have reported an overall 
greater up-regulation of genes compared to down-regulated genes when assessed using 
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microarray analysis (6,33), and the present examination clustering subjects by soreness 
level after eccentric exercise found a similar response. Of the 546 genes with significant 
changes, more than 70% (409 genes) were up-regulated. The up-regulated genes are 
involved in the events of lipid and cholesterol synthesis (35), protein synthesis (33), 
cellular growth (33), inflammation (6,35), and muscle repair (2,35). These changes in 
gene regulation are consistent with remodeling of skeletal muscle to better enable it to 
withstand the strain of high-force eccentric exercise.  
In addition to discovering which genes differentially regulated in the presence or 
absence of high soreness, we also identified biological functions and networks using 
Ingenuity Pathway Analysis (IPA; Appendix H). The top biological functions identified 
by IPA contained molecules (either genes or proteins) that are involved in the events of 
protein synthesis and cellular growth. In addition to the top biological functions being 
involved in synthesis and growth, the top two networks (score of 51 and 41) identified 
molecules involved in development, metabolism, and tissue morphology. Networks 
identify the strongest interrelationships between the molecules that were altered 
according to the microarray and the current literature. However, the networks also 
include molecules that were not altered that may be relevant based on the relationships 
identified by previous researchers. The high-scoring network (>50) identified molecules 
involved in carbohydrate metabolism, tissue morphology, and cardiovascular tissue 
development and function in the high-soreness responders. Of these, the molecules 
involved in cardiovascular tissue development seem unusual because our analysis was 
done in skeletal muscle. But because IPA network creations are based on previous 
research and the great majority of prior work in this area has been done in heart tissue, it 
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is not surprising that the top network identified by IPA has been more frequently 
observed in cardiovascular tissue. Further, many of the molecules in the top network are 
involved in both cardiac and skeletal muscle tissue development and function (e.g. 
vascular endothelial growth factor [VEGF], endothelial growth factor [EGF], and 
Vitamin D receptor [VDR]).  
Previous studies on exercise-induced muscle damage (1,4,11,40,49) have 
proposed that muscle soreness after eccentric exercise was due to mechanical damage in 
the muscle and connective tissue after eccentric exercise. The biological functions and 
networks we identified with IPA suggest that muscle soreness may be related to 
molecules involved in metabolism, development, and tissue morphology. It is possible 
that the networks we identified are in response to damage of the muscle and connective 
tissue and that muscle soreness is a side effect of the remodeling and repair process.  
Unlike previous microarray studies, the larger sample size of the present study 
(n=30) allowed us to perform correlations between muscle soreness (one functional 
indicator of muscle damage) and the differentially regulated genes from a microarray 
analysis. Despite finding that the up-regulated genes had more significant correlations 
and a greater number of genes with significant correlations compared to the down-
regulated genes, these up-regulated genes were not more commonly found in one 
pathway compared to another (e.g. the inflammation pathway contained both up- and 
down-regulated genes). The variability in muscle soreness among individuals after 
eccentric exercise suggested that the gene and protein expression involved in muscle 
soreness may also differ. Because previous investigations of muscle soreness after 
eccentric exercise have focused on a single cellular event (46) (e.g. elevation of cellular 
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Ca2+) or biochemical signaling (45,46,51), mechanical disruption (11,18,19,32,39,47,55), 
or increased neural sensitivity (14,25) we had expected to find that the high-soreness 
individuals would have a greater elevation of genes involved in one of these processes 
compared to the low-soreness individuals. Our use of microarray analysis to examine two 
disparate groups of muscle soreness provided us an unbiased examination of genes 
involved in the potential events and pathways that other researchers previously examined.  
However, we were unable to identify a leading cellular event or pathway that contributed 
to the variability in muscle soreness. Based on prior literature, including differential 
responses in men and women (48), inflammatory processes were a likely candidate to 
play an important role in muscle soreness, and we expected that molecules involved in 
the acute inflammation pathway would be elevated in the HSG. Instead, our results 
suggest that DOMS after eccentric exercise is not simply due to one molecule or cellular 
function/pathway (e.g. inflammation), but likely multiple overlapping pathways and 
events as shown by the biological functions and networks we found using IPA. We did 
identify the gene SPINK1 to be significantly up-regulated in the high-soreness 
individuals compared to the low-soreness individuals. SPINK1 is a protease inhibitor that 
has mitogenic capabilities in fibroblasts (42) and endothelial cells (36) and is involved in 
a cell migration process, epithelial restitution, wherein healthy cells from the border of 
the injury migrate to the damaged site. These biological functions—mitogenesis and 
restitution of SPINK—may play an important role in repairing skeletal muscle after 
eccentric exercise damage, and in the processes of repairing the muscle, SPINK1 may 
contribute to muscle soreness. Unfortunately however, we did not have enough tissue to 
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confirm this up-regulation and further examine the role, if any, of SPINK1 in muscle 
soreness.  
In conclusion, understanding the role muscle soreness plays in the muscle 
remodeling and repair process may provide further clues to the variability in muscle 
soreness among individuals who perform eccentric exercise. Unpublished data in our lab 
has shown that low-soreness individuals (n=13) compared to high-soreness individuals 
(n=13) had less of a loss in isometric strength after a single and repeated bout of exercise. 
However, after the repeated bout of exercise, isometric strength in the high-soreness 
individuals did not return to baseline strength unlike the low-soreness individuals. These 
unpublished results along with the present study suggest that up-regulation of genes 
involved in mediating tissue repair (e.g. SPINK1, C7, DLL1, SPINT2, and AGER) in the 
high-soreness individuals results in a repair and remodeling process that ensures 
adaptation to the strenuous exercise. It is possible that the variability of muscle soreness 
after eccentric exercise is a consequence of the variability in the repair and adaptation of 
skeletal muscle after eccentric exercise. This variability in remodeling and repair may 
have functional consequences in mediating the return of strength loss in high-soreness 
individuals compared to low-soreness individuals (unpublished data).   
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Table 5.1. Fold differences and correlations of statistically significant (p >0.01) normalized gene expression of the top 
100 up-regulated probe sets between the high-soreness and low-soreness individuals. Continued onto next few pages. 
Gene Symbol Probeset ID Full Name Biological and Molecular Processes 
Fold-
Change 
(FC) 
p-value 
(FC) 
Correla-
tion ( r )  
p-value 
( r ) 
 
Extracellular Region 
      
SPINK1 A_23_P214079 
Serine protease 
inhibitor Kazal type-
1 
Negative regulator of: Ca import, NO 
mediated signaling, Serine 
endopeptidase activity,Mitogenesis, 
Cell migration 18.68 0.0017 0.643 0.0001 
C7 A_32_P384246 
Complement 
component C7 
Complement activation, Cytolysis, 
Innate immune response, Regulation 
of complement activation 3.07 0.0000 0.284 0.1217 
DLL1 A_23_P167920 Delta-like protein 1 
Cell differentiation, Cell-cell 
signaling, Notch signaling pathway, 
Positive regulation of transcription 
from RNA polymerase II promoter, 
Calcium ion binding, Notch binding, 
Protein binding 2.63 0.0000 0.237 0.2002 
SPINT2 A_23_P27795 
Kunitz-type protease 
inhibitor 2 
Serine-type endopeptidase inhibitor 
activity, Cellular component 
movement, Negative regulation of 
endopeptidase activity 2.67 0.0004 0.370 0.0407 
        Apical Plasma Membrane 
      
PROM1 A_23_P258463 Prominin-1 
Actinin binding, Cadherin binding, 
Protein binding 2.63 0.0024 0.386 0.0321 
TREML2 A_23_P7932 
Trem-like transcript 
2 protein 
T-cell activation, protein binding, 
receptor activity 4.27 0.0000 0.349 0.0540 
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THBD A_23_P91390 Thrombomodulin 
Transmembrane signaling receptor 
activity, Protein binding, 
Carbohydrate binding, Calcium ion 
binding, Leukocyte migration, 
Negative regulation of blood 
coagulation, Negative regulation of 
fibrinolysis, Negative regulation of 
platelet activation, Blood coagulation, 
Embryo development, Female 
pregnancy 3.36 0.0022 0.520 0.0027 
AGER A_23_P93360 
Advanced 
glycosylation end 
product-specific 
receptor 
Protein binding, Receptor activity, 
Transmembrane signaling, Response 
to wounding, Positive regulation of 
NF-kappa B transcription factor 
activity, Innate immune response, 
Inflammatory response, Cell surface 
receptor signaling pathway, Induction 
of positive chemotaxis 2.43 0.0041 0.354 0.0504 
SELP A_23_P137697 P-selectin 
Cell adhesion, Carbohydrate binding, 
Inflammatory response, Leukocyte 
cell-cell adhesion, Leukocyte 
migration, Regulation of integrin 
activation, Positive regulation of 
platelet activation, PI3K signaling, 
Protein binding, Lipopolysaccharide 
binding, Glycosphingolipid binding 2.42 0.0000 0.370 0.0404 
Plasma Membrane 
      
RRAD A_23_P88849 
GTP-binding protein 
RAD 
Signal transduction, GTP binding, 
GTPase activity, Small GTPase 
mediated signal transduction 2.66 0.0097 0.360 0.0465 
RAP1B A_23_P2661 
Ras-related protein 
Rap-1b 
GTP binding, GTPase activity, Small 
GTPase mediated signal transduction, 
Cell proliferation 2.22 0.0000 0.350 0.0539 
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LRP8 A_23_P200222 
Low-density 
lipoprotein receptor-
related protein 8 
Integral to Membrane, Ca ion binding, 
transmembrane signaling, 
apolipoprotein binding, very low 
density lipoprotein particle receptor 
activity, Cytokine mediated signaling 
pathway 7.91 0.0010 0.532 0.0020 
SLC4A4 A_32_P358887 
Electrogenic sodium 
bicarbonate 
cotransporter 1 
Integral to plasma membrane, 
Bicarbonate transport, Ion transport, 
protein binding 6.18 0.0008 0.570 0.0008 
MPP3 A_23_P141346 
MAGUK p55 
subfamily member 3 
Signal transduction, PDZ domain 
binding, guanylate kinase activity 4.15 0.0091 0.388 0.0310 
CACNA2D
2 A_23_P346900 
Voltage-dependent 
calcium channel 
subunit alpha-
2/delta-2 
Energy reserve metabolic process, 
Muscle fiber development, 
Neuromuscular junction development, 
Regulation of insulin secretion, Metal 
ion binding, Voltage-gated calcium 
channel activity 2.52 0.0087 0.365 0.0433 
SEMA4C A_23_P114057 Semaphorin-4C 
Semaphorin-plexin signaling pathway, 
Cerebellum development, Receptor 
activity 2.45 0.0036 0.357 0.0487 
        Integral component of membrane 
     
PXK A_32_P115606 
PX domain-
containing protein 
kinase-like protein 
Phosphatidylinositol binding, ATP 
binding, Cell communication, Protein 
kinase activity,  2.21 0.0038 0.229 0.2154 
SLC45A3 A_24_P208345 
Solute carrier family 
45 member 3 
Integral to plasma membrane, 
Bicarbonate transport, Ion transport, 
protein binding 4.26 0.0088 0.508 0.0035 
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CLEC7A A_23_P2640 
C-type lectin 
domain family 7 
member A 
Carbohydrate mediated signaling, Cell 
recognition, Cell-cell adhesion, 
Inflammatory response, Innate 
immune response, Leukocyte 
activation, Positive regulation of 
phagocytosis, T-cell activation, 
Carbohydrate binding, Metal ion 
binding, MHC protein binding 2.46 0.0000 0.226 0.2211 
BTN2A2 A_24_P337592 
Butyrophilin 
subfamily 2 member 
A2 
Negative regulation of activated T cell 
proliferation, Negative regulation of 
cellular metabolic process, Negative 
regulation of cytokine secretion 2.58 0.0098 0.418 0.0194 
GRIK4 A_23_P116249 
Glutamate receptor 
ionotropic, kainate 4 
Glutamate receptor signaling pathway, 
Extracellular-glutamate-gated ion 
channel activity, Synaptic 
transmission 2.56 0.0000 0.264 0.1517 
ADCY3 A_23_P67864 
Adenylate cyclase 
type 3 
Intracellular signal transduction, 
Integral component of membrane, 
Nucleotide binding, Phosphorus-
oxygen lyase activity, Transmembrane 
transport, Synaptic transmission, 
Synaptic transmission, 2.52 0.0035 0.326 0.0738 
PLXNA1 A_23_P57667 Plexin-A1 
Semaphorin receptor activity, 
Multicellular organismal development 2.51 0.0075 0.468 0.0079 
GALNAC4
S-6ST A_23_P383986 
Carbohydrate 
sulfotransferase 15 
Small molecule metabolic process, 
Chondroitin sulfate biosynthetic 
process, Hexone biosynthetic process, 
N-acetylgalactosamine 4-sulfate 6-O-
sulfotransferase activity, 3'-
phosphoadenosine 5'-phosphosulfate 
binding 3.15 0.0002 0.392 0.0294 
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Cytosolic: Plasma Membranes 
      
CD44  A_23_P24870 CD44 antigen 
Cell adhesion, Hyaluronic acid 
binding, Wnt signaling pathway, 
Positive regulation of gene expression 2.80 0.0078 0.532 0.0021 
RAB43 A_32_P86318 
Ras-related protein 
Rab-43 
GTP binding, Small GPTase mediated 
signal transduction, Protein transport 2.46 0.0000 0.364 0.0444 
SAMD9 A_23_P355244 
Sterile alpha motif 
domain-containing 
protein 9 Protein binding 3.03 0.0055 0.228 0.2168 
MAP1LC3C A_24_P216456 
Microtubule-
associated proteins 
1A/1B light chain 
3C Autophagy, Protein binding 3.51 0.0067 0.459 0.0095 
BBS1 A_23_P150267 
Bardet-Biedl 
syndrome 1 protein 
Protein binding, Patched binding, 
Photoreceptor cell maintenance, 
Response to stimulus, Cilium 
assembly,  3.29 0.0055 0.448 0.0114 
        Cytosolic 
       
HLCS A_23_P304991 
Biotin--
[methylmalonyl-
CoA-
carboxytransferase] 
ligase 
Response to biotin, Protein 
homodimerization activity, Cell 
proliferation, ATP binding, Biotin-
protein ligase activity, Histone 
modification, Small molecule 
metabolic process,  2.54 0.0000 0.152 0.4140 
TBC1D24 A_23_P391637 
TBC1 domain 
family member 24 
Neuron projection development, 
Protein binding, Rab GTPase activator 
activity 3.56 0.0000 0.521 0.0027 
KLHL21 A_23_P341223 
Kelch-like protein 
21 
Mitosis, Protein ubiquination, 
Ubiquitin protein ligase activity, 
Regulation of cytokinesis 2.67 0.0076 0.372 0.0392 
C14orf140 A_23_P99785 
Zinc finger C2HC 
domain-containing 
protein 1C Metal ion binding 2.25 0.0065 0.507 0.0036 
RBBP9 A_23_P257538 Putative hydrolase Hydrolase activity, Regulation of cell 2.60 0.0072 0.366 0.0432 
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RBBP9 proliferation            1 
ENST00000
227451 A_24_P158718 
E3 ubiquitin-protein 
ligase DTX4 
Innate immune response, Notch 
signaling pathway, Positive regulation 
of type I interferon production, Protein 
ubiquination, Ligase activity, Zinc ion 
binding 2.79 0.0050 0.471 0.0075 
PPAT A_23_P80940 
Amidophosphoribos
yltransferase 
Metabolic processes, Sulfur cluster 
binding, Metal ion binding, Organ 
regeneration 2.25 0.0039 0.318 0.0817 
SPAG1 A_23_P146066 
Sperm-associated 
antigen 1 
GTP binding, Hydrolase activity, 
Single fertilization 8.11 0.0085 0.463 0.0088 
NUDT11 A_23_P62387 
Diphosphoinositol 
polyphosphate 
phosphohydrolase 3-
beta 
Small molecule metabolic process, 
Metal ion binding, Diphosphatase 
activity 4.61 0.0044 0.504 0.0039 
NEFH A_23_P300600 
Neurofilament 
heavy polypeptide 
Cell death, Cytoskeleton organization, 
Peripheral nervous system neuron 
axongenesis, Structural molecular 
activity 2.68 0.0091 0.394 0.0281 
GM2A A_23_P144872 
Ganglioside GM2 
activator 
Lipid storage, Sphingolipid processes, 
small molecule metabolic processes, 5.13 0.0088 0.402 0.0251 
XDH A_23_P39590 
Xanthine 
dehydrogenase/oxid
ase 
Lactation, Negative regulation of 
endothelial cell 177ifferentiation and 
proliferation, Negative regulation of 
gene expression, Negative regulation 
of PKB signaling, Negative regulation 
of protein phosphorylation, Position 
regulation of p38MAPK cascade, 
Small molecule metabolic processes, 
Xanthine catabolic processes, Electron 
carrier activity, Protein 
homodimerization activity, Iron ion 
binding 3.39 0.0084 0.290 0.1139 
RASGEF1B A_23_P331186 
Ras-GEF domain-
containing family 
member 1B GTPase mediated signal transduction 3.65 0.0000 0.405 0.0236 
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C20orf172 A_23_P165937 
Kinetochore-
associated protein 
DSN1 homolog 
Protein binding, Chromosome 
segregation, Mitosis 3.28 0.0038 0.326 0.0734 
NEK3 A_23_P333705 
Serine/threonine-
protein kinase Nek3 
ATP binding, Protein kinase activity, 
Protein phosphorylation, Protein 
binding, Metal ion binding 2.99 0.0059 0.286 0.1182 
BIRC3 A_23_P98350 
Baculoviral IAP 
repeat-containing 
protein 3 
Negative Regulation of Apoptotic 
processes, Cell surface receptor 
signaling pathway, Innate Immune 
response, Toll-like receptor signaling 
pathway, Negative Regulation of 
necrosis, Negative regulation of ROS 
metabolic processes, NIK/NF-kappa B 
cascade, Regulation of inflammatory 
processes, Zinc ion binding, 
Ubiquitin-protein ligase activity, 
Protein binding 3.69 0.0045 0.536 0.0019 
MXD1 A_24_P379750 
Max dimerization 
protein 1 
Protein dimerization activity, 
Transcription-DNA templated, Cell 
proliferation, DNA binding, 
Transcription cofactor activity 2.54 0.0084 0.463 0.0087 
MT1M A_23_P66241 Metallothionein 
Metal ion binding, Negative 
regulation of growth 2.99 0.0044 0.299 0.1027 
RPS15A A_32_P175580 
40S ribosomal 
protein S15a 
Translation, Cellular protein metabolic 
process, mRNA metabolic process, 
Positive regulation of cell 
proliferation, RNA metabolic process, 
RNA binding 2.41 0.0067 0.340 0.0611 
Cytosolic: Cytoskeleton 
      
MICAL2 A_23_P13442 
Protein-methionine 
sulfoxide oxidase  
Actin binding, zinc ion binding, 
Oxidation reduction processes, 
Oxidoreductase activity 5.77 0.0074 0.349 0.0545 
COTL1 A_23_P3866 
Coactosin-like 
protein 1 
Defense response to fungus, Actin 
binding, Enzyme binding 2.92 0.0000 0.442 0.0127 
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COTL1 A_32_P158385 
Coactosin-like 
protein 1 
Defense response to fungus, Actin 
binding, Enzyme binding 2.89 0.0000 0.453 0.0105 
    
 
   Nucleus 
       
SHOX2 A_23_P124384 
Short stature 
homeobox protein 2 
DNA binding, Transcription 
regulation, Organ system development 3.85 0.0010 0.694 0.0000 
C11orf17 A_23_P52161 
A-kinase-interacting 
protein 1 Protein binding 3.26 0.0087 0.376 0.0371 
ZNF682 A_24_P944588 
Zinc finger protein 
682 
Regulation of transcription, Nucleic 
acid binding 3.12 0.0062 0.298 0.1033 
DENND4A A_23_P420092 
C-myc promoter-
binding protein 
Regulation of transcription, Rab 
guanyl-nucleotide exchange factor 
activity, DNA binding 2.50 0.0061 0.368 0.0419 
MAFB A_23_P17345 
Transcription factor 
MafB 
Protein binding, Sequence-specific 
DNA binding, Transcription factor 
activity 2.49 0.0024 0.380 0.0349 
PCGF5 A_24_P880043 
Polycomb group 
RING finger protein 
5 
Protein binding, DNA-templated 
transcription 2.23 0.0000 0.424 0.0175 
TRIB1 A_24_P252497 Tribbles homolog 1 
ATP binding, Protein kinase activity, 
Transcription factor binding, 
Ubiquitin protein ligase binding, JNK 
cascade, Mitogen-activated protein 
kinase binding 2.29 0.0045 0.443 0.0126 
Z21967 A_24_P876352 
POU domain, class 
6, transcription 
factor 1 
Organ development, Sequence-
specific DNA binding, Transcription 
factor activity 2.79 0.0013 0.426 0.0168 
XPO5 A_23_P256855 Exportin-5 
Protein transporter, tRNA binding, 
Protein binding 3.67 0.0002 0.241 0.1924 
NFE2 A_23_P13753 
Transcription factor 
NF-E2 45 kDa 
subunit 
Cell-cell signaling, Negative 
regulation of bone mineralization, 
Sequence-specific DNA binding 3.29 0.0000 0.234 0.2051 
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ELL3 A_23_P3237 
RNA polymerase II 
elongation factor 
ELL3 
Positive regulation of DNA templated 
transcription, Transcription from RNA 
polymerase II promoter, Enhancer 
binding, Negative regulation of 
apoptotic process 2.56 0.0075 0.380 0.0349 
GNL3 A_23_P41025 
Guanine nucleotide-
binding protein-like 
3 
Regulation of cell proliferation, GTP 
binding, GTPase activity, GTP 
catabolic processes, Potein binding, 
Ribosome biogenesis 2.88 0.0034 0.442 0.0129 
PRIM2A A_24_P282237 
DNA primase large 
subunit 
DNA replication initiation, DNA 
strand elongation, Mitotic cell cycle, 
DNA binding, DNA primase activity, 
Metal ion binding 2.45 0.0000 0.383 0.0336 
GEMIN4 A_23_P66867 
Gem-associated 
protein 4 
RNA metabolic processes, rRNA 
processing, Gene expression, Protein 
binding 3.51 0.0025 0.376 0.0371 
NEDD4L A_24_P108311 
E3 ubiquitin-protein 
ligase Ubiquitin-dependent ligase activity 2.58 0.0008 0.403 0.0245 
MAP2K3 A_24_P296698 
Dual specificity 
mitogen-activated 
protein kinase 
kinase 3 
Activation of MAPK activity, 
Inflammatory response, Innate 
immune response, MyD88 dependent 
toll-like receptor signaling pathway, 
Positive regulation of protein kinase 
activity, Positive regulation of 
transcription, Signal transduction, 
Stress-activated MAPK cascade, 
MAPK kinase kinase activity, Protein 
binding, Protein kinase activity,  2.77 0.0011 0.403 0.0244 
        Unknown transcripts 
      FAM43B A_32_P125338 - - 3.06 0.0034 0.417 0.0197 
ENST00000
375284 A_24_P106910 - - 3.04 0.0002 0.511 0.0033 
MGC40579 A_23_P258582 - - 3.03 0.0100 0.226 0.2214 
A_24_P933 A_24_P933027 - - 2.86 0.0071 0.238 0.1973 
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027 
AL133627 A_32_P114372 - - 2.69 0.0000 0.251 0.1731 
C14orf28 A_24_P33048 - - 2.68 0.0073 0.043 0.8192 
C15orf34 A_23_P37455 - - 2.63 0.0000 0.284 0.1218 
LOC285535 A_32_P491904 - - 2.62 0.0043 0.345 0.0573 
THC231847
4 A_32_P46456 - - 2.59 0.0018 0.244 0.1865 
ENST00000
334827 A_23_P435904 - - 2.59 0.0077 0.315 0.0845 
CXorf38 A_24_P36745 - - 2.54 0.0088 0.411 0.0216 
A_32_P100
475 A_32_P100475 - - 2.50 0.0000 0.195 0.2923 
A_32_P190
864 A_32_P190864 - - 2.46 0.0089 0.545 0.0015 
BC044628 A_32_P117453 - - 2.42 0.0003 0.492 0.0050 
BX101252 A_32_P56463 - - 2.41 0.0086 0.477 0.0067 
AI431972 A_32_P165823 - - 2.36 0.0034 0.334 0.0662 
A_24_P929
279 A_24_P929279 - - 2.35 0.0031 0.314 0.0856 
KBTBD11 A_23_P94319 - - 2.34 0.0064 0.314 0.0859 
THC231913
8 A_32_P27097 - - 2.23 0.0000 0.194 0.2957 
LOC647131 A_32_P88905 - - 9.04 0.0020 0.639 0.0001 
THC234495
6 A_23_P35546 - - 6.81 0.0011 0.351 0.0525 
AK125361 A_24_P245838 - - 5.92 0.0022 0.446 0.0118 
ENST00000
357283 A_24_P186401 - - 5.48 0.0033 0.583 0.0006 
C15orf37 A_32_P85330 - - 4.63 0.0084 0.506 0.0037 
FAM102A A_23_P112531 - - 3.53 0.0058 0.347 0.0559 
AK022016 A_24_P762767 - - 3.52 0.0035 0.282 0.1241 
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LOC200312 A_32_P420563 - - 3.51 0.0000 0.268 0.1450 
THC234106
0 A_32_P174629 - - 3.49 0.0077 0.493 0.0049 
AA344632 A_32_P29140 - - 3.17 0.0065 0.478 0.0065 
THC231735
3 A_24_P748389 - - 3.17 0.0065 0.391 0.0295 
WDR89 A_24_P301186 - - 3.12 0.0000 0.328 0.0715 
U92817 A_23_P44534 - - 3.11 0.0025 0.453 0.0105 
AK023663 A_32_P83256 - - 3.10 0.0091 0.502 0.0040 
GRRP1 A_23_P46131 - - 3.10 0.0041 0.423 0.0176 
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Table 5.2: Fold differences and correlations of statistically significant (p < 0.01) normalized gene expression of the top 100 
down-regulated probe sets between the high-soreness and low-soreness individuals. Continued onto next few pages. 
Gene Symbol Probeset ID Full Name Biological and Molecular Processes 
Fold-
Change 
(FC) 
p-value 
(FC) 
Correla-
tion ( r ) 
p-value 
( r ) 
Extracellular Region 
      
EXOC6 A_32_P58280 
Exocyst complex 
component 6 
Erythrocyte differentiation, Vesicle 
docking exocytosis, -2.13 0.01 -0.13 0.50 
FAM108A1 A_24_P324563 
Alpha/beta 
hydrolase domain-
containing protein 
17A Hydrolase activity, Protein binding -2.09 0.01 -0.08 0.67 
MLN A_23_P19523 Promotilin 
Cell-cell signaling, G-protein 
coupled receptor pathway, Hormone 
activity, Receptor binding -3.19 0.01 0.23 0.20 
UCN3 A_23_P136184 Urocortin-3 
Adenylate cyclase-activation G-
Protein coupled receptor signaling 
pathway, Cellular response, 
Corticotropin-releasing hormone 
receptor 2 binding, Hormone activity -1.52 0.00 -0.10 0.59 
Plasma membrane 
      
BBS7 A_23_P252913 
Bardet-Biedl 
syndrome 7 protein 
Organ development, Protein 
localization, Smoothened signaling 
pathway, Protein binding -2.27 0.00 0.26 0.15 
CDRT15 A_24_P756766 
CMT1A duplicated 
region transcript 15 
protein-like protein Unknown -1.52 0.00 0.09 0.61 
C9orf71 A_24_P132633 
Transmembrane 
protein 252 Unknown -1.38 0.00 -0.11 0.57 
ENST00000229
088 A_32_P206050 
TBC1 domain 
family member 30 Rab GTPase activator activity -1.50 0.00 -0.22 0.24 
ENST00000229
088 A_32_P206050 
TBC1 domain 
family member 30 GTPase activator activity -1.50 0.00 -0.22 0.24 
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ITGB8 A_24_P273599 Integrin beta-8 
Cell adhesion, Cell Matrix Adhesion, 
Extracellular matrix organization, 
Integrin mediated signaling pathway, 
Placenta blood vessel development, 
Receptor activity -1.75 0.00 -0.20 0.27 
PAPPA A_23_P216742 Pappalysin-1 
Cell differentiation, Glucocorticoid 
Stimulus, Endopeptidase Activity, 
Proteolysis, Zinc ion binding, 
Metallopeptidase activity -2.36 0.00 -0.07 0.70 
PKD1 A_24_P477127 
Serine/threonine-
protein kinase D1 
Carbohydrate binding, Neuropeptide 
signaling pathway -1.91 0.00 -0.08 0.68 
SEMA3F A_23_P6878 Semaphorin-3F 
Receptor activity, Multicellular 
organismal development  -1.54 0.00 0.14 0.44 
SLC6A7 A_23_P343766 
Sodium-dependent 
proline transporter 
Transmembrane transport, 
Neurotransmitter: sodium symporter 
activity, Proline transport -1.71 0.00 -0.09 0.64 
SLC26A3 A_23_P123228 
Solute carrier 
family 26, member 
3, isoform CRA_a 
Sulfate transport, Anion antiporter 
activity -1.41 0.00 -0.03 0.89 
TAS2R48 A_23_P340308 
Taste receptor type 
2 member 19 
Sensory perception of taste, Protein 
coupled receptor activity -1.66 0.00 -0.18 0.34 
TMUB2 A_23_P36647 
Transmembrane 
and ubiquitin-like 
domain-containing 
protein 2 Unknown -1.43 0.00 -0.12 0.52 
Cytosolic 
       
ACRV1 A_23_P202894 
Acrosomal protein 
SP-10 
Multicellular organismal 
development -1.38 0.00 0.04 0.83 
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BAG4 A_23_P146217 
BAG family 
molecular 
chaperone 
regulator 4 
Cellular response to tumor necrosis 
factor, Negative regulation of 
apoptotic process, Positive regulation 
of fibroblast migration, Positive 
regulation of cell adhesion, Positive 
regulation of protein kinase B 
signaling cascade, Positive regulation 
of protein kinase B signaling 
cascade, Chaperone binding, -2.10 0.00 -0.20 0.28 
BBS7 A_23_P252913 
Bardet-Biedl 
syndrome 7 protein 
Organ development, Smoothened 
Signaling pathway -2.27 0.00 0.26 0.15 
CIB4 A_23_P56913 
Calcium and 
integrin-binding 
family member 4 Calcium ion binding -1.56 0.00 -0.25 0.17 
CMAH A_23_P351467 
Putative cytidine 
monophosphate-N-
acetylneuraminic 
acid hydroxylase-
like protein 
CMP-N-acetylneuraminate 
monooxygenase activity, Iron-sulfur 
cluster binding -1.54 0.00 -0.12 0.53 
C11orf60 A_23_P116207 
Intraflagellar 
transport protein 46 
homolog 
Intraflagellar transport, Protein 
stabilization, Protein C-terminus 
binding -1.33 0.00 -0.09 0.63 
C16orf44 A_23_P88802 
Kelch-like protein 
36 Protein ubiquitination -1.70 0.01 0.36 0.05 
DDX19B A_23_P140994 
ATP-dependent 
RNA helicase 
DDX19B 
ATP binding, ATP-dependent 
helicase, Nucleic acid binding, 
Protein transport, mRNA export from 
nucleus, -1.54 0.00 -0.04 0.84 
EEF2 A_24_P87763 Elongation factor 2 
GTP binding, GTPase , Translation 
elongation factor activity -2.01 0.00 -0.18 0.34 
EXOD1 A_23_P129717 
ERI1 
exoribonuclease 2 
Exonuclease activity, Nucleic acid 
binding, Zinc ion binding -1.96 0.00 -0.36 0.04 
KIAA0652 A_23_P95292 
Autophagy-related 
protein 13 
Autophagic vacuole assembly, 
Protein binding, Protein kinase 
binding  -1.54 0.01 -0.22 0.23 
KIAA1967 A_24_P38446 
DBIRD complex 
subunit KIAA1967 
Apoptotic processes, Enzyme 
inhibitor activity -1.40 0.00 0.10 0.58 
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MKRN3 A_23_P21333 
Probable E3 
ubiquitin-protein 
ligase makorin-3 
Protein ubiquination, Ligase activity, 
Protein binding, Zinc ion binding -2.35 0.00 -0.31 0.09 
OR5H1 A_24_P366566 
Olfactory receptor 
5H1 
G-protein coupled receptor activity, 
Olfactory receptor activity -1.38 0.00 -0.23 0.20 
PLEKHA7 A_24_P109487 
Pleckstrin 
homology domain-
containing family 
A member 7 Phospholipid binding, Cell junction -2.96 0.00 -0.11 0.55 
PRKAA2 A_23_P60811 
5' AMP-activated 
kinase catalyic 
subunit alpha-2 
Autophagy, Metabolic processes, 
Cellular response to nutrient levels, 
Lipid & Cholesterol biosynthesis, 
Regulation of glycolysis, Protein 
phosphorylation, Signal transduction, 
Wnt receptor signaling pathway, 
ATP binding, Chromatin binding, 
Protein binding, Metal ion binding   -1.97 0.01 0.13 0.49 
PSMD3 A_24_P289726 
26S proteasome 
non-ATPase 
regulatory subunit 
3 
Regulation of proteasomal ubiquitin-
dependent catabolic processes, 
Regulation of apoptotic processes, 
Regulation metabolic processes, 
Gene expression, Mitotic cell cycle, 
Protein polyubiquitination -1.52 0.00 -0.15 0.44 
RIOK3 A_23_P55578 
Serine/threonine-
protein kinase 
RIO3 
ATP binding, Catalytic activity, 
Protein binding, Chromosome 
segregation -1.41 0.00 0.03 0.88 
RUNDC2A A_24_P150665 Sorting nexin-29 
Cell communication, 
Phosphatidylinositol binding -2.75 0.00 -0.20 0.29 
ZCCHC14 A_24_P176484 
Zinc finger CCHC 
domain-containing 
protein 14 
Cell communication, Nucleic Acid 
binding, Phosphatidylinositol 
binding, Zinc ion binding -2.22 0.00 0.12 0.51 
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Cytosolic, Cytoskeleton 
      
EVL A_23_P129038 
Ena/VASP-like 
protein 
Profilin binding, Organ development, 
Cell surface receptor signaling 
pathway, Actin filament 
organization, Axon guidance,  -1.53 0.00 -0.04 0.83 
KIAA1731 A_32_P31256 
Centrosomal 
protein KIAA1731 Unknown -2.06 0.00 -0.12 0.52 
Endoplasmic reticulum 
      
CYP4A11 A_24_P191013 
Cytochrome P450 
4A11 
Electron carrier activity, Heme 
binding, Iron ion binding, 
Monooxygenase activity, 
Oxidoreductase activity, Small 
molecule metabolic processes,  -1.53 0.00 0.14 0.44 
CYP3A7 A_23_P358917 
Cytochrome P450 
3A7 
Metabolic processes, Aromatase 
activity, Heme binding, Electron 
carrier activity, Iron binding, Oxygen 
binding,  -2.01 0.00 -0.17 0.37 
ENST00000378
624 A_23_P44781 
Threonylcarbamoyl
adenosine tRNA 
methylthiotransfera
se 
RNA modification, tRNA 
processing, Metal ion 
binding,transferase activity -2.05 0.00 -0.42 0.02 
MCFD2 A_24_P103060 
Multiple 
coagulation factor 
deficiency protein 
2 
Post-translational protein 
modification, Protein transport, 
Metabolic processes, Calcium ion 
binding, Vesicle mediated transport -2.88 0.00 -0.37 0.04 
Mitochondrion 
       
ARS2 A_24_P383080 
Alanine--tRNA 
ligase, 
mitochondrial 
Gene expresison, tRNA 
aminoacylation, tRNA ligase 
activity, Metal ion binding, tRNA 
binding -1.94 0.00 -0.11 0.56 
SARDH A_24_P35400 
Sarcosine 
dehydrogenase, 
mitochondrial 
Aminomethyltransferase activity, 
Oxidoreductase activity, Glycine 
catabolic  process -1.87 0.00 -0.20 0.28 
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Nucleus 
       
BUB3 A_23_P46924 
Mitotic checkpoint 
protein BUB3 
Regulation of chromosome 
segregation -1.49 0.00 -0.10 0.59 
DLG7 A_23_P88331 
Disks large 
homolog 7 
Cell proliferation, Cell-cell signaling, 
M phase of mitotic cell cycle, 
Positive regulation of mitosis 
transitions, Phosphoprotein 
phosphatase activity, Protein binding, -1.68 0.00 -0.10 0.60 
ENST00000265
271 A_24_P927222 
RNA-binding 
protein 27 
mRNA processing, Metal ion 
binding, Nucleotide binding, RNA 
binding -1.41 0.00 -0.10 0.58 
HELB A_23_P2294 DNA helicase B 
DNA replication, DNA helicase 
activity,  DNA polymerase, ATP 
binding -2.14 0.00 -0.17 0.37 
MAFK A_23_P111698 
Transcription 
factor MafK 
Sequence specific binding, DNA-
dependent transcription, Blood 
coagulation, DNA transcription 
factor activity -1.36 0.00 0.00 0.98 
MBNL1 A_24_P128057 
Muscleblind-like 
protein 1 
Metal ion binding, Regulation of 
mRNA splicing, Skeletal muscle 
tissue development -1.77 0.01 0.10 0.58 
POLD3 A_24_P75056 
DNA polymerase 
delta subunit 3 
DNA dependent replication, DNA 
repair, Mitotic cell cycle, Telomere 
maintenance,  -1.56 0.00 -0.10 0.59 
SAPS3 A_24_P261488 
Serine/threonine-
protein 
phosphatase 6 
regulatory subunit 
3 
Regulation of phosphoprotein 
phosphatase activity, Protein 
188hosphatase binding, Protein 
binding -1.51 0.00 0.01 0.94 
SIM1 A_23_P214743 
Single-minded 
homolog 1 
Cell differentiation, DNA dependent 
transcription, DNA binding, Protein 
heterodimerization activity, 
Sequence specific DNA binding 
transcription factor activity, Signal 
transducer activity -1.59 0.00 -0.21 0.26 
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TLK2 A_23_P38365 
Serine/threonine-
protein kinase 
tousled-like 2 
ATP binding, serine/threonine kinase 
activity -1.61 0.00 -0.09 0.63 
VCP A_24_P127828 
Transitional 
endoplasmic 
reticulum ATPase 
Aggresome assembly, Positive 
regulation of proteosomal ubiquitin-
dependent catabolic process, ATPase 
activity, Polyubiquitin binding,  -1.91 0.00 -0.08 0.67 
XRCC3 A_23_P48470 
DNA repair protein 
XRCC3 
Response to organic substance, DNA 
metabolic processes, ATP binding, 
DNA binding -1.75 0.00 -0.11 0.55 
ZIM2 A_23_P78479 
Zinc finger 
imprinted 2 
DNA dependent transcription, DNA 
binding, Zinc ion binding -1.47 0.00 0.02 0.91 
ZNF621 A_24_P340800 
Zinc finger protein 
621 
Regulation of transcription, DNA 
binding, Metal ion binding -4.75 0.00 -0.39 0.03 
ZNF664 A_24_P232659 
Zinc finger protein 
664 
Regulation of transcription, DNA 
binding, Metal ion binding,  -1.34 0.00 0.03 0.88 
ZNF670 A_23_P74981 
Zinc finger protein 
670 
Regulation of transcription, Nucleic 
acid binding -1.83 0.00 0.00 0.99 
ZNF585A A_23_P90220 
Zinc finger protein 
585A 
Regulation of transcription, Metal 
ion binding, Nucleic acid binding, -2.73 0.00 -0.08 0.68 
 
Unknown transcripts Unknown Unknown 
    A_23_P300563 A_23_P300563 " " " " -1.35 0.00 0.03 0.87 
A_24_P152566 A_24_P152566 " " " " -2.02 0.00 -0.13 0.47 
A_24_P187365 A_24_P187365 " " " " -1.41 0.00 -0.06 0.77 
A_24_P316059 A_24_P316059 " " " " -1.58 0.00 -0.07 0.70 
A_24_P75408 A_24_P75408 " " " " -2.04 0.00 -0.22 0.22 
A_24_P934975 A_24_P934975 " " " " -2.84 0.01 0.29 0.11 
A_32_P208533 A_32_P208533 " " " " -1.58 0.00 -0.02 0.91 
A_32_P44932 A_32_P44932 " " " " -1.53 0.00 0.06 0.74 
AK094167 A_23_P344655 " " " " -1.70 0.00 -0.12 0.50 
AK096129 A_24_P247872 " " " " -1.57 0.00 -0.22 0.23 
AK097351 A_32_P188850 " " " " -2.75 0.00 -0.15 0.41 
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AK097371 A_24_P661612 " " " " -3.22 0.00 0.12 0.51 
ATXN7L4 A_23_P356109 " " " " -1.82 0.00 -0.15 0.41 
BC034812 A_32_P125803 " " " " -1.42 0.00 -0.01 0.95 
BF928446 A_32_P136588 " " " " -1.34 0.00 0.10 0.59 
BQ064481 A_32_P163937 " " " " -1.45 0.00 -0.22 0.23 
CA420688 A_24_P602052 " " " " -1.44 0.00 0.13 0.48 
CN418636 A_24_P935045 " " " " -2.66 0.01 0.13 0.47 
ENST00000280
576 A_32_P228268 " " " " -2.47 0.01 -0.20 0.28 
ENST00000310
146 A_24_P417831 " " " " -1.63 0.00 -0.04 0.83 
ENST00000377
226 A_24_P494425 " " " " -1.73 0.00 0.00 0.98 
ENST00000379
870 A_32_P69475 " " " " -1.46 0.00 -0.05 0.78 
ENST00000379
879 A_32_P51988 " " " " -3.91 0.00 -0.19 0.32 
FLJ30851 A_24_P169386 " " " " -2.19 0.00 -0.26 0.16 
KIAA1875 A_24_P282363 " " " " -2.44 0.00 -0.19 0.31 
LOC339105 A_24_P73817 " " " " -1.67 0.00 -0.19 0.30 
LOC390211 A_24_P890995 " " " " -2.93 0.00 0.00 0.99 
LOC401351 A_32_P123804 " " " " -1.80 0.00 0.04 0.82 
MAGEB4 A_24_P83272 " " " " -1.47 0.00 -0.15 0.43 
QSER1 A_23_P139059 " " " " -1.45 0.00 0.06 0.74 
T75585 A_24_P536974 " " " " -1.56 0.00 -0.22 0.24 
THC2280383 A_32_P128974 " " " " -2.86 0.01 0.04 0.82 
THC2316466 A_24_P681250 " " " " -1.86 0.00 -0.25 0.17 
THC2344984 A_32_P184667 " " " " -1.40 0.00 -0.17 0.36 
THC2391003 A_32_P226449 " " " " -2.01 0.00 -0.02 0.90 
THC2406779 A_32_P81806 " " " " -1.68 0.00 0.01 0.96 
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THC2420896 A_24_P600371 " " " " -1.41 0.00 -0.22 0.24 
U85992 A_24_P17011 " " " " -1.46 0.00 -0.07 0.73 
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CHAPTER 6 
SUMMARY 
Introduction 
The studies presented in this dissertation answered the following questions: 1) 
What is the effect of a single muscle biopsy and repeated muscle biopsies on skeletal 
muscle soreness? 2) Is the muscle soreness resultant from a biopsy similar to eccentric 
exercise muscle soreness? 3) What are the effects of a single and repeated bout of stair 
descent exercise on extracellular matrix selected gene expression, protein expression, and 
zymography at 24 h after exercise bout? and 4) Does a systems biology approach identify 
novel genes and or pathways that are associated with high soreness responders compared 
to low soreness responders? This chapter will provide a summary of how these questions 
were examined, the results from these studies, and suggestions for future research. 
Study 1 
Specific Aim: To examine the effects of a single and repeated muscle biopsies 
compared to eccentric exercise on muscle soreness  
Muscle biopsy procedures are commonly used to examine the underlying 
molecular mechanisms of muscle soreness. Although muscle biopsy procedures are often 
used in kinesiology research, little information is known regarding the effects of a biopsy 
on muscle soreness and daily physical activity, both of which could confound 
interpretation of study results. Muscle soreness was examined using the visual analog 
scale and two tasks (e.g. stand-to-sit-to stand and stair descent), two questionnaires (the 
Brief Pain Inventory Short Form and the McGill Pain questionnaire) and on daily 
physical activity using an activity monitor and daily physical activity levels in 12 healthy 
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adults (6 men and 6 women) after a single muscle biopsy of the vastus lateralis. Muscle 
soreness was measured prior to the muscle biopsy and at 24 h intervals until 120 h.  
Hypothesis #1: A skeletal muscle biopsy will produce a significant elevation in 
muscle soreness. 
The rationale for this hypothesis is that because the extracellular matrix (ECM) is 
a scaffold for fine nerve endings, a muscle biopsy will disrupt the ECM and likely affect 
the fine nerve endings (34,39). The results from Study 1 show that there was a significant 
increase in muscle soreness after the biopsy (23%), but that this soreness was less and 
resolved earlier than that reported for a moderate bout of eccentric exercise soreness (40–
80%) (6,10,19). Therefore, when researchers are studying the underlying mechanisms of 
muscle soreness, they should account for a modest increase in muscle soreness due to the 
biopsy. 
Hypothesis #2: A muscle biopsy and eccentric exercise would produce significantly 
greater levels of delayed onset muscle soreness (DOMS) compared to a muscle 
biopsy alone in skeletal muscle. 
In support of this hypothesis, the first hypothesis found that muscle soreness after 
a biopsy was lower compared to previously reported soreness values after eccentric 
exercise (19). We examined muscle soreness from the control group and the exercise 
group and found that muscle soreness was less for the control group after a muscle biopsy 
compared to the exercise group at 24 h post-biopsy/exercise. Furthermore, we also found 
that after a repeated bout of exercise the soreness levels from the exercise group were not 
significantly different from the control group soreness levels. This study shows that 
muscle biopsy soreness levels are significantly lower than after a bout of naïve exercise, 
but similar to the soreness level after a repeated bout of exercise. 
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Hypothesis #3: A skeletal muscle biopsy will produce a significant decrease in 
physical activity. 
The rationale for this hypothesis is that studies of patients recovering from 
surgery have found that physical activity measured using activity monitors increased as 
the patients recovered from the surgery (20,33,49). And because a muscle biopsy is a 
minor surgery (46), we thought that the physical activity monitors would provide a 
quantitative measure of how the muscle biopsy affected the subjects’ daily life. I found 
that there were no differences in physical activity levels (sedentary, light, moderate, and 
vigorous) after a muscle biopsy compared to baseline. There was a significant decrease in 
steps and physical activity count. However, subjects were instructed to take it easy after 
the muscle biopsy, and these results reflect their adherence to the post-biopsy instructions 
and are likely not indicative of muscle soreness affecting their daily activity level. 
Study 2 
Specific Aim: To examine the effects of a single and repeated bout of eccentric 
exercise on ECM genes, proteins, and zymography 
After a second bout of eccentric exercise, the muscle becomes “accustomed” to 
the strain, such that there is less soreness and strength loss in response to a repeated bout 
(9,32). Stauber et al. (42) showed that in cross sections from skeletal muscle biopsy 
samples, the tight packing of the muscle fibers were widened, and thus the ECM 
appeared to be disrupted after eccentric exercise. While that study did not investigate 
specific components of the ECM, others have shown that a few molecules of the ECM 
are affected by eccentric exercise (11,12,27,28,38). Expression of laminin, collagens, and 
integrins have been shown to be increased after stretching or exercise (1,22,36). Focal 
adhesion kinase (FAK) phosphorylation has been linked to activating second messengers 
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(e.g. PI3K), which promote muscle synthesis. FAK phosphorylation has been found to 
increase after exercise. Present studies on the ECM (11,12,27,28,38) have focused on 
molecular changes that occurred 2–10 d post-exercise, or if they examined earlier time 
points it was using an endurance exercise model (38) instead of eccentric exercise. It is 
possible that the muscle adaptation to eccentric exercise has begun as early as 48 h (40) 
and is evident by 120 h (15). In addition to exercise causing an increase in mRNA and 
protein expression levels, exercise has also been shown to increase gelatinolytic activity 
of matrix metalloproteinases (MMPs) (7,38). However, the studies on MMPs only 
investigated MMPs in response to endurance exercise(37,38). At present, only one study 
has investigated changes in the ECM molecules after a repeated bout (27), but they 
electrically stimulated (eSTIM) the muscle to perform the eccentric exercise. To 
understand the role of the ECM in muscle adaptation, the ECM must be examined after a 
single and repeated bout of eccentric exercise without electrical stimulation, especially 
since the repeated eSTIM bout did not confer a repeated bout effect for muscle soreness 
(27). To examine these alterations in Study 2, eight individuals (4 men and 4 women, 
exercise group) descended 10 flights of stairs 15 times. They repeated this exercise two 
weeks later. At 24 h after each bout of exercise, the subjects had a muscle biopsy of the 
vastus lateralis. A baseline muscle biopsy was collected one week prior to the first 
exercise bout. Four additional individuals (2 men and 2 women, control group) were 
recruited for this study and served as controls.  All subjects were recruited at the same 
time and then randomized into the exercise or control group. The control group did not 
complete the exercise, but had a muscle biopsy at the same time points as the exercise 
group. Muscle biopsies were analyzed at both the message (qRT-PCR analysis) and 
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signal (western blotting and zymography) level to identify changes in gene expression 
and respective protein products of the selected ECM targets proposed to promote skeletal 
muscle adaptation to eccentric exercise. 
Hypothesis: ECM remodeling molecules (MMP9, MMP2, TIMP1, TIMP2, and 
TNC) and mechanotransduction molecules (ITGA7, ITGB1, COL3, COL4, and 
LAMA2) are involved in the adaptation process that occurs after a single bout of 
exercise and provide protection to the muscle after a second bout. 
In support of this hypothesis we found that skeletal muscle ECM is affected by an 
acute bout of eccentric exercise, and that the expression of MMP9, tenascin-C (TNC), 
collagen 3, and integrin α7 likely contribute to this adaptation. We found that TNC was 
one of the four genes that were significantly changed at 24 h after eccentric exercise. 
Furthermore, the expression was significantly blunted at 24 h after a repeated bout of 
exercise compared to Bout 1. Aside from the time point used, these results are not novel, 
but confirm work by Mackey et al. (27) who showed that TNC mRNA and protein 
expression at 48 h was elevated after a single bout of eccentric exercise via eSTIM and 
then reduced after a repeated bout of eccentric exercise via eSTIM.   
The expression of MMP9 mRNA was significantly different between men and 
women, and a trend (p=0.08) for group (e.g. exercise and control) differences was found. 
Combining the exercise and control group mRNA levels after Bout 1, we found that men 
had a 2.1-fold increase in MMP9 gene expression, and women had a 1.8-fold decrease. 
MMP9 is secreted by neutrophils (25) and leukocytes (24), and MMP9 has been 
correlated to activation of neutrophils (25) and recruitment of pro-inflammatory 
macrophages (24). In view of previous work showing differences in inflammation 
between men and women after exercise (26,43,44), the differential regulation of MMP9 
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found in the current study is not surprising and would also explain the differences in 
mRNA levels between men and women after an acute and repeated bout of exercise. 
While we were not sufficiently powered to detect differences between men and women, 
this study provides compelling data that suggest there is a difference between MMP 
levels in men and women after eccentric exercise. At present, this is the first study to 
investigate the changes in MMP9 mRNA in skeletal muscle after eccentric exercise in 
humans.  
To our knowledge, this is the first study to show an increase in integrin α7 
(ITGA7) mRNA in humans. Our increase in integrin α7 mRNA after a single bout of 
exercise is consistent with animal research showing acute increases in mRNA after 
exercise (4,5). However, we found a decrease in the protein level of α7 integrin at this 
same time point (Bout 1/MB2), and these results do not support previous research (4,5). 
But we identified three isoforms (7X12X2B, 7X1B, and 7X2B) of integrin α7 being 
expressed in the exercise and control individuals. The 7X2B isoform of integrin α7 was 
the protein that we found to decrease at MB2 and return to baseline at MB3. This isoform 
has an extracellular domain, and animal and cell literature indicate that the isoforms bind 
to different extracellular molecules, promote clustering of focal adhesion molecules, and 
initiate phosphorylation cascades (2,5,41). It is likely that the observed changes in protein 
levels for α7 integrin after Bout 1/MB2 are actually related to the baseline muscle biopsy 
(MB1) and not due to the exercise, as both the control and exercise group showed this 
decrease.  
Finally, we found mRNA expression of collagen type 3A1 (COL3) in skeletal 
muscle to be higher in women after a single bout of exercise compared to baseline, a 
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repeated bout, and in men after a single bout. These results suggest that remodeling after 
eccentric exercise may be initiated earlier in women than men as shown by the elevated 
mRNA levels for COL3 in women after Bout 1 compared to men. However, at baseline, 
women had significantly lower levels of COL3 mRNA compared to men. I must again 
state that we were not sufficiently powered to detect differences between men and 
women, but our data are in agreement with results from studies examining COL3 and 
differences between men and women (17,18,45). 
Overall, these results confirm only one aspect of our initial hypothesis, as we 
found TNC to be increased after Bout 1, decreased after Bout 2, and it was correlated to 
muscle soreness. We did not find any changes in skeletal muscle zymography levels at 24 
h after a single or repeated bout of exercise. But we did identify that TNC was not 
correlated to peak soreness from a muscle biopsy, and therefore its expression is related 
to eccentric exercise, and potentially, the adaptation process as it was decreased in Bout 2 
for the exercise group. While we were not sufficiently powered to detect sex differences, 
our data suggest that the mRNA expression levels of MMP9 and COL3 were 
differentially regulated between men and women after eccentric exercise. Finally, we 
identified that three isoforms of integrin α7 are expressed in humans via western blotting, 
and that the expression is likely very sensitive to eccentric actions because both the 
exercise and control groups showed a decrease in the 7X2B isoform after MB2 compared 
to MB1. The leg that was biopsied in MB2 was not biopsied in MB1, and it is likely that 
subjects relied on the non-biopsied leg when sitting, descending stairs, or bending down 
to pick something up after MB1. These subjects may have inadvertently performed 
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eccentric exercise with this muscle and initiated the expression change we observed at 
MB2.  
Study 3 
Specific Aim: To examine delayed onset muscle soreness 
 using a systems approach 
To examine further the relationship of soreness and the ECM, this experiment 
analyzed existing microarray data in a novel way. Presently, 14 microarray studies 
(3,8,13,14,16,21,23,29–31,35,47,48), aside from the recent study performed in our lab 
(19), have been published that investigated human skeletal muscle after eccentric exercise. 
The goal of many of these previous microarray studies was to identify novel targets 
differentially regulated after eccentric exercise. While these previous microarray studies 
informed the targeted approach used in Study 2, none of the studies used a systems 
approach to identify targets associated with muscle soreness. To identify novel targets 
and pathways associated with muscle soreness I used microarray data collected in our lab 
from a previous study (19). This study had 30 men with viable RNA for microarray 
analysis, and these subjects performed one bout of eccentric exercise (100 unilateral 
contractions) on the Biodex® dynamometer and had a muscle biopsy taken 3 h after the 
exercise bout. The non-exercised leg was also biopsied and used as a control. The peak 
soreness response reported at 24 h or 48 h post-eccentric exercise was clustered using 
hierarchical cluster analysis to identify soreness response clusters. Of the 30 males, five 
clustered into a high-soreness group (HSG) and seven clustered into a low-soreness group 
(LSG). The microarray data were log transformed, and then each subject’s exercised leg 
was normalized to the control leg. An ANOVA was performed on the microarray data 
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between the HSG and LSG using Partek Genomics Suite software (Version 6.4), and the 
outputs were filtered on p-value (p=0.01). These results were then uploaded into 
Ingenuity Pathway Analysis (IPA) to identify novel targets associated with muscle 
soreness after eccentric exercise.  
Hypothesis: The high-soreness individuals would have a unique set of differentially 
regulated genes compared to the lower-soreness individuals. 
Of the 41,000 genes that were differentially regulated after eccentric exercise 
compared to the control leg at p <0.05 using microarray analysis, 1517 genes were 
differentially regulated in individuals with high soreness compared to those with low 
soreness. However, using IPA, we wanted to identify only the most significant 
differentially regulated networks and novel genes, so we used a more stringent p-value (p 
<0.01) that yielded 546 differentially regulated genes. Of the 546 genes, the up-regulated 
genes were more robustly altered (10 genes were up-regulated by at least 4.2-fold) than 
the down-regulated genes (the top gene [ZNF44] was down-regulated by 3.3-fold) in the 
HSG relative to the LSG. The top target, serine protease inhibitor Kazal-type 1 (SPINK1), 
was differently up-regulated by 18.67-fold, and the second target, sperm-associated 
antigen (SPAG1), was up-regulated by 8.10-fold. 
Limitations 
The studies presented in this dissertation have several limitations that should be 
taken into account when interpreting the results or designing future experiments. Studies 
2 and 3 in particular have several limitations that must be addressed. A major limitation 
for both studies was the availability of skeletal muscle biopsy material obtained for 
analysis. At each muscle biopsy we were able to collect 100–175 mg of muscle tissue. In 
  
 
201 
Study 2, the analysis of the nine genes via qRT-PCR analysis and 11 proteins in Study 2 
required 25–50 mg of tissue for each analysis technique. And zymography required 25–
50 mg of muscle tissue. The amount of muscle tissue was problematic in the 
zymography. Because zymography had to be in replicated, the analysis was performed on 
a subset of subjects (n=7 exercise and n=3 control) for two of the time points analyzed 
(control and Bout 2). In Study 3, although I had access to the published microarray data, I 
was unable to perform any confirmational analysis on these samples due to a lack of 
muscle tissue available for RNA isolation and subsequent qRT-PCR analysis.  
The reported changes in gene and protein expression from Study 2 must be 
viewed with caution, because it is possible that changes shown in the Bout 1 and Bout 2 
biopsy data may not be due to the acute bout of exercise. For example, the control and 
exercise group changed from baseline in the same direction despite the exercise session 
24 h prior to the muscle biopsy in the exercise group. 
Factors that affected the analysis included the variability in response observed 
between men and women at the gene and protein expression level as evident in the 
MMP9 and COL3 mRNA results. It was thought that the exercise would produce changes 
in gene and protein expression in the same direction (e.g. both men and women down-
regulated the gene), but that the magnitude of change might be different. However, we 
found that both direction and magnitude were different between men and women for the 
control and exercise group at baseline/MB1, Bout 1/MB2, and Bout 2/MB3. The results 
indicate that although measures of muscle function (e.g. immediate strength loss or peak 
muscle soreness) after eccentric exercise are not different between men and women, the 
underlying mechanisms to muscle adaptation may be.   
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Finally, in Study 2 all subjects were randomized to having their left or right leg 
biopsied at baseline, resulting in the contralateral leg being biopsied in Bout 1 and Bout 
2. The control and exercise groups were balanced for left or right leg biopsies at baseline. 
While all subjects were right-leg dominant, the stair descent exercise that subjects 
performed resulted in them always making a right turn to descend the next flight of stairs, 
and it is possible that the workload to each leg during that exercise was unequal. This 
may explain the differences seen for INTGA7 mRNA levels between leg for Bout 1 and 
Bout 2. Because I had collected muscle soreness data on the left and right leg after the 
exercise, I was able to determine if the exercise resulted in a significant difference in 
muscle soreness development between legs, but as shown in Figures 2A and 3A of Study 
2 at 24 h, the range of muscle soreness indicates that there was not a difference in muscle 
soreness between legs. However, the measurement of muscle soreness may not be 
sensitive enough to detect a difference between legs and therefore we believe that the 
observed differences in mRNA levels between legs are not spurious.  
Future Directions 
The overall findings from these three studies suggest that muscle soreness 
development due to eccentric exercise is different from a minor surgery, and that the 
variability in muscle soreness levels is likely due to the expression and depression of 
specific genes. Studies examining muscle soreness treatments via muscle biopsies should 
be aware that the muscle biopsy introduces a 20% increase in recorded muscle soreness 
levels at 24 h post-biopsy.  
Future studies should include men and women in their analysis of muscle 
adaptation. The results from this study suggest that men and women have a different 
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muscle response to eccentric exercise at the molecular level. At present, very few studies 
have examined the response of skeletal muscle at the molecular level in men and women 
after eccentric exercise. This information would help both men and women use 
appropriate measures to promote muscle adaptation and recovery from a naïve and 
strenuous exercise or activity (e.g. snow shoveling or raking).  
The microarray analysis performed in Study 3 of the HSG and LSG found 546 
differentially expressed genes. This study has provided future researchers with many 
tools to generate new hypotheses regarding differences in soreness levels among 
individuals. 
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APPENDIX A 
SAMPLE SIZE ESTIMATES 
The sample size estimates below were calculated using the Cohen’s d Effect Size 
and Cohen’s f Effect Size to determine sample size estimates for Study 1 and Study 2. 
Because Study 1 was examining muscle soreness measures of all subjects it was expected 
that by calculating the effect size for Study 2, Study 1 would be more than sufficiently 
powered. We calculated effect size for Study 1 based on muscle soreness between 
baseline, Eccentric exercise bout 1, and Eccentric exercise bout 2. Study 2 had to be 
sufficiently powered to detect a difference in molecular outcomes (mRNA and protein 
levels) among baseline, Eccentric exercise bout 1, and Eccentric exercise bout 2.  
The Cohen’s d Effect Size calculation is the commonly used calculation, however 
it is only able to estimate a sample size for a paired t-test (e.g. pre vs. post) and the 
present study has at least 3 time-points (Baseline, Bout 1 and Bout 2) for analysis in 
Study 2. Therefore a second Effect Size calculation as used to ensure that the samples 
size estimate was appropriate for the present population and the time-points. The Cohen’s 
d Effect Sizes were input into the G*Power calculator (1) to determine the Effect Size for 
a paired t-test. The Cohen’s f Effect Sizes were input into the G*Power calculator to 
determine Effect Size for a repeated measures ANOVA between and within interactions 
group, based on 2 groups and 2 time points.  
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Table A.1: Calculating sample size estimate for muscle soreness. Please note  
all values (mean and SD) were derived or reported from Marginson et al. (4).    
Variable Exercise Group N=10 
Baseline muscle soreness –visual analog scale (VAS) 0 ± 0 
Bout 1 (24 hr Post-Exercise) muscle soreness VAS 5.7 ± 1.58 
Bout 2 (24 hr Post-Exercise) muscle soreness VAS 2.7 ± 1.58 
Effect Size (f) 1.054 
Sample Size Estimate 6.0 
Paired t-test Effect Size (d)  -1.33 
Paired t-test Sample Size Estimate (d) 7.0 
 
Table A.2: Calculating sample size estimate for tenascin-C  
immunohistochemistry protein. Please note all % values (mean and SD)  
were derived or reported from Crameri et al. (1). 
Variable 
Voluntary Exercise 
N=8 (left leg) 
Voluntary Exercise 
Time 1 (Baseline) 0% ± 0% 
Time 2 (6 hr Post-Exercise) 0.4% ± 0.3% 
Time 3 (24 hr Post-Exercise) 2.0% ± 0.7% 
rm ANOVA Effect Size (f)  1.745 
rm ANOVA Sample Size Estimate (f) 4 
Paired t-test Effect Size (d)  3.18 
Paired t-test Sample Size Estimate (d) 4 
 
 
Table A.3:  Calculating sample size estimate for CSRP mRNA. Please note all  
values (mean and SD) were derived or reported from Kostek et al. (3).  
Variable Exercise N=5 
Time 1 (Baseline- used to normalize Time 2 and 3) - 
Time 2 (4 hr Post-Exercise) 2.9 ± 0.67 
Time 3 (24 hr Post-Exercise) 4.2 ± 2.02 
rm ANOVA Effect Size (f) 1.7449 
rm ANOVA Sample Size Estimate 4.0 
Paired t-test Effect Size (d)  2.166 
Paired t-test Sample Size Estimate (d) 4.0 
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APPENDIX B 
BRIEF PAIN INVENTORY SHORT FORM 
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APPENDIX C 
MCGILL PAIN QUESTIONNAIRE 
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APPENDIX D 
QRT-PCR INDIVIDUAL AND MEAN RESULTS FOR CONTROL AND 
EXERCISE GROUP  
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Table D.1: Mean CT values from interplate calibrator (e.g. same subject) for qRT-PCR 
analysis.  
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APPENDIX E 
WESTERN BLOTTING: RAW VALUES, MEANS, AND BLOTS FOR CONTROL 
AND EXERCISE GROUP BY GEL 
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APPENDIX F 
ZYMOGRAPHY: RAW VALUES, MEANS, AND GELS FOR CONTROL AND 
EXERCISE GROUP BY GEL 
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APPENDIX G 
TOP 10 UP- AND DOWN-REGULATED GENES IN HSG VS. LSG 
 
Table G.1 Top 10 up-regulated genes in HSG vs. LSG, p <0.05. 
Gene 
HS  
Least Squares 
Mean 
LS  
Least Squares 
Mean p Value 
Fold 
Change 
SPINK1 4.4123 0.1910 0.001746 18.6770 
A-24-P937936 1.4125 -2.0566 0.041102 11.0743 
AQP9 2.0699 -1.3114 0.012575 10.4197 
ZNF708 1.1537 -2.1852 0.035606 10.1182 
LOC647131 4.0939 0.91780 0.001952 9.0377 
SPAG1 2.0527 -0.9667 0.008520 8.1084 
FGFR1 2.6307 -0.3868 0.018492 8.0975 
LRP8 2.1224 -0.8609 0.001000 7.9079 
RAB31P 1.6791 -1.2912 0.038268 7.8368 
SENP6 1.1058 -1.7903 0.033275 7.4443 	  
 
Table G.2 Top 10 down-regulated genes in HSG vs. LSG, p <0.05. 
Gene 
HS  
Least Squares 
Mean 
LS  
Least Squares 
Mean p Value 
Fold 
Change 
MTG1 -1.72782 0.53698 0.0188601 -4.80589 
ZNF621 -1.71472 0.53283 0.0010537 -4.784893 
WBP2 -0.966156 1.15275 0.0417093 -4.34364 
A1042062 -2.39327 -0.309382 0.0039793 -4.23949 
GPR137 -0.372891 1.6514 0.0177804 -4.06792 
SLC41A1 -1.44948 0.571611 0.0469249 -4.0589 
C21orf119 -1.86022 0.135117 0.0167561 -3.98709 
UBE2E1 -1.39578 0.59303 0.0302372 -3.96909 
CXorf21 -1.07156 0.911525 0.0454999 -3.95337 
A_24_P918454 -1.22839 0.740385 0.0107892 -3.91434 
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APPENDIX H 
TOP IPA NETWORK FUNCTIONS AND NETWORK SCORE 
 
Table H.1. Top IPA network functions and network score. 
Top Networks Score 
1. Carbohydrate metabolism, cardiovascular system development & function, 
tissue morphology 51 
2. Cell to cell signaling & interaction, cellular development, hematological 
system development & function 41 
3. Cancer, renal & urological disease, reproductive system disease 38 
4. Cellular compromise, infection mechanism, endocrine system disorders 34 
5. Nervous system development & function, cellular growth & proliferation, 
cellular movement 27 
6. Hematological System Development and Function, Tissue Morphology, 
Cellular Development 25 
7. Cancer, Gene Expression, Infection Mechanism 21 
8. Cellular Development, Gene Expression, Cell Death 20 
9. Gene Expression, Cell Morphology, Cellular Development 20 
10. Cellular Movement, Hematopoiesis, Immune Cell Trafficking 19 
11. Hematological System Development and Function, Immune Cell Trafficking, 
Inflammatory Response 18 
12. Cellular Development, Cellular Growth and Proliferation, Hematological 
System Development and Function 16 
13. Cell-To-Cell Signaling and Interaction, Hematological System Development 
and Function, Inflammatory Response 16 
14. Hematological System Development and Function, Immune Cell Trafficking, 
Inflammatory Response 15 
15. Gene Expression, Organismal Injury and Abnormalities, Cancer 13 
16. Gene Expression, Genetic Disorder, Hematological Disease 13 
17. Gene Expression, Cell Signaling, Cell Cycle 13 
18. Cellular Growth and Proliferation, Cell-To-Cell Signaling and Interaction, 
Lipid Metabolism 13 
19. Cell-To-Cell Signaling and Interaction, Embryonic Development, Hair and 
Skin Development and Function 11 
20. Lipid Metabolism, Small Molecule Biochemistry, Nucleic Acid Metabolism 2 
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